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Congenital heart disease (CHD) is defi ned as a developmental malformation 
of the heart chambers, valves or great vessels. The incidence of newborns 
with CHD has increased signifi cantly over the past century, thereby making 
CHD a major public health issue. The number of adult CHD patients has also 
increased in the past decades, as nowadays over 90% of pediatric patients 
survive into adulthood due to improved clinical care and surgical techniques. 
Although survival of CHD patients has been signifi cantly prolonged, many of 
them frequently experience complications such as rhythm disorders by the 
time they reach adulthood. These postoperative dysrhythmia may cause a 
wide range of symptoms, ranging from palpitations to even sudden cardiac 
death. Many of these late postoperative tachyarrhythmia are, however, 
insuffi  ciently controlled by antiarrhythmic drugs. Atrial pacing in order 
to prevent tachyarrhythmia is o en not eff ective. However, endovascular 
catheter ablation has arisen since the 1990s and both short- and long-term 
outcomes are promising. The high incidence of tachyarrhythmia in ageing 
patients with CHD and the improved mapping techniques over the years 
went together with increased knowledge of the underlying mechanism and 
improved outcome of ablative therapy. Another challenge is to elucidate 
the mechanism of atrial fi brillation (AF) in this study population, as the 
incidence of AF continues to rise in this ageing population. The aim of this 
thesis is to gain further insight into the pathophysiology of post-operative 
dysrhythmia in patients with CHD.
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General Introduction and Outline of the Thesis
General Introduction 13
GeneRaL inTRoDuCTion
Congenital heart disease (CHD) is defined as a developmental malformation of the heart 
chambers, valves or great vessels. The incidence of newborns with CHD has increased 
over the past century from 0.6 per 1000 live births in 1930, to 9.1 per 1000 live births after 
1995, thereby making CHD a major public health issue.(1) This development is caused 
by more accurate registration procedures and improved diagnostic tools (e.g. cardiac 
imaging techniques). However, there are still geographical differences in the prevalence 
of CHD birth rates, which can be explained by e.g. genetic or environmental factors.(1) 
The number of adult CHD patients has also increased in the past decades, as nowadays 
over 90% of pediatric patients survive into adulthood due to improved clinical care and 
surgical techniques.(2) Although survival of CHD patients has been significantly pro-
longed, many of them frequently experience complications such as rhythm disorders by 
the time they reach adulthood.(3) These postoperative dysrhythmia may cause a wide 
range of symptoms, ranging from palpitations to even sudden cardiac death.
Many of these late postoperative tachyarrhythmia are, however, insufficiently con-
trolled by antiarrhythmic drugs.(4) A lifetime usage of class III antiarrhythmic drugs such 
as amiodarone may result in less recurrences (5), but also increases the risk of adverse 
effects in the relatively young adult CHD patient, particularly in women with CHD, cya-
notic patients and patients with a Fontan circulation.(6) Atrial pacing in order to prevent 
tachyarrhythmia is often not effective.(7) However, endovascular catheter ablation has 
arisen since the 1990s and both short- and long-term outcomes are promising.(8)
Most studies reporting on late postoperative tachyarrhythmia in CHD patients de-
scribed the incidence of the various types of tachyarrhythmia, the outcome of different 
treatment modalities, and in case of ablative therapy, the mechanism of the tachyar-
rhythmia and the location of successful target sites for catheter ablation in small groups 
of patients with a variety of CHD.
atrial macro reentrant tachycardia
Atrial macro-reentrant tachycardia are the most frequently reported atrial tachyarrhyth-
mia in patients with both repaired and unrepaired CHD. They can be classified as either 
an intra-atrial reentrant tachycardia (IART) or typical clockwise and counterclockwise 
(counter)clockwise atrial flutter (AFL) which also occurs in patients without CHD.(3) 
(9-12) Most macro-reentry circuits in CHD patients are located within the right atrium.
(8) The incidence of typical AFL has mainly been observed in patients with tetralogy of 
Fallot (ToF) or atrial septal defect (ASD).(10, 12-14) AFL is caused by a macro-reentrant 
circuit located within the right atrium (Figure 1) and it is bordered by the tricuspid an-
nulus (anteriorly), the orifices of the superior and inferior caval vein (Eustachian ridge, 
posteriorly), the coronary sinus and the crista terminalis. The smallest pathway within 
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Figure 1. Anatomy of the cavotricuspid isthmus.
Postmortem human heart with a superolateral view of the right atrium (turned inside out) with a bicaval 
incision. The cavotricuspid isthmus, which is regarded as the zone of slow conduction, is encircled. The 
isthmus is bordered anteriorly by the TA and posteriorly by the orifice of the ICV.
CS coronary sinus; CTI cavotricuspid isthmus; ICV inferior vena cava; TA tricuspid annulus.
Typical Flutter
1: slowly descending component
2: rapid negative deflection
3: sharp upstrok
4: minor overshoot
II
1
2
3
4
Atypical Flutter
II
Figure 2. ECG characteristics of regular atrial tachycardia.
Left panel: typical atrial flutter consisting of flutter waves with 1) flat descending part, 2) steep descending 
transition, 3) sharp upstroke and 4) a minor overshoot.
Right panel: intra-atrial reentrant tachycardia; the four characteristics of the typical flutter waves are miss-
ing.
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the reentry circuit is the cavotricuspid isthmus, which is often a zone of slow conduc-
tion. Typical counterclockwise AFL waves on the surface electrocardiogram (left panel 
of Figure 2) consist of a slowly descending component, rapid negative deflection, sharp 
upstroke and minor overshoot.(15) Catheter ablation is aimed at creating a linear lesion 
across the cavotricuspid isthmus which establishes a line of conduction block which in 
turn interrupts the reentrant wavelet.
All other atrial reentry tachycardia, not using the reentry circuit of typical AFL in 
either the right or left atrium, are defined as IART and have frequently been described 
in patients with a univentricular heart and transposition of the great arteries (TGA).(12, 
16) The cavotricuspid isthmus may still be part of the reentry circuit, but the reentry 
wavelet may circulate around other structures, such as areas of scar tissue, surgically 
inserted material or suture lines.(17) The reentrant wavelet in the atria of CHD patients 
can often follow different pathways due to the presence of multiple corridors between 
patchy areas of scar tissue, anatomical structures or surgically inserted material.(18) As 
demonstrated by the surface ECG in the right panel of Figure 2, the four characteristics 
of typical flutter waves are usually not present.
Reentry pathways of IARTs described in literature are highly variable. The right atri-
otomy scar, creating crucial pathways of conduction between the right atriotomy site 
and the inferior caval vein, is often involved in IART.(10-12, 18) In patients with a univen-
tricular heart or TGA, areas of slow conduction have been found along inserted prosthetic 
materials such as the Fontan conduit or intra-atrial baffles after the Senning or Mustard 
procedure.(8, 10, 18) Furthermore, regions around the septal patch in patients with ASD 
after surgical correction commonly function as crucial pathways of conduction (Figure 3).
Reentry circuits have also been found in the left atrium, though less frequently. They 
have been observed in patients with ASD, TGA, univentricular heart and ToF, but descrip-
tions of the exact pathways have not been given.(12, 18)
Although an ECG might provide a clue about the pathway of the reentrant wavelet, 
invasive electrophysiological studies are essential to determine the underlying mecha-
nism of the arrhythmia and to identify the crucial pathway of conduction.(19) Endovas-
cular catheter ablation is then aimed at transecting this pathway in order to terminate 
the tachyarrhythmia.
Initial ablation procedures of postoperative atrial tachycardia in CHD patients were 
guided by fluoroscopy only.(20) Target sites for ablation were solely selected by using 
entrainment mapping techniques. However, selection of the appropriate target site for 
ablation was difficult as it required an imaginary three-dimensional (3D) reconstruction 
of the (multiple) reentrant circuits in a complex cardiac anatomy. The success rate often 
depended on the complexity of the underlying heart defect.(8, 20)
The introduction of 3D electroanatomical mapping techniques enabled 3D visualisa-
tion of the patterns of activation (Figure 4), thereby facilitating selection of appropriate 
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target sites for ablation. The use of this technology resulted in improved outcomes of 
ablative therapy.(18) In addition to this, new techniques facilitated navigation to the tar-
get site and the usage of irrigated tip catheters improved lesion formations and further 
increased the success rate.(21-23) Although catheter ablation with a success rate of 90% 
has been reported, ablation of IART is less successful than that of AFL. This may be due 
to e.g. insufficient lesion depth in the thickened atrial wall or conversion from one atrial 
tachycardia to another during ablation due to the presence of multiple pathways.
Despite successful procedural outcome of catheter ablation, atrial tachycardia recurs 
frequently. The reentry circuit and subsequently the crucial pathway of conduction 
may be located at the same site of the previous ablation (8), but they have often been 
found at other sites.(24) Recurrences of atrial tachycardia may also be caused by differ-
ent mechanisms. For example, a focal atrial tachycardia may develop after successful 
ablation of IART.(24) The arrhythmogenic substrate of recurrences was often located at 
other atrial sites, indicating that the atrial tachycardia was not related to the previous 
tachycardia. These ‘recurrent’ tachycardia after ablative therapy may simply reflect a 
progressive cardiomyopathy caused by the persisting pressure/volume overload in CHD 
patients after cardiac surgery. This on-going remodelling process affects intra-atrial 
conduction, thereby creating a new arrhythmogenic substrate facilitating development 
of other tachyarrhythmia.
ICV
CS
SCV
Figure 3. Anatomy of heart with CHD.
Postmortem human heart of a 4-year-old child with a large atrial septal defect. The heart is shown from 
a lateral view through a right atriotomy incision into the right atrium. In adult patients with congenital 
heart defects, the intra atrial reentry tachycardia is frequently observed around the right atriotomy scar (red 
marked area), but also around the atrial septal defect (yellow marked area).
ASD atrial septal defect; CS coronary sinus; ICV inferior caval vein; RAA right atrial appendage; RV right ven-
tricle; SCV superior caval vein
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Focal atrial tachycardia
Focal atrial tachycardia are defined as arrhythmias originating from a small, circum-
scribed area from where it expands to the remainder of the atria and have been observed 
in various types of CHD (Figure 5).(10, 11, 13)
Expansion of the wavefront from its site of origin through multiple areas of conduc-
tion delay can bridge the diastolic interval thereby giving rise to flutter waves on the 
surface ECG. Hence, differentiation between a focal atrial tachycardia and an IART may 
be difficult using the surface ECG only and invasive electrophysiological studies are 
therefore crucial to correctly diagnose the underlying mechanism.
Several studies demonstrated that the origins of focal atrial tachycardia were located 
along the borders of areas of scar tissue. Although areas of scar tissue are found scattered 
throughout both the right and left atrium in patients with CHD, they mainly originate 
from the right atrium.(10, 24)
Theoretically, focal atrial tachycardia can be caused by enhanced automaticity, trig-
gered activity or micro-reentry.(25) De Groot et al. observed prolonged fractionated 
potentials at the origins of focal atrial tachycardia reflecting local dissociation in conduc-
tion suggestive of micro-reentry as the underlying mechanism.(10)
RAOLAO
Figure 4. Electroanatomical mapping of IART.
Three-dimensional electroanatomical mapping of the right atrium in a 15-year-old patient, 12 years after 
completion of the Fontan correction, who was referred for ablative therapy of an incessant atrial tachy-
cardia. The colour-coded right atrial activation map shows a figure-of-eight reentry around 2 areas of scar 
tissue. The tachycardia was eliminated by constructing a linear lesion between 2 areas of scar tissue.
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The success rate of ablative therapy of focal atrial tachycardia in patients with a vari-
able complexity of CHD was high (86% - 100%).(10, 26) However, comparable with atrial 
reentry tachycardia, ‘recurrences’ of atrial tachyarrhythmia after ablation of focal atrial 
tachycardia have been reported. Most atrial tachycardia developed within three years or 
even less and was mainly caused by other mechanisms (e.g. IART).(24)
atrial fibrillation
Atrial fibrillation (AF) is less frequently observed in CHD patients than regular atrial 
tachycardia.(27, 28) Whereas ablative therapy is nowadays an accepted treatment mo-
dality for regular atrial tachycardia in CHD patients, endovascular catheter ablation of 
AF in CHD patients is less well established. In addition to this, it is unknown whether the 
mechanism underlying AF in CHD patients is comparable with patients without CHD. The 
lifetime pressure and stretch may lead to sinus node dysfunction and increased ectopy 
(triggers) that initiate atrial tachyarrhythmia.(29) The overload may result in fibrosis and 
thereby conduction disorders which are likely to form a substrate for arrhythmias such 
as AF and regular atrial tachycardia. In a recent study including 199 patients with various 
CHD, it was indeed shown that AF and regular atrial tachycardia co-exist.(27) De Groot et 
al. found that a surface ECG resembling AF in two patients was the result of continuous 
Focal Atrial Tachycardia
SPV SPV
IPV IPV
AP PA
-60ms
21ms
2
3
LA LA
Figure 5. Electroanatomical mapping of focal atrial tachycardia.
A 17-year-old patient with patent foramen ovale presented with paroxysmal episodes of regular atrial 
tachycardia. During an invasive electrophysiological study with 3D activation mapping, the atrial tachy-
cardia (cycle length 348 ms) had a focal origin at the left atrial free wall. The map shows expansion from 
one circumscribed area in the anterior-posterior view (AP) to the remainder of the atrium in the posterior-
anterior view (PA). After construction of a circular lesion around the earliest activated area, the tachycardia 
terminated.
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electrical activity within a circumscriptive area at the right atrial posteroseptal and the 
anterolateral free wall.(10) Isolation of these areas by ablative therapy terminated AF. 
In line with these findings, Takahashi et al. also demonstrated that AF was the result of 
continuous fractionated electrical activity in the right atrial free wall and lower interatrial 
septum.(30) After ablation of these sites, the patient converted to sinus rhythm.
Endovascular pulmonary vein isolation (PVI) has been described in a limited number 
of patients. Four patients with an ASD and either paroxysmal (N=2) or persistent (N=2) 
AF were scheduled for percutaneous closure of the ASD.(31) Prior to closure, endovascu-
lar PVI was performed in all 4 patients; additional lesions were created in the 2 patients 
with persistent AF including a circular lesion around the superior caval vein and a linear 
lesion connecting the right and left pulmonary veins and mitral isthmus line. A recurrent 
AF episode occurred in only 1 patient after a follow-up period of 21 months in the early 
postoperative period after an orthopaedic surgical operation and was controlled with 
antiarrhythmic drug therapy (dronedarone). Philip et al. performed PVI in 36 patients 
with CHD (ASD, ventricular septal defect (VSD), ASD and VSD, ToF, double outlet left 
ventricle and TGA, coarctation of the aorta, Ebstein anomaly, Bland-Garland White syn-
drome) with paroxysmal (n=26) or persistent (n=10) AF. After a mean follow-up period 
of 4 years, freedom of AF was achieved in 27%.(32)
In patients with CHD and AF, the Cox-Maze technique has been applied since the 
1990s. A right-sided Maze procedure was performed in 77 CHD patients with preopera-
tive AF (left atrial size <41 mm).(33) After a follow-up period of 2.7 years, 90% (n=56) of 
the patients were free from AF. However, other studies showed higher recurrence rates 
of AF in CHD patients who underwent only a right-sided Maze procedure compared with 
patients with a right- and left-sided Maze. Im et al. reported sinus rhythm without epi-
sodes of atrial tachyarrhythmia or pacemaker implantation in 69% of the patients with 
right- and left-sided Maze procedure after 5 years of cardiac surgery compared with only 
45% of the patients with a right-sided Maze.(34) Moreover, recurrences of AF seem to be 
rare in other studies when antiarrhythmic surgery includes the right and left atrium, sug-
gesting that the left atrium plays a (major) role in the pathophysiology of AF in patients 
with CHD as well.(35) Altogether, a concomitant Maze procedure should be considered 
in CHD patients known with AF who undergo corrective/palliative surgery at adult age.
atrioventricular reentry tachycardia
Although less common than other supraventricular tachycardia, atrioventricular reen-
try tachycardia (AVRT) due to accessory bundles in CHD patients has been described, 
especially in patients with Ebstein anomaly.(36) Moreover, approximately half of these 
patients have multiple accessory bundles which often have antegrade and retrograde 
conduction. Antegrade fast conduction during atrial tachyarrhythmia can lead to 
life-threatening arrhythmias of the ventricles. Catheter ablation is used to interrupt 
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the accessory pathway in both children and adults with CHD. However, the possibil-
ity of multiple accessory bundles and defiant morphology of the heart with abnormal 
endocardial electrograms makes successful ablative therapy more challenging.(36) If 
catheter ablation is unsuccessful, surgical treatment of the accessory bundles might be 
an alternative.(37)
Ventricular tachycardia
Ventricular tachycardia (VT) also develops in patients with CHD, although with a lower 
prevalence than atrial tachyarrhythmia. Scars in the ventricular wall caused by surgical 
procedures or implantation of septal patches may form borders of complex reentry 
circuits thereby facilitating development of reentry tachycardia.(38) However, VT also 
occurs in CHD patients who have not undergone surgery.(39) Therefore, next to suture 
lines impairing ventricular conduction, other mechanisms may be involved as well. 
Structural alterations such as increment in fibrotic tissue or myocyte hypertrophy due 
to volume overload may result in conduction abnormalities, giving rise to VT.(40, 41) 
Cardiac magnetic resonance imaging can be useful to identify the substrate underlying 
the VT.(42)
VT have mainly been described in patients with ToF, but also in patients with other 
CHD such as aortic valve disease, pulmonary valve stenosis, VSD and TGA.(40, 43) The 
consequences of VT are severe and may result in syncope and even sudden cardiac 
death. Effective management of this tachyarrhythmia is therefore essential. According 
to the European guidelines, an implantable cardioverter defibrillator (ICD) is indicated 
and recommended in patients with ventricular fibrillation or sustained VT with unsuc-
cessful catheter ablation therapy (44); earlier studies have shown that appropriate 
shocks occur in around 25-30% of these CHD patients with an ICD.(45) Unfortunately, 
inappropriate shocks occur frequently as well (up to 40%).(45) On top of that, an ICD 
implantation appears to have a great impact on the quality of life in these patients.(46) 
Primary prevention of sudden cardiac death remains challenging and is mostly based on 
multiple additional determinants such as increased QRS duration and depressed ven-
tricular function. There is no evidence that programmed ventricular stimulation predicts 
sudden cardiac death; however, it may be valuable in patients with ToF.(47)
Invasive electrophysiological studies have been performed in order to locate the sub-
strate of VT in CHD patients with e.g. ToF and VSD.(40, 43) These studies demonstrated 
that crucial pathways were indeed often bordered by unexcitable tissue around surgi-
cally corrected areas such as the infundibulotomy scar, right ventricular outflow tract 
and ventricular septal patch. Although left-sided VT has also been reported (48), VT in 
these patients has mainly been observed to originate from the right ventricle.
Gonska et al. reported acute procedural successful outcome of ablative therapy of 
94%, using fluoroscopy-guided catheter ablation.(40) It is likely that, comparable with 
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atrial reentry tachycardia, the introduction of 3D electroanatomical mapping technique 
facilitated identification of reentrant pathways, leading to improved outcomes of abla-
tive therapy.(43) Zeppenfeld et al. performed 3D electroanatomical mapping studies and 
subsequently ablative therapy in 11 CHD patients.(43) They achieved non-inducibility of 
all VTs (N=15), including ablative therapy of haemodynamically unstable VTs that were 
guided by sinus rhythm mapping only. However, Morwood et al. reported an acute suc-
cess rate of only 50%, caused by either non-inducibility of the clinical VT or induction of 
haemodynamically unstable VT.(49)
As for the long-term success, Gonska et al. observed recurrences in 20% of the success-
fully ablated patients (N=15) after a follow-up period of 16±9 months.(40) Zeppenfeld et 
al. did not document any recurrences in the 11 patients but an ICD was implanted in 1 
patient because of inducibility of sustained VT during a second electrophysiology study.
(43) Comparable with CHD patients with atrial tachyarrhythmia, surgical ablation is pos-
sible in CHD patients with VT.(50) During the operation, VT can be induced after which 
mapping is subsequently possible in order to locate the substrate of VT and perform 
cryo-ablation. Previous studies showed considerable success rates of cryo-ablation with 
a 3-year VT recurrence-free survival of 80%.(50)
ouTLine oF THe THesis
In summary, the high incidence of tachyarrhythmia in ageing patients with CHD and the 
improved mapping techniques over the years went together with increased knowledge 
of the underlying mechanism and improved outcome of ablative therapy. In patients 
with haemodynamically unstable tachyarrhythmia or patients with symptoms and 
drug-refractory tachyarrhythmia, catheter ablation should be considered. The possibil-
ity of multiple arrhythmias and previous, failed invasive procedures should be taken into 
account in order to estimate the success rate of ablative therapy. Yet, after successful 
ablative therapy new tachycardia continue to develop. Insight into the development 
of these recurrent tachycardia is essential in order to develop preventive strategies. 
Another challenge is to elucidate the mechanism of AF in this study population, as the 
incidence of AF continues to rise in this ageing population.
The aim of this thesis is to gain further insight into the pathophysiology of post-oper-
ative dysrhythmia in patients with CHD. In adult CHD patients, we examined incidences 
of post-operative supraventricular beats during the first five days after cardiac surgery 
using continuous rhythm monitoring and correlated their occurrence with development 
of early, post-operative AF (chapter 3). In pediatric patients, we determined incidences 
of intraoperative arrhythmias during surgery for CHD and examined whether intraop-
erative arrhythmias are associated with development of persistent arrhythmias during 
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long-term follow-up (chapter 4). In the ageing CHD population, we examined in a large 
cohort of patients with a variety of CHD development of AF over time and progression 
of paroxysmal to long-standing persistent/permanent AF during long-term follow-up 
(chapter 5). The onset and progression of AF during long-term follow up in ToF patients 
who underwent total corrective surgery was studied in chapter 6. We investigated the 
immediate and long-term outcome of arrhythmia surgery in CHD patients and progres-
siveness of recurrent AF after arrhythmia surgery (chapter 7). The time course of VT in 
a large cohort of patients with various CHDs and the predictive value of non-sustained 
VT for the occurrence of VT/VF is described in chapter 8. We also studied whether 
the occurrence of fractionated QRS complexes in patients with various types of CHD 
were associated with development of VT/VF (chapter 9). In chapter 10, we examined 
whether there are preferential sites of electropathology during sinus rhythm in patients 
with CHD and RA volume overload using a novel, intraoperative, high resolution map-
ping technique. In addition, the unipolar voltage distribution of the entire epicardial 
surface of the RA, Bachmann’s Bundle (BB), and the left atrium (LA) during sinus rhythm 
(SR) at a high resolution scale was examined. (chapter 11) In chapter 12, we presented 
a patient with recurrence of a surgically repaired congenital left ventricular aneurysm 
who underwent endovascular ablative therapy of post-operative VT. Reports on VT asso-
ciated with congenital left ventricular aneurysm are rare and so far limited to epicardial 
ablative therapy. With these studies, we hope to improve our comprehension of these 
complex, but ever-challenging arrhythmias.
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absTRaCT
Due to improved surgical technologies and post-operative care, long-term survival has 
improved in patients with congenital heart disease. Atrial fibrillation is increasingly ob-
served in this aging population and is associated with morbidity and mortality. However, 
reports about the pathophysiology and the outcome of different treatment modalities 
of atrial fibrillation are still scarce in patients with congenital heart disease. In this review 
we describe the epidemiology, pathophysiology and outcome of the different therapies 
of atrial fibrillation in this specific patient population.
Keywords:
Congenital heart disease; Atrial fibrillation; Cardiac surgery; Pharmacological therapy; 
Mapping; Pulmonary vein isolation.
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inTRoDuCTion
Congenital heart defects (CHD) occur in approximately 9 per 1000 newborns and are 
responsible for almost 30% of all major congenital defects.(1) Due to improved care 
and surgical techniques, over 90% of children with CHD nowadays reach the age of 
adulthood.(2, 3) As a result, the number of adults with CHD increased and reaches now 
around 3 million patients in the Western world.(4, 5) In this aging population, new com-
plications develop over time. Particularly cardiac dysrhythmia occur frequently and are 
an important cause for both morbidity and mortality.(6, 7) These dysrhythmia include 
not only atrial and ventricular tachyarrhythmia, but also bradycardias and atrioventricu-
lar conduction abnormalities. There are numerous papers on diagnosis and manage-
ment of some of these dysrhythmia such as atrial flutter.(8, 9) However, although atrial 
fibrillation (AF) is also one of the most commonly observed dysrhythmia in adults with 
CHD, (10, 11) reports on the pathophysiology, complications and outcome of different 
treatment modalities are rare. As the incidence of AF also increases in CHD patients with 
aging, it is nowadays a more frequently encountered clinical problem. AF is associated 
with severe complications such as heart failure, thromboembolic events and even with a 
higher mortality.(12-16) On top of that, development of AF in CHD patients contributes 
to the higher number of hospital admissions and, thereby also to the ongoing rise in 
healthcare costs.(17-19) The goal of this review is to summarize the current knowledge 
of epidemiology, pathophysiology and outcome of various treatment modalities of AF 
in patients with CHD.
ePiDeMioLoGy oF aTRiaL FibRiLLaTion
The incidence of AF in CHD patients has been reported mainly in adults and depends par-
tially on the type of CHD. Kirsh et al. investigated 149 CHD patients with supraventricular 
tachyarrhythmia of whom 47 patients (32%) had AF.(20) AF developed at an age of 24 
years (compared to 21 years for atrial re-entry tachycardia (ART)) and was associated with 
palliated CHD and residual left sided lesions. In our institution, Ramdjan et al. studied 
193 CHD patients with AF and divided the study population according to the severity of 
CHD into three categories: simple, moderate or complex.(21) Patients with simple defects 
developed AF at a relatively old age (59±15 years) compared to patients with moderate 
defects (47±14 years). The oldest patients within the study population were patients 
with atrial septal defects (ASD), which can be classified as simple and moderate defects 
depending on the type of ASD, in whom AF occurred at an age of 57±15 years. In contrast, 
patients with complex defects already had AF at the age of 36±15 years (P<0,01); patients 
with a univentricular heart (UVH, N=17) were the youngest patients developing AF (age 
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30±12 years). AF has most frequently been reported in patients with an ASD. Children and 
young adults with a corrected ASD are at a low risk for developing AF. The incidence of 
AF has been studied in ASD patients who were corrected before 15 years of age and who 
were followed up to 33 years after closure of the defect;(22, 23) none of these patients 
had episodes of AF during 24-hour Holter registrations. Although these numbers are 
promising, other studies reported frequently AF in adults with corrected and uncorrected 
ASD. Gatzoulis et al. investigated the incidence and predictors of atrial arrhythmia in 213 
patients with ASD who underwent surgical closure.(11) Forty patients (19%) had ART/AF 
prior to surgery, of whom 35 patients (16%) had AF. After a follow-up period of 3,8 years, 
only 5 patients (2.3%) developed new-onset ART or AF; all these patients were older 
than 40 years at the time of ASD closure. However, 60% of the patients (N=24) with ART/
AF prior to surgery continued to have atrial arrhythmia during follow-up. The authors 
concluded that an age of 40 years or older at the moment of surgery was associated with 
both persistence and new-onset of ART/AF. Similar observations were made by Murphy 
et al.; over 50% of the 29 patients who were >41 years at the moment of surgical closure 
developed ART/AF.(24) Development of AF has also been studied after ASD closure with 
a percutaneous device. In a cohort of 132 patients who underwent percutaneous closure, 
older age (≥55 years) at the time of ASD closure was again associated with development 
of atrial tachyarrhythmia including AF.(25) Spies et al. reviewed 1.062 patients who un-
derwent percutaneous closure of an ASD or a patent foramen ovale (PFO).(26) A total 
of 6.3% patients (ASD: N=53, PFO: N=14) had AF prior to closure of the defect. After the 
intervention, 70 patients (mean age 54±14 years) had new-onset AF (8%). There was a 
trend towards an association between a residual shunt in patients with PFO and develop-
ment of AF, but this was not observed in the ASD patients.(26)
ToF is a frequently observed cyanotic CHD with an incidence of 1 in 3,600 live births.
(27) Although ToF is often associated with ventricular tachycardia, (28, 29) AF has also 
frequently been observed in ToF patients. Ramdjan et al. demonstrated that AF occurred 
in ToF patients at a mean age of 45±15 years.(21) Khairy et al. reviewed a total of 556 
ToF patients (age 37±12 years) in order to determine the prevalence of arrhythmia and 
found AF in forty-one (7%) patients.(10) AF occurred more frequently after the age of 45 
years, with a prevalence reaching over 30% at the age of 55 years. AF was more often 
seen in patients with a higher number of surgical interventions. Moreover, AF was as-
sociated with a lower left ventricular ejection fraction and left atrial dilatation.
The UVH such as hypoplastic left heart syndrome, tricuspid atresia, double-inlet ven-
tricle and double outlet ventricle is considered to be one of the most complex cyanotic 
CHD. The Fontan operation is an accepted palliative surgical procedure for UVH and was 
introduced in the seventies.(30) Peters et al. reported that 10% of the 60 patients (N=6; 
age 12±7 years) who underwent a Fontan procedure had early post-operative AF.(31) 
Early post-operative AF was more often observed in patients with double inlet ventricle 
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compared to patients with a tricuspid atresia. One patient had pre-operative AF, which 
recurred in the early post-operative period. All 6 patients with early post-operative AF 
died as a result of hemodynamic instability. During a follow-up period of 12±4,2 years, 
AF occurred in another 3 patients (6%). Fujita et al. reported on the incidence of post-
operative AF in 199 UVH patients in whom palliative surgery was performed at the age of 
11±6 years.(32) After a follow-up period of 19±5 years, only 16 patients (8%) developed 
AF; AF was either persistent or permanent in 10 of them.
Ebstein’s anomaly (EA) is a rare CHD and is frequently concomitant with other car-
diac abnormalities such as ASD and accessory pathways.(33-35) Fast conduction of AF 
over these accessory pathways can result in ventricular fibrillation and hence sudden 
cardiac death. Chavaud et al. studied 98 patients with EA of whom 45 patients had pre-
operative arrhythmia including 12 with AF;(36) patients with an arrhythmia (e.g. ART 
and AF) appeared to be older (33 vs. 21 years). Pre-operative tricuspid insufficiency, ASD 
and severity of EA were not associated with AF. Forty-five patients with pre-operative 
arrhythmia were followed after the procedure. Early post-operative AF developed in 8 
patients of whom 6 also had pre-operative AF. During follow-up (58±50 months), five 
Table 1. Development of AF in various types of CHD.
Study (year) Patients
(N)
Age at correction
(years)
Follow-up
(years)
AF
(N)
Ref.
CHD Mean±SD
Median (range)
Mean±SD
Median (range)
ASD / PFO
- Murphy et al. (1990) 123 26±17 27.2±2 13* [24]
- Gatzoulis et al. (1999) 213 41±14 3.8±2.5 29* [11]
- Roos-Hesselink et al. (2002) 135 7.5±3.5 26** (21–33) 0 [23]
- silversides et al. (2004) 132 44±16 1.4±0.9 8 [25]
- spies et al. (2008) 1062 50±15 1.7 (-) 130 [26]
ToF
- Khairy et al. (2010) 556 5.0 (3–9) 36.8±12*** 41 [10]
UVH / Fontan
- Peters et al. (1992) **** 60 12.3±6.8 12±4.2 9 [31]
- Fujita et al. (2009) 199 11.1±6 19.1±4.7 16 [32]
Ebstein anomaly
- Chavaud et al. (2001) **** 45 33±15 4.8±4.2 9 [36]
TGA
- Houck et al. (unpublished) ***** 2450 – – 10 [38]
AF: Atrial fibrillation; ASD: Atrial septal defect; CHD: Congenital heart disease; PFO: Patent foramen ovale; 
TGA: Transposition of the great arteries; ToF: Tetralogy of Fallot; UVH: Univentricular heart
* Atrial re-entry tachycardia/atrial fibrillation; ** Mean follow-up; *** Mean age at the time of the study; **** 
Including early post-operative AF; ***** Review
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patients with either pre-operative or early post-operative AF still had AF; two patients 
(17%) with pre-operative AF died suddenly.
The arterial switch procedure is nowadays the standard correction for transposition 
of the great arteries (TGA) though we still have many patients who were corrected with 
the Senning or Mustard procedure.(37) These surgical procedures result in extensive 
damage of atrial tissue and it is therefore likely that these patients are prone to AF as 
well. AF in this patient group develops in the fourth decade of life.(21) Interestingly, in 
a recent review from our institution by Houck et al. the incidence of AF in patients with 
TGA corrected by either one of the three procedures, appeared to be low (<1% of all 
arrhythmia).(38)
Altogether, AF develops in various types of CHD, from simple to complex, which is 
summarized in Table 1. Note that in all CHD, besides the type of defect, age of the pa-
tient plays an important role in the occurrence of AF. Whereas ART used to be the most 
frequent dysrhythmia in CHD, it might be possible that the incidence of AF will exceed 
the numbers of ART in this further aging population. The increase in the number of CHD 
patients with AF is thereby conform the development of AF in the general population 
without CHD.(39)
DiaGnosis oF aTRiaL FibRiLLaTion
The surface electrocardiogram (ECG) of AF is characterized by a beat-to-beat change 
in the morphology of atrial waves and usually irregular R-R intervals. However, patients 
with CHD also frequently have atrial macro re-entry tachycardia. Whereas atrial macro 
re-entry tachycardia in patients without CHD are usually the result of a cavo-tricuspid 
isthmus dependent re-entrant circuit (typical atrial flutter (AFL)), (40, 41) atrial tachy-
cardia in patients with CHD are often due to re-entry circuits bordered by areas of scar 
tissue or surgically inserted material (intra atrial re-entry tachycardia, IART, also called 
“incisional tachycardia”).(42-44) The re-entrant circuit may vary over time due to the 
presence of multiple corridors.(45) This may result in different morphologies of the flut-
ter waves on the surface ECG over time hampering differentiation from AF.(46)
Co-exisTenCe oF aTRiaL FibRiLLaTion anD ReGuLaR aTRiaL 
TaCHyCaRDia
The ECG shown in Figure 1 is obtained from a patient with a hypoplastic left heart syn-
drome palliated with a Norwood I procedure followed by a Fontan correction. At the age 
of 17, he developed an atrial tachycardia, which recurred frequently over the years for 
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Figure 1. Electrocardiogram of a patient with a hypoplastic left heart syndrome. The patient presented for 
the first time with a regular atrial tachycardia at the age of 17 years.
Figure 2. Electrocardiogram of the same patient as demonstrated in Figure 1. Three years after develop-
ment of regular atrial tachycardia, he presented with AF.
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which he underwent multiple cardioversions. At the age of 20 years, he developed AF 
(Figure 2).
Mavroudis et al. performed arrhythmia surgery for AF in 15 Fontan patients and re-
ported that all patients had ART preceding AF.(47)
Longstanding ART causes shortening of the atrial effective refractory period and 
reversion of the physiological rate adaptation (shortening of the atrial refractory period 
at slower heart rates). This process of atrial electrical remodeling in turn facilitates induc-
ibility and stability of AF.(48-50) Thus, in order to reduce the risk of AF, ART needs to be 
treated at an early stage.(51-55)
Vice versa, AF converting to AFL has also been reported in animal and electrophysi-
ological studies in humans.(56-59) In these studies, AF lasted until a functional line of 
conduction block developed between the superior and inferior caval vein and then 
converted to AFL. Likewise, it can be postulated that ART following episodes of AF in 
patients with CHD is the result of development of a line of functional block between, for 
example, areas of scar tissue which are usually present scattered throughout the atria. 
Co-existence of AF and regular atrial tachycardia has indeed been reported in CHD pa-
tients.(20) Extensive rhythm monitoring is therefore essential to select the appropriate 
therapy. Zartner et al. reported that modern implantable devices are useful in detecting 
arrhythmic events in young CHD patients.(60)
MaPPinG oF aTRiaL FibRiLLaTion
Episodes of AF can be triggered by ectopic activity.(49) In patients without CHD, ectopic 
activity triggering AF most often originates from the pulmonary veins.(61) Though 
several studies suggest that the left atrial posterior wall may play a role in the patho-
physiology of AF in patients with CHD as well, the role of pulmonary vein ectopy in 
patients with CHD has been less well established.(47, 62-64) If patients with CHD have 
a persisting pressure-volume overload after cardiac surgery, it is most likely that these 
patients have a high incidence of supraventricular premature beats induced by stretch 
of the atrial wall.(65)
To our knowledge, there are only 3 reports on electro-anatomical mapping (EAM) and 
subsequent ablation of AF in patients with CHD.(66, 67) Interestingly, EAM was sugges-
tive of a focal mechanism giving rise to fibrillatory conduction in all patients. In one 
report, the surface ECG obtained from a patient with a tricuspid atresia palliated with 
a Fontan procedure revealed AF at the onset of an electrophysiological study.(66) EAM 
of the right atrium demonstrated that large parts of the atria were activated more or 
less regularly but a circumscriptive area with a diameter of 18mm containing continu-
ous electrical activity was found at the right atrial postero-septal wall. Isolation of this 
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area by construction of a circular lesion around this area eliminated AF. Takahashi et 
al. also observed continuous electrical activity in the right atrium of a Fontan patient 
during AF which could also be successfully ablated by targeting areas of fractionated 
atrial potentials.(67) Another patient was born with a double outlet right ventricle, TGA 
and a ventricular septal defect.(66) She was initially corrected with a Mustard procedure, 
which was eight years later followed by a Jatene procedure. At the age of 27, she was 
referred for ablative therapy as she was experiencing symptomatic, drug refractory atrial 
tachyarrhythmia. The surface ECG on arrival at the catheterization laboratory clearly 
showed AF (Figure 3).
Figure 3. Electrocardiogram of a patient with a double outlet right ventricle, transposition of the great ar-
teries and a ventricular septal defect. The electrocardiogram at the onset of the electrophysiological study 
showed AF.
The left panel of Figure 4 shows bipolar electrograms recorded by the mapping catheter 
(M) and reference catheter (R). The mapping catheter recorded continuous electrical ac-
tivity from an area at the middle of the right atrial free wall. AF converted spontaneously 
to sinus rhythm. Bipolar electrograms recorded from a multipolar catheter positioned 
at the right atrial free wall are demonstrated in the right panel of Figure 4. At the site 
of continuous electrical activity during AF, a prolonged (130ms), fractionated potential 
filling the gap between the early activated high right atrial free wall and the late acti-
vated lower part of the right atrium was found during sinus rhythm. These findings were 
interpreted as very slow conduction through a narrow pathway bordered by areas of 
scar tissue, as demonstrated by the schematic presentation in the right panel of Figure 5. 
Ablative therapy was aimed at creating a linear lesion transecting the narrow isthmus 
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Figure 4. Left panel: Mapping during AF revealed continuous electrical activity recorded by the mapping 
catheter (M) from the middle of the right atrial free wall whereas diastolic intervals are present between the 
bipolar potentials recorded from the remainder of the atria ( R).
Right panel: Bipolar electrograms recorded during sinus rhythm by a multipolar catheter positioned at the 
right atrial free wall, demonstrating an area of conduction delay. See text for a detailed explanation.
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Figure 5. Upper left panel: Bipolar electrograms recorded rhythm from the right atrial free wall during si-
nus rhythm. Upper right panel: schematic presentation of the right atrial free wall; the grey area represents 
an area of scar tissue. During AF, continuous electrical activity was recorded from within the area of scar 
tissue. During sinus rhythm, a prolonged, fractionated electrogram originated from the entrance of the area 
of scar tissue.(3) Lower panel : Bipolar electrograms recorded from the right atrial free wall during sinus 
rhythm. after ablation. At some electrodes, there was no electrical activity. Lower right panel: the linear le-
sion constructed across the entrance of the area of scar tissue resulted in isolation of an area of myocardium 
resulting in electrical silence.
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(lower panel of Figure 5, area 3). After completion of this lesion, procedural outcome was 
successful as electrical activity could not be recorded in the region embedded within 
the areas of scar tissue.
THeRaPy oF aTRiaL FibRiLLaTion
Treatment of AF in patients with CHD is, analogously to patients without CHD, aimed 
at termination of the tachyarrhythmia, maintenance of sinus rhythm, rate control and 
prevention of thromboembolic events.
Thromboembolic prevention
In patients without CHD, the choice of antithrombotic therapy is determined by calcula-
tion of the CHA2DS2 VASc score in order to assess the risk of thromboembolic events.(68) 
However, in patients with CHD, the choice of antithrombotic therapy also depends on 
other factors such as the severity of the CHD, the surgical procedure, presence of shunts 
and hyperviscosity.(69) In 1995, Rosenthal et al. reported that thromboembolic events 
occur frequently in patients after a Fontan procedure. Seventy patients underwent a 
Fontan procedure at the age of 8±8 years and were followed for a period of 5.2±4.7 
years. Fourteen patients developed a thromboembolic event at a mean age of 7±5 years 
(overall rate: 3.9 per 100 patient-years).(13) Ten of them (71%) had a history of sinus 
node dysfunction, atrioventricular conduction delay or atrial tachyarrhythmia. However, 
70% had sinus rhythm at the moment of the thromboembolic event and 30% had atrial 
tachyarrhythmia. Thrombi were not only found in the left atrium, but also in the right 
atrium or lateral tunnel. Right-sided thrombi were thought to be the result of elevated 
venous pressure, although other studies suggested an abnormal thrombogenesis in 
Fontan patients.(70) In a more recent study by Potter et al., prophylactic use of aspirin 
and warfarin therapies in 210 patients with UVH and Fontan palliation was associated 
with a reduction of thromboembolic events.(71) Patients with AF were at a higher risk 
to develop a thromboembolic event (Hazard Ratio 3.10 (1.20 – 7.96)). From their ob-
servation, it might be hypothesized that an aggressive use of aspirin or anti-coagulant 
therapy can be reasonable, especially in patients with complex CHD.
Treatment of aF: Rhythm Control
Pharmacological conversion of AF by ibutilide has been reported in a study with 4 
CHD patients with AF. Conversion to sinus rhythm was achieved in 3 patients (75%).
(72) In addition, Wells et al. studied the effect of dofetilide in 4 CHD patients with AF; 
conversion of AF with dofetilide was successful in all patients.(73) However, in this same 
study, 2 patients with atrial tachycardia (10%) developed torsade des pointes. Kirsh et al. 
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performed 102 cardioversions in 47 patients with AF.(20) In the patients with recurrent 
AF episodes, intervals between successive cardioversions become shorter over time, 
which suggests on-going structural and functional alterations of the atrial myocardium 
favouring development of AF. Amiodarone appears to be effective in preventing AF 
recurrences in patients without CHD.(74) However, amiodarone is also known for its side 
effects such as photo sensibility (erythema), liver and thyroid toxicity, tremor, sleeping 
disorders and bradycardia.(75) As AF arises at a relative young age in patients with 
CHD, a life time use of amiodarone increases the risk to develop side effects. This occurs 
especially in women with CHD and in patients after a Fontan procedure.(76) Sotalol is 
reasonably effective in CHD patients with supraventricular tachycardia in general.(77) 
However, effectiveness decreased when a tachyarrhythmia, such as IART, occurred in 
combination with AF. In a recent study by Koyak et al., 92 CHD patients presented with 
first-onset supraventricular tachycardia, including AF in 68% of the patients.(78) After 
a follow-up period of 2.5±1.4 years, sotalol was associated with less side effects than 
amiodarone and with significantly less recurrences of supraventricular tachycardia 
compared to other anti-arrhythmic drugs. AF did not recur more frequently than other 
supraventricular tachycardia.
Treatment of aF: Rate Control
Implantation of a pacemaker followed by atrioventricular nodal ablation can be con-
sidered if other treatment modalities are ineffective. However, right ventricular pacing 
might not be preferable in patients with depressed ventricular function. Despite poten-
tial positive effects of this treatment modality, to our knowledge, randomized clinical 
trials evaluating the effect of atrioventricular nodal ablation in CHD patients with AF 
are lacking. However, atrioventricular nodal ablation has been performed in patients 
after the Fontan procedure for therapy resistant ART and appeared a reasonable last 
non-surgical treatment option.(79)
endovascular isolation of the Pulmonary Veins
An overview of the ablative outcome is given in Table 2, starting with endovascular 
catheter ablation (CA). CA as an invasive therapy for AF has widely been evaluated in 
patients without CHD. Since the role of the pulmonary veins in initiation of AF has been 
elucidated at the end of the twentieth century, CA aimed at isolating the pulmonary 
vein (PVI) has become an accepted treatment modality.(61) However, in patients with 
CHD, PVI has only been reported in case reports or small groups of patients. PVI was per-
formed in 4 patients with paroxysmal (N=2) or persistent (N=2) AF prior to percutaneous 
closure of the ASD.(62) In the 2 patients with persistent AF, additional lesions during 
PVI consisted of a circular lesion to isolate the superior caval vein in one patient and 
a roofline connecting the right and left superior pulmonary veins and mitral isthmus 
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line in the other patient. Three of the 4 patients remained free of AF nearly 2 years after 
ASD closure; only one patient had recurrent AF after orthopedic surgery. Philip et al. 
performed PVI in a more diverse group of CHD patients (N=36), including ASD, ventricu-
lar septal defect, ToF, UVH, coarctation aorta and an anomalous origin of the left main 
coronary from the pulmonary artery.(64) A cohort of 355 patients without CHD was 
included as control group. After a follow-up period of 4-years, 27% of the CHD patients 
were free of AF compared to 36% of the patients without CHD.
surgical isolation of the Pulmonary Veins
The surgical Maze procedure was for the first time performed in 1987 by Cox et al. in 
patients without CHD.(80) Stulak et al. performed surgical CHD repair with an additional 
right-sided Maze procedure in 99 CHD patients with various congenital defects such as 
EA, UVH and ASD.(81) Seventy-seven patients (78%) had pre-operative AF. Patients were 
excluded if the left atrium was dilated (>41mm), except for 2 patients who had a left 
atrial size of 44 and 45mm. Sixty-two patients were followed for a mean period of 2,7 
years of whom 56 (90%) were free from AF. Among the 6 patients with AF during follow-
up, 1 patient had a dilated left atrium pre-operatively. Mavroudis et al. performed Cox-
Maze III procedure, which includes right and left sided maze, in 14 patients with AF who 
Table 2. Ablation strategies for AF in CHD patients.
Study Patients
(N)
Mean
follow-up
(months)
AF Recurrence
(%)
Ref.
Ablation strategy
Transcather
- Pulmonary vein isolation
Crandall et al. (2012) 4 21* 25 [62]
Philip et al. (2012) 36 48 73 [64]
- Focal substrate ablation
De Groot et al. (2006) 2 – – [66]
Takahashi et al. (2008) 1 12 0 [67]
Surgical
- Right-sided Maze
stulak et al. (2006) 99** 32 8 [81]
- Cox-Maze iii
Mavroudis et al. (2001) 40*** 19 0 [47]
Deal et al. (2007) 70 36 0 [63]
AF: Atrial fibrillation; CHD: Congenital heart disease
* Follow-up started after ASD closure instead of pulmonary vein isolation; ** 77 patients with AF, 22 patients 
with atrial flutter; *** 40 patients had arrhythmia surgery of whom 14 had Cox-Maze III for AF.
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underwent a Fontan conversion.(47) One patient underwent a heart transplantation, the 
remaining 13 patients were free from AF episodes after 19±18 months follow-up. Deal 
et al. reported that 70 Fontan patients with AF underwent a Cox-Maze III procedure.
(63) Of these patients, none had AF recurrences during the 36±30 months of follow-up. 
However, 9 patients (12,8%) developed ART. Despite the occurrence of ART, the outcome 
of these studies suggests that CHD patients with AF might benefit from surgical PVI.
exPeRT CoMMenTaRy/FiVe yeaR View
AF in patients with CHD becomes a more frequently encountered clinical problem due 
to aging of this population. The ongoing reduction in size of implantable loop record-
ers will facilitate diagnosis of AF at an earlier stage. Although pharmacological therapy 
may be effective, their usage is often limited by severe side effects. In the past decades, 
evolvement of sophisticated mapping and ablation techniques have improved the 
outcome of ablative therapy of post-operative atrial and ventricular tachyarrhythmia. 
However, there are only a few reports on ablative therapy of AF in patients with CHD. 
Ablative therapy in these studies consisted of either isolation of the pulmonary veins 
or an area of continuous electrical activity in the right atrium. These findings suggest 
that both the right and left atrium may be involved in the pathogenesis of AF. AF may 
also co-exist with regular atrial tachyarrhythmia, though the exact interplay is unknown. 
Further research is essential in order to comprehend the pathophysiology of AF and the 
co-existence with other arrhythmia in patients with CHD. The acquired knowledge will 
be used to develop innovative treatment modalities.
Key issues
– The number of patients with congenital heart disease and atrial fibrillation (AF) 
has increased in the past years and will probably increase even further in the next 
decades.
– The pathophysiology of AF in patients with congenital heart disease is largely un-
known.
– Co-existence of AF and regular atrial tachycardia (AT) has been observed in patients 
with congenital heart disease.
– Pharmacological therapy of AF is limited due to side-effects.
– The on-going evolvement of sophisticated mapping and ablation techniques will 
further improve the outcome of ablative therapy of atrial tachyarrhythmia in patients 
with a complex atrial anatomy.
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– The role of the pulmonary veins in the pathophysiology of AF in patients with con-
genital heart disease is unknown.
– Further research in patients with congenital heart disease and AF is essential in order 
to comprehend the pathophysiology of AF and to develop effective therapies.
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Intraoperative Arrhythmias in Children with 
Congenital Heart Disease: Transient, Innocent Events?
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absTRaCT
Introduction: the significance and incidences of intraoperative arrhythmias occurring in 
the operating room (OR) in children with congenital heart disease (CHD) are unknown. 
Aims of this study were to determine incidences of intraoperative arrhythmias in chil-
dren with CHD and to examine whether they are associated with persistent arrhythmias 
during follow-up.
Methods: continuous ECG recordings obtained from 134 consecutive pediatric CHD 
patients were manually examined from the moment the aortic cross-clamp (ACC) was 
removed (use of ACC and cardiopulmonary bypass (CPB)), when CPB was stopped (use 
of only CPB) or when the sternum was closed (no use of ACC and CPB) until departure 
from the OR.
Results: in the OR, 2nd (60%) and 3rd (34%) degree atrioventricular conduction block 
(AVB), ectopic atrial rhythm (30%) and junctional rhythm (32%) were most often ob-
served in patients who underwent surgery with both ACC and CPB. Incidences of these 
arrhythmias decreased after cessation of CPB (p<0.01). (Supra)ventricular premature 
beats were mostly observed between end of ACC time and sternum closure (64-84%), 
but decreased before departure from the OR (6-16%, p<0.01). During a median follow-up 
of 37 months, 17 patients (13%) had new onset, late postoperative arrhythmias. Of these 
patients, 88% had intraoperative arrhythmias compared to 85% of patients without late 
postoperative arrhythmias (p=1).
Conclusion: intraoperative arrhythmias, mainly 2nd degree AVB and (supra)ventricular 
premature beats, were frequently observed in children with CHD undergoing cardiac 
surgery with use of CPB and ACC. Most arrhythmias were short-lasting and transient and 
appeared not to be related to late postoperative arrhythmias.
Keywords: Cardiac surgery; Intraoperative arrhythmia; Pediatric Congenital heart dis-
ease; Postoperative arrhythmia
what’s new?
– This study showed that intraoperative arrhythmias, mainly 2nd degree atrioventricular 
conduction block and (supra)ventricular premature beats, were frequently observed 
in children with congenital heart disease.
– Intraoperative arrhythmias were most often observed in children undergoing cardiac 
surgery with cardiopulmonary bypass.
– Incidences of all intraoperative arrhythmias were low before departure of the oper-
ating room.
Intraoperative arrhythmias were generally short-lasting and transient and appeared not 
to be related to late postoperative arrhythmias.
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inTRoDuCTion
Congenital heart disease (CHD) occurs in 9 per 1000 live births.(1) A well-known com-
plication of surgical correction of CHD is development of late postoperative brady- and 
tachyarrhythmia.(2-5) Reported incidences of early postoperative brady- and tachyar-
rhythmia, occurring between admission to the (pediatric) intensive care unit (ICU) until 
intensive care or hospital discharge, vary between 15 and 79%.(6-9)
In the intraoperative period, the child is vulnerable to development of arrhythmias due 
to multiple factors including cooling and rewarming, surgical manipulation, electrolyte 
imbalance, hypovolemia and diffuse myocardial damage.(8, 10) However, incidences of 
intraoperative arrhythmias in CHD patients occurring in the operating room (OR) have 
so far never been reported. Furthermore, it is unknown whether the occurrence and 
type of intraoperative arrhythmias might predispose to development of late postopera-
tive arrhythmias or mortality during follow-up.
The aims of this study were 1) to determine incidences of intraoperative arrhythmias 
in children during and after surgery for CHD using continuous ECG recordings, 2) to 
identify procedural characteristics of patients with intraoperative arrhythmias and 3) 
to examine whether intraoperative arrhythmias are associated with development of 
arrhythmias during follow-up.
MeTHoDs
study population
This retrospective study is part of the rotterdAm rhythM mOnitoring pRoject (AMOR), 
which was approved by the institutional medical ethical committee (MEC 2012-481). 
Perioperative data were retrieved from patients’ medical records. Patients visited the 
pediatric cardiology outpatient clinic at regular intervals postoperatively: at t≈1 month, 
t≈3 months, t≈9 months and hereafter at least once every 1 to 1.5 years. If necessary, 
patients visited the outpatient clinic at shorter time intervals. All postoperative letters, 
ECGs and 24h-Holter recordings during follow-up were reviewed for the occurrence of 
arrhythmias.
All patients ≤18 years of age who underwent cardiac surgery for CHD between April 
2011 and June 2012 at our hospital were included. Patients with a paced rhythm preop-
eratively or with incomplete continuous ECG recordings were excluded. Seven patients 
underwent more than one operation during the study period. In these cases, the opera-
tion on the main CHD was included.
Diagnoses of CHD and performed surgical procedures were classified according to the 
International Nomenclature for Congenital Heart Surgery (INCHS).(11) In contrast to the 
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INCHS, we classified patients who were diagnosed with hypoplastic left heart syndrome 
in the single ventricle category instead of left heart lesions.
intra- and postoperative continuous eCG recordings
Continuous ECG recordings obtained by cardiac telemetry were analyzed either from 
the moment the ACC was removed (in case of use of both ACC and cardiopulmonary 
bypass (CPB)), when CPB was stopped (in case of use of only CPB) or when the sternum 
was closed (in case of no use of ACC and CPB). ECG recordings during the first postopera-
tive hours were analyzed from the moment the child arrived at the cardiothoracic ICU 
until discharge to the pediatric ICU.
Continuous ECG recordings were semi-automatically analyzed and event lists with 
arrhythmias were generated, which were manually verified or adjusted by one of the 
investigators with final confirmation from one of the staff electrophysiologists. For a 
more detailed description of the acquisition and analysis of the ECG recordings and used 
software, see Supplementary file 1.
Classification of arrhythmias
For the occurrence of arrhythmias, this article defines the intraoperative period (in the 
OR), early postoperative period (at the ICU) and late postoperative period (from hospital 
discharge until last visit to outpatient clinic, also referred to as ‘follow-up’).
Intraoperative arrhythmias were diagnosed according to the following definitions. 
Supraventricular (SV-)ectopy included supraventricular premature beat (SPVB), SV-
couplet and SV-run. A SVPB was defined as a supraventricular beat with cycle length 
≤25% of the average cycle length of the 2 preceding beats and SV-couplets consisted 
of two consecutive SVPBs. Three or more consecutive SVPBs above the maximum heart 
rate according to age were classified as SV-run (≤29 seconds) or atrial tachycardia (AT, 
≥30 seconds).(12) Ectopic atrial rhythm (EAR) was defined as a series of supraventricular 
beats with abnormal P-wave morphology under the maximum heart rate according to 
age and junctional rhythm (JR) as a narrow complex rhythm in the absence of P-waves 
or in the presence of retrograde P-wave activation. Junctional ectopic tachycardia (JET) 
was defined as JR above the maximum heart rate according to age.(12)
Ventricular (V-)ectopy included ventricular premature beat (VPB), V-couplet and V-
run. A VPB was defined as a premature contraction originating from one of the ventricles 
with a different and prolonged QRS complex compared to the patients’ usual QRS mor-
phology.(7) Two consecutive VPBs formed a V-couplet and 3 to 10 VPBs were defined as 
a V-run. Ten or more ventricular beats above the maximum heart rate according to age 
were classified as non-sustained ventricular tachycardia (VT, ≤29 seconds) or sustained 
VT (≥30 seconds).(12)
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Second degree atrioventricular conduction block (AVB) was defined as missed ven-
tricular beats with consistent PR-durations (e.g. 2:1) or with progressive prolongation 
of PR-duration. Third degree AVB was defined as atrioventricular dissociation with a 
junctional or ventricular escape rhythm.
statistical analysis
Continuous variables were expressed as mean ± standard deviation or median (mini-
mum – maximum). The ANOVA or Mann-Whitney U test was used to compare procedural 
characteristics. Categorical variables, including the incidence of arrhythmias and pro-
cedural characteristics, were denoted by percentages and compared with Chi-square, 
Fisher’s exact or McNemar’s tests. Spearman’s correlation coefficient was used to cal-
culate measures of association between (S)V-ectopy and procedural characteristics. A 
p-value <0.05 was considered statistically significant. Statistical analysis was performed 
with SPSS, version 21 (IBM, Armonk, New York).
ResuLTs
study population
We included 134 consecutive patients with a median age at the moment of cardiac 
surgery of 10 months (0.2 months–17 years). Table 1 provides an overview of the under-
lying CHDs; most patients had a septal defect (37%), right sided heart lesion (22%) or 
single ventricle (12%).
Surgical procedures included procedures for septal defects (N=46, 34%), right sided 
heart lesions (N=25, 19%), palliative procedures (N=22, 16%, thoracic arteries and veins 
(N=12, 9%), left sided heart lesions (N=11, 8%), pulmonary venous anomalies (N=6, 4%), 
single ventricle (N=6, 4%) or transposition of the great arteries (N=6, 4%). Most patients 
underwent surgery with use of both ACC and CPB (N=99, 74%); 13 patients (10%) had 
only CPB and 22 (16%) had no CPB. Ninety-six patients (72%) were exposed to hypother-
mia <35°C. ACC duration ranged from 6 to 267 minutes and CPB duration from 15 to 360 
minutes. Duration from end of ACC time until end of CPB ranged from 4 to 188 minutes, 
from end of CPB time until sternum closure from 9 to 164 minutes and from sternum 
closure until departure from the OR from 6 to 115 minutes.
Preoperative ECGs were available in 126 patients (94%) at an average of 14 days 
(1–194 days) prior to the surgical procedure. Sinus rhythm was present in 124 patients 
(98%) and two patients (2%) had an AT.
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intraoperative arrhythmias
In total, 114 patients (85%) had one or more intraoperative arrhythmias. Arrhythmias 
were observed in 100% of patients who underwent surgery with use of ACC and CPB 
or CPB only compared to only 9% of patients without use of CPB (p<0.01). Figure 1 il-
lustrates examples of arrhythmias that occurred in the intraoperative period.
Table 1. Classification of CHD according to the INCHS.
CHD Patients,
n=134
Male age
(months)
Double outlet right ventricle 9(7) 5(56) 3(0.5 – 46)
Left sided heart lesions 11(8) 7(64) 53(6 – 168)
- Aortic valve disease 11
- Shone’s syndrome 1
Pulmonary venous anomalies 4(3) 2(50) 6(2 – 201)
- TAPVC 2
- PAPVC 2
Right sided heart lesions 29(22) 13(45) 12(0.3 – 188)
- Pulmonary atresia 12
- RVOT obstruction 7
- Tetralogy of Fallot 10
Septal defects 49(37) 25(51) 10(2 – 170)
- Atrial septal defect 17
- Ventricular septal defect 22
- Atrioventricular canal 8
- Truncus arteriosus 1
- Aortopulmonary window 1
Single ventricle 16(12) 14(88) 3(0.2 – 39)
- Hypoplastic left heart syndrome 4
- Left ventricular hypoplasia 2
- Double inlet left ventricle 3
- Atresia AV valve 6
- cAVSD and straddling AV valves 1
Thoracic arteries and veins 11(8) 6(55) 33(0.5 – 182)
- Coronary artery anomalies 1
- CoA, aortic arch hypoplasia 9
- Vascular rings and slings 1
Transposition of the great arteries 5(4) 3(60) 0.5(0.2 – 16)
Patients and gender: N(%), age: months (minimum – maximum).
AV: atrioventricular, cAVSD: complete atrioventricular septal defect, CHD: congenital heart disease, CoA: 
coarctation of the aorta, PAPVC: partial abnormal pulmonary venous connection, RVOT: right ventricular 
outflow tract, TAPVC: total abnormal pulmonary venous connection.
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Episodes of intraoperative 2nd degree AVB had a median duration of 79 seconds (5 
seconds–21 minutes), whereas the median duration of 3rd degree AVB episodes was 
25 seconds (4 seconds–17 minutes). Median durations of episodes of EAR and JR were 
respectively 44 seconds (2 seconds–63 minutes) and 20 seconds (1 second–62 minutes).
Figure 2 shows time-dependent prevalence of the aforementioned arrhythmias in 
a subset of 96 patients who underwent a surgical procedure with both ACC and CPB. 
Three patients were excluded from this sub analysis because of missing data concerning 
time points of end of CPB (N=2) or sternum closure (N=1). All arrhythmias were most 
often observed during CPB (T1, 30–60%) but decreased significantly after cessation of 
CPB (T2, 0–18%; p<0.01) and after closure of the sternum (T3, 0–5%; p<0.01).
A.
B.
C.
D.
Figure 1. Examples of arrhythmias that occurred in the intraoperative period.
a. Second degree AVB during the first 5 minutes after removal of the ACC in a 4 month old patient who un-
derwent correction of a VSD and patent foramen ovale. b. Alternating JR and EAR in a 4 month old patient 
who underwent correction of a large VSD and an atrial septal defect type 2. C. Episode of ventricular fibril-
lation in a 1 year old patient with an interrupted aortic arch type B, a VSD and a relatively small left ventricle 
who underwent repair of the aortic arch, banding of the arteria pulmonalis and an atrioseptectomy. D. 
Episode of supraventricular tachycardia up to 300 beats per minute in a 1 month old patient with tricuspid 
and pulmonary atresia who underwent an atrioseptectomy and construction of a central shunt.
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The number of (S)V-ectopy and their time-dependent occurrence in the subset of 96 
patients with ACC and CPB is shown in Figure 3 and Figure 4, respectively. The number 
of patients with SVPBs and SV-couplets was higher between the end of CPB and sternum 
closure (T2) compared to during CPB (T1; respectively p<0.01 and p=0.03). A relatively 
large number of patients developed VPBs, V-couplets and V-runs in the intraoperative 
period before sternum closure (41–84%) but this number decreased significantly after 
closure of the sternum (0–6%), p<0.01). All episodes of non-sustained VT and VF oc-
curred during CPB (not shown in Figure 4).
Three patients underwent one or more cardioversions for AT, AF or VF. Temporary 
pacemaker leads were inserted in 3 patients with persistent JR (N=2) and 2nd degree AVB 
(N=1).
Procedural characteristics of patients with intraoperative arrhythmias
Patients with intraoperative AVB, JR or (S)V-ectopy more often had septal defect surgery 
compared to patients without these arrhythmias (AVB: 43% vs. 24%, p=0.02; JR: 49% vs. 
29%, p=0.04; (S)V-ectopy: 40% vs. 0%, p<0.01). Patients with atrial (88%) or combined 
atrioventricular (100%) septal defect surgery more often had V-ectopy compared to pa-
tients with only ventricular septal defect surgery (67%, p=0.02). Other types of surgery 
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Figure 2. Intraoperative arrhythmias in patients with use of both ACC and CPB.
Prevalence of 2nd degree AVB, 3rd degree AVB, EAR and JR are shown for each part of the surgical procedure 
in a subset of 96 patients who underwent surgery with use of both ACC and CPB.
ACC: aortic cross-clamp, AVB: atrioventricular conduction block, CPB: cardiopulmonary bypass, OR: operat-
ing room. * p<0.01 compared to T1. † p <0.01 compared to T2. ǂ p=0.04 compared to T2.
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Figure 3. Time-dependent frequency of intraoperative SVPBs, SV-couplets and SV-runs.
The number of SVPBs, SV-couplets and SV-runs in a subset of 96 patients who underwent surgery with use 
of ACC and CPB during each part of the surgical procedure. Percentages indicate the number of patients 
with the arrhythmia and the bars depict the median number of SV-ectopy.
* p<0.01 compared to T1. † p=0.03 compared to T1. §p=0.02 compared to T1. ǂ p<0.01 compared to T2.
ACC: aortic cross-clamp, CPB: cardiopulmonary bypass, OR: operating room, SV: supraventricular, SVPB: su-
praventricular premature beat.
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Figure 4. Time-dependent frequency of intraoperative VPBs, V-couplets and V-runs.
The number of VPBs, V-couplets and V-runs in a subset of 96 patients who underwent surgery with use of 
ACC and CPB during each part of the surgical procedure. Percentages indicate the number of patients with 
the arrhythmia the bars depict the median number of V-ectopy. * 1 patient had 67 VPBs.
† p<0.01 compared to T1. § p<0.01 compared to T2.
ACC: aortic cross-clamp, CPB: cardiopulmonary bypass, OR: operating room, V: ventricular, VPB: ventricular 
premature beat.
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did not differ between patients with and without these arrhythmias; neither did they 
differ between patients with and without EAR.
Hypothermia was significantly more often used in patients with AVB (92% vs. 48%), 
EAR (90% vs. 65%), JR (92% vs. 65%) or (S)V-ectopy (85% vs. 0%) compared to patients 
without these arrhythmias (all p<0.01).
Patients with AVB or (S)V-ectopy had longer median duration of ACC time (AVB: 58 
minutes, 14–175 vs. 45, 6–189; p=0.03 and (S)V-ectopy: 57 minutes, 6–189 vs. 26, 17–36; 
p<0.01) compared to patients without these arrhythmias. Duration of CPB was compa-
rable in patients with versus without AVB (p=0.06) and none of the patients without 
(S)V-ectopy had CPB. ACC and CPB duration did not differ between patients with and 
without EAR or JR and it was not correlated with the number of (S)V-ectopy/hour.
early postoperative period
Median duration of continuous ECG recordings during the first postoperative hours in 
the cardiothoracic ICU was 2.3 hours (0.7–20.9 hours). The number of patients with per-
sistent and de novo arrhythmias in the ICU is shown in Figure 5. One patient developed 
de novo 2nd degree AVB, which resolved before transfer to the pediatric ICU.
OR
1.2 hrs (0.2 – 4.7)
2nd degree AVB
3rd degree  AVB
EAR
JR
Other
SV-ectopy
V-ectopy
N=63 N=1
Nn=1
N=0
N=33 N=0 N=0
N=38 N=5
Nn=4
N=1
Nn=6
N=35 N=5
Nn=1
N=1*
Nn=1
N=104 N=64
Nn=7
NA
N=104 N=27
Nn=3
NA
NA NA N=8†
ICU
2.3 hrs (0.7–20.9)
Follow-up
37 mo (1 d–54 mo)
Figure 5. Persistence of intraoperative arrhythmias.
The number of patients with persistent or de novo intraoperative (= OR), early postoperative (= ICU) and 
late postoperative (= follow-up) arrhythmias. Nn indicates patients with de novo arrhythmias.
* this patient also had paroxysmal AT. † sinus bradycardia (N=2), paroxysmal AT (N=2), sinus rhythm with 
SVPB bigeminy (N=2) or VPB bigeminy (N=1), sick sinus syndrome (N=1).
AVB: atrioventricular conduction block, EAR: ectopic atrial rhythm, ICU: intensive care unit, JR: junctional 
rhythm, NA: not applicable, OR: operating room, SV: supraventricular, V: ventricular.
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SVPBs occurred at a median of 1.3 per hour (0.2–22) in 72 patients (54%) and VPBs at 
a median of 0.6 per hour (0.2–35) in 29 patients (22%). Three patients developed one or 
more V-runs; one of them developed a non-sustained VT.
Of 114 patients with an intraoperative arrhythmia, 79 (69%) still had an arrhythmia in 
the ICU, whereas of 20 patients without intraoperative arrhythmias only 4 (20%) devel-
oped an arrhythmia in the ICU (p<0.01).
Follow-up
Median follow-up duration was 37 months (1 day–54 months): 2 patients had only 1 day 
of follow-up as they died on the first postoperative day. The 2 patients with preopera-
tive paroxysmal AT did not develop any postoperative arrhythmias. Seventeen patients 
(13%) with preoperative sinus rhythm had late postoperative arrhythmias, including 
EAR (N=7), JR (N=2, one of which also had paroxysmal AT), sinus bradycardia (N=2), par-
oxysmal AT (N=2), sinus rhythm with SVPB bigeminy (N=2) or VPB bigeminy (N=1) and 
sick sinus syndrome (N=1). In only 2 patients, the intraoperative arrhythmia persisted 
during follow-up (1 EAR, 1 JR). The other patients had late postoperative arrhythmias 
that differed from their intraoperative arrhythmia(s) (Figure 5).
Comparing patients with new onset, late postoperative arrhythmias to patients who 
did not develop postoperative arrhythmias, there was no difference in the number of 
Table 2. Incidence of intra- and early postoperative arrhythmias in patients with and without late postop-
erative arrhythmias.
Late arrhythmia
n=17
no late arrhythmia
n=116
P-value
Intraoperative arrhythmias 15(88) 98(85) 1
- 2nd degree AVB 7(41) 56(48) 0.58
- 3rd degree AVB 2(12) 31(27) 0.24
- EAR 5(29) 32(28) 1
- JR 4(24) 30(26) 1
- SV-ectopy 13(77) 90(78) 1
- V-ectopy 14(82) 89(77) 0.76
Early postoperative arrhythmias 9(53) 74(64) 0.39
- 2nd degree AVB 1(6) 1(1) 0.24
- 3rd degree AVB 0 0
- EAR 2(12) 7(6) 0.32
- JR 2(12) 4(3) 0.17
- SV-ectopy 8(50) 63(54) 0.75
- V-ectopy 1(6) 29(25) 0.12
N(%). AVB: atrioventricular conduction block, EAR: ectopic atrial rhythm, ICU: intensive care unit, JR: junc-
tional rhythm, SV: supraventricular, V: ventricular.
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patients with intraoperative arrhythmias or early postoperative arrhythmias in the ICU 
(Table 2).
Seven patients died during follow-up at a median age of 0.4 years (0–5); characteris-
tics of these patients are shown in Table 3. The number of patients with intraoperative 
arrhythmias, early postoperative arrhythmias or late postoperative arrhythmias did not 
differ between deceased and surviving patients (p>0.05).
DisCussion
With our study, we intended to provide insight into the incidence of different types of 
intraoperative arrhythmias in CHD patients and to determine whether these arrhyth-
mias are of any clinical significance during follow-up. Intraoperative arrhythmias were 
observed in 85% of children undergoing cardiac surgery for CHD and were related to use 
of CPB, either with or without ACC. Although 2nd and 3rd degree AVB, EAR and JR were 
often observed, these arrhythmias were generally short-lasting and often resolved after 
cessation of CPB. (S)V-ectopy was also relatively often observed in patients with use of 
CPB but the number of patients with these arrhythmias strongly decreased in the last 
intraoperative period.
To the best of our knowledge, we only found one other study that mentioned the 
incidence of intraoperative arrhythmias in pediatric patients. Cohen et al. studied the 
Table 3. Postoperative mortality and patient characteristics.
# CHD type Main surgery oR* arrhythmias iCu† 
arrhythmias
Cause of death (time 
postoperatively)
1 TOF Central shunt 2nd AVB, V-ectopy SV-ectopy Circulatory failure (1d)
2 PA, VSD Central shunt (S)V-ectopy EAR, JR, (S)
V-ectopy
Circulatory failure (1d)
3 HLHS PA banding SV-ectopy – Circulatory failure (2m)
4 DORV, AVSD PA banding – – Circulatory failure (4m)
5 Tricuspid atresia, 
pulmonary atresia
Central shunt 2nd/3rd AVB, EAR, JR, 
AT, VF, (S)V-ectopy
SV-ectopy Circulatory failure (3y)
6 AVSD, straddling 
AV valves
Atrioseptectomy JR, (S)V-ectopy SV-ectopy Circulatory failure (4y)
7 DORV, AVSD, TGA, 
PA, TAPVC
Central shunt re-
operation
(S)V-ectopy – Cerebral infarction (4y)
* intraoperative arrhythmias in the OR. † early postoperative arrhythmias in the ICU.
AT: atrial tachycardia, AV: atrioventricular, AVB: atrioventricular conduction block, AVSD: atrioventricu-
lar septal defect, CHD: congenital heart disease, DORV: double outlet right ventricle, EAR: ectopic atrial 
rhythm, HLHS: hypoplastic left heart syndrome, ICU: intensive care unit, JR: junctional rhythm, OR: operat-
ing room, PA: pulmonary artery, SV: supraventricular, TAPVC: total abnormal pulmonary venous connection, 
TGA: transposition of the great arteries, TOF: tetralogy of fallot, V: ventricular, VF: ventricular fibrillation.
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occurrence of intraoperative adverse events in 29.220 pediatric patients – most without 
cardiovascular disease – undergoing various types of surgery under general anesthesia.
(13) The incidence of intraoperative arrhythmias (defined as (supra)ventricular arrhyth-
mias and heart block) varied between 0.86% and 9.33% depending on patient age. 
Arrhythmia definitions and methods of arrhythmia detection were not further specified; 
therefore, an adequate comparison to our results is not possible.
intraoperative arrhythmias: transient events?
Our results show that by the time the sternum was closed, the number of patients with 
AVB, EAR or JR had decreased significantly. Diffuse myocardial damage due to hypoxia 
and ischemia during CPB and reperfusion after cessation of CPB has been suggested to 
contribute to development of early postoperative arrhythmias.(7, 9, 14, 15) Several stud-
ies assessing the incidence of early postoperative arrhythmias in children after surgery 
for CHD identified longer duration of CPB as an independent risk factor for postopera-
tive arrhythmias.(6, 8, 9, 15, 16) Hypothermia during CPB results in slowing of impulse 
conduction, which may lead to various degrees of AVB.(17) Reversal of nearly all AVBs 
after CPB with ACC (and thus during normothermia) in our study strongly suggests that 
transient intraoperative AVBs were caused by hypothermia rather than by injury to the 
conduction system itself.
Hypothermia additionally reduces automaticity of cardiac pacemaker cells.(18) The 
relatively high prevalence of EAR and JR during CPB might be explained by reduced 
automaticity of the sinoatrial node, which may lead to increased competition between 
activity from the sinoatrial node, ectopic atrial foci and the atrioventricular node. After 
cessation of CPB, 10% of patients still had EAR or JR. Persistence of these arrhythmias 
after cessation of CPB might be a result of diffuse myocardial damage that occurred 
during CPB or from atrial manipulation during surgery.(15)
The number of patients with (S)VPBs and (S)V-couplets increased after cessation of 
CPB. This finding is in line with the study of Mallet et al., who suggested that ventricular 
ectopy is often suppressed by mild degrees of hypothermia but reappears with rewarm-
ing.(19) Furthermore, the increased number of patients with (S)VPBs and (S)V-couplets 
after cessation of CPB might be the result of longer duration of the time period between 
end of CPB and sternum closure compared to end of ACC and end of CPB. The number of 
patients with (S)V-ectopy decreased significantly after the sternum was closed. It is likely 
that mechanical manipulation of the heart by the surgeon for decanulation, hemostasis 
and drainage, which can occur until the sternum is closed, provokes (S)V-ectopy.
During the early postoperative hours at the cardiothoracic ICU, incidences of all ar-
rhythmias were low. The number of patients with intraoperative arrhythmias did not 
differ between patients with and without late postoperative arrhythmias. Furthermore, 
intraoperative arrhythmias persisted in only 2 patients during follow-up.
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Our results indicate that intraoperative arrhythmias, similar to early postoperative 
arrhythmias, are mainly transient.(7-9)
intraoperative arrhythmias: innocent events?
Active termination of arrhythmias by cardioversion was necessary in 3 patients and 
temporary pacemaker wires were implanted in 4 patients. In other patients, intraopera-
tive arrhythmias were generally self-limiting. During the intra- and early postoperative 
period, death or other major complications did not occur due to arrhythmias, which is in 
line with outcomes of studies assessing the incidence of early postoperative arrhythmias 
in CHD children.(6, 8, 9)
significance of intraoperative arrhythmias
The etiology of early postoperative arrhythmias differs from that of late postoperative 
arrhythmias. Late postoperative arrhythmias mostly develop as a complication of scar-
ring or longstanding volume/pressure overload leading to conduction disorders or 
ventricular failure.(20, 21) Several studies found an association between early postop-
erative arrhythmias, defined as any arrhythmia within 30 days, and late postoperative 
arrhythmias in patients who underwent surgical correction of a CHD at young age.(2-5) 
The association between early and late postoperative arrhythmias may also apply to 
intraoperative arrhythmias. While short and subtle intraoperative arrhythmias often ap-
peared to be benign, occurrence of these arrhythmias indicates electrical instability of 
the myocytes.(7) A longer follow-up duration is necessary to further study the relation 
between intraoperative electrical instability and the propensity to develop late postop-
erative arrhythmias.
Limitations
Due to the retrospective nature of this study, several data regarding patient character-
istics and intraoperative details were missing. However, the number of patients with 
missing data was limited and these patients were excluded from sub analyses.
Furthermore, since patients were transferred to the pediatric ICU in the children’s 
hospital after several hours postoperatively and subsequently to the pediatric ward, 
we only analyzed postoperative ECG recordings during the stay at the cardiothoracic 
ICU; ‘longer-term’ rhythm observations are missing. However, we analyzed follow-up 
letters, ECGs and 24h-Holter recordings in order to assess the occurrence of de novo or 
persistent arrhythmias.
Due to the various types of intraoperative arrhythmias, heterogeneous patient 
population and relatively low incidence of late postoperative arrhythmias, it was not 
possible to perform predictive analyses with intraoperative arrhythmias and patient and 
procedural characteristics.
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ConCLusion
We conclude that intraoperative arrhythmias were frequently observed in children un-
dergoing surgery for CHD with use of CPB, both with and without use of ACC. However, 
these arrhythmias were generally short-lasting, transient and clinically insignificant. 
Even though 13% of patients had new onset, late postoperative arrhythmias during 
follow-up, development of these postoperative arrhythmias appeared not to be related 
to arrhythmias in the OR or at the ICU.
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suPPLeMenTaRy FiLe 1
Methods: intra- and postoperative continuous eCG recordings
Intra- and postoperative continuous ECG recordings were obtained from bedside Infin-
ity® monitors (Draeger, Lubeck, Germany). Data were stored on hard disk as CPZ-files 
(compressed monitoring data) collected using a custom-made program (Taperec, 
Rotterdam, the Netherlands) with sampling rate of 200Hz.(1) CPZ-files were converted 
into International Society for Holter and Noninvasive Electrocardiology (ISHNE) files, a 
standard Holter output file format.(2) ECG recordings were semi-automatically analyzed 
in multichannel Holter scanning software Synescope™ (Sorin Group, Ela Medical, Cla-
mart, France) using standardized algorithms. Two electrocardiogram (ECG) leads were 
selected from lead I, II and III, since the precordial leads are not available during cardiac 
surgery. Hereafter, QRS-complexes were automatically classified and grouped into one 
of three templates, including normal, ventricular and supraventricular beats. After 
manual correction of all templates and marking the start and end time of arrhythmias 
on the rhythm strips, an event list was automatically generated and verified or adjusted 
by one of the investigators, with final confirmation from one of the staff electrophysiolo-
gists (Yaksh A, MD, unpublished data, 2016). After analysis of ECG recordings, data were 
exported as ASCII text files from Synescope™ into a custom-made program to convert 
ASCII files into database format.
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absTRaCT
Background: the incidence of atrial fibrillation (AF) is rising in the aging patients with 
congenital heart disease (CHD). However, studies reporting on AF in CHD patients are 
scarce. The aim of this multicenter study was to examine in a large cohort of patients 
with a variety of CHD 1) the age of onset and initial treatment of AF, co-existence of atrial 
tachyarrhythmia 2) progression of paroxysmal to (long-standing) persistent/permanent 
AF during long-term follow-up.
Methods and Results: patients (N=199) with 15 different CHD and documented AF 
episodes were studied. AF developed at 49±17 years. Regular atrial tachycardia (AT) co-
existing with AF occurred in 65 (33%) patients; 65% initially presented with regular AT. At 
the end of a follow-up period of 5 (0–24) years, the ECG showed AF in 81 patients (41%). 
In a subgroup of 114 patients, deterioration from paroxysm of AF to (long-standing) 
persistent/permanent AF was observed in 29 patients (26%) after only 3 (0–18) years 
of the first AF episode. Cerebrovascular accidents/transient ischemic attacks occurred 
in 26 patients (13%), although a substantial number (N=16) occurred before the first 
documented AF episode.
Conclusion: age at development of AF in CHD patients is relatively young compared to 
patients without CHD. Co-existence of episodes of AF and regular AT occurred in a con-
siderable number of patients; most of them initially presented with regular AT. The fast 
and frequent progression from paroxysmal to (long-standing) persistent or permanent 
AF episodes justifies close follow-up and early, aggressive therapy of both AT and AF.
Keywords:
Congenital Heart Defects, Atrial Fibrillation, Atrial Tachyarrhythmia, Ablation Therapy, 
Stroke
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inTRoDuCTion
Atrial fibrillation (AF) and regular atrial tachycardia (AT) such as typical atrial flutter (AFL) 
or intra-atrial reentry tachycardia (IART) occur frequently in patients with congenital 
heart defects (CHD).(1, 2) The reported incidence of AF in adult CHD patients reaches 
over 10%.(3-5) Kirsh et al. examined characteristics of CHD patients (N=149) who were 
scheduled for electrical cardioversion of regular AT (N=102, 68%), AF (N=30, 20%) or 
both (N=17, 11%) and found that compared to IART patients, those with AF were older 
(24 versus 21 years) and the arrhythmia developed later after surgery (13 versus 11 
years), though these differences were not statistically significant.(6) Furthermore, AF 
was more frequently observed in patients with residual left sided obstructive lesions or 
unrepaired heart disease.
Knowledge of the time course of AF in CHD patients is limited but is essential as AF 
is associated with severe complications such as cerebrovascular events or heart failure.
(6-8)
The aim of this multicenter study was 1) to examine the age of onset of AF, co-existence 
of atrial tachyarrhythmia and initial treatment of AF in a large cohort of subjects with a 
variety of CHD and 2) to study the progressive nature of AF after the first episode during 
long-term follow-up.
MeTHoDs
This retrospective longitudinal multicenter study was designed as part of the “Dysrhyth-
miAs in patieNts with congenitAl heaRt diseAse” (DaNaRA) project (MEC-2012-482), 
which was approved by the local ethics committee in the Erasmus University Medical 
Center Rotterdam. Informed consent was not obliged.
study population
Patients with CHD and at least one documented episode of AF observed during routine 
control at the outpatient clinic, hospitalization or at the emergency room were derived 
from medical databases of the participating hospitals in the Netherlands including Eras-
mus University Medical Center, Rotterdam; Amphia Hospital, Breda; Medisch Spectrum 
Twente, Enschede; VU Medical Center, Amsterdam; Haga Hospital, The Hague; Catharina 
Hospital, Eindhoven and Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Data on demographics and clinical characteristics including type of congenital heart 
defects, echocardiograms, cardiac surgery, prescribed anti-arrhythmic drugs (AAD), out-
come of cardioversion (CV) and ablative therapy such as endovascular catheter ablation 
for pulmonary vein isolation (ePVI), surgical pulmonary vein isolatioin (surPVI), transient 
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ischemic attacks (TIA), cerebrovascular accidents (CVA) or death were retrieved from the 
patient medical records. Pulmonary vein isolation, either endovascular or surgical, was 
considered successful when isolation of all pulmonary veins was achieved. Regarding 
the type of CHD, we grouped the patients according to complete repair (aortic valve 
disease (AVD), atrial septal defect (ASD), atrioventricular septal defect (AVSD), ventricu-
lar septal defect (VSD), patent ductus arteriosus (PDA), pulmonary stenosis (PS) and cor 
triatrium (CT)); complex repair (coarctation of the aorta (CoA), Ebstein anomaly, pulmo-
nary atresia with VSD, situs inversus, tetralogy of Fallot (ToF), transposition of the great 
arteries (TGA), congenitally corrected TGA (ccTGA)); and patients with a univentricular 
heart (UVH). Patients were followed untill their last visit until June 2014.
analysis of the Rhythm Registrations
Electrocardiograms (ECG) and 24-hour Holter registrations were reviewed for episodes 
of AF or regular AT; all registrations were independently examined by two investigators. 
AF was defined as an irregular rhythm combined with a clear beat-to-beat variation in 
the morphology of atrial waves. We did not differentiate between a typical (counter) 
clockwise AFL, IART or ectopic atrial tachycardia, as differentiation between these types 
of AT cannot always be made based on the surface ECG only.(9) The time frame of pro-
gression from paroxysmal AF to (long-standing) persistent/permanent AF was defined 
as the moment of the initial AF episode until the moment of the persistent AF episode.
statistical analysis
Continuous variables were expressed as mean ± standard deviation or median and 
interquartile range (25% and 75%). Student’s t-test or ANOVA test were used to compare 
patient groups. Categorical data were denoted by percentages and compared with the 
McNemar test, X² test or Fisher’s exact test. Factors associated with the age of devel-
opment of AF were estimated with the use of linear regression models. Kaplan-Meyer 
curves were made to illustrate the risk of progression from paroxysmal to longstanding 
persistent/permanent AF. A p-value of <0.05 was considered statistically significant. 
Statistical analysis was performed with SPSS, version 21 (IBM, Armonk, New York).
ResuLTs
study population
A total of 199 CHD patients with documented AF episodes are outlined in Table 1. The 
study population consisted of 15 different CHD, including ASD (N=58), AVD (N=34), ToF 
(N=21), TGA (N=17), UVH (N=16), VSD (N=12), CoA (N=9), PDA (N=7), pulmonary stenosis 
(PS, N=7), AVSD (N=4), ccTGA (N=4), Ebstein anomaly (N=4), pulmonary atresia with 
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VSD (N=4), cor triatrium (N=1) and situs inversus (N=1). Corrective or palliative cardiac 
surgery was performed in 150 patients (75%) at a median age of 12 (3 – 37) years; the 
median number of surgical procedures performed was 1 (0–6). Eighteen of them had the 
first documented AF episode 1 (0 – 3) year before the initial surgical procedure.
First episode of atrial fibrillation
In the entire study population, the first episode of AF was documented at a mean age of 
49±17 years. As demonstrated in Figure 1, the age of AF onset was widespread in most 
of the various CHD groups. Yet, patients with ‘more complex’ defects such as TGA (35±7 
years) and UVH (29±11 years) mainly developed AF before the age of 40 years which 
is significant younger than patients with ASD (57±6 years, p<0.01), AVD (53±15 years, 
p<0.01) or VSD (54±18 years, p<0.01).
Echocardiographic findings <1 year prior to the first episode of AF were obtained in 
94 patients (47%). Thirty-nine patients (41%) were known with a septal defect (ASD N=9, 
VSD N=9), severe valvular dysfunction (aortic N=4, mitral N=4, pulmonary N=8, tricuspid 
Table 1. Baseline characteristics.
CHD n Males surgery age FP age initial aF
all 199 109 (55%) 150 (75%) 22±22 (0-77) yrs 49±16 (15-91) yrs
ASD 58 (29%) 28 (48%) 41 (71%) 34±18 (0–77) 57±6 (19–83)
AVD 34 (17%) 23 (68%) 20 (59%) 38±21 (1–66) 53±15 (23–82)
AVSD 4 (2%) 2 (50%) 3 (75%) 28±16 (13–44) 46±15 (31–66)
ccTGA 4 (2%) 3 (75%) 4 (100%) 25±30 (1–63) 47±16 (32–63)
CoA 9 (5%) 3 (33%) 8 (89%) 11±11 (1–28) 41±12 (29–65)
CorT 1 (1%) 0 – – 59
Ebs 4 (2%) 1 (25%) 2 (50%) 36±15 (25–46) 43±15 (25–62)
PA+VSD 4 (2%) 2 (50%) 3 (75%) 6±3 (3–9) 46±14 (34–64)
PDA 7 (4%) 2 (29%) 3 (43%) 31±24 (8–56) 55±12 (32–66)
PS 7 (4%) 6 (86%) 6 (86%) 20±21 (5–58) 47±11 (30–59)
SI 1 (1%) 0 – – 91
TGA 17 (8%) 9 (53%) 17 (100%) 1±1 (0–5) 35±7 (24–46)
ToF 21 (11%) 13 (62%) 20 (95%) 12±14 (0–58) 44±15 (17–72)
UVH 16 (8%) 10 (63%) 16 (100%) 5±8 (0–29) 29±11 (15–50)
VSD 12 (6%) 7 (58%) 7 (58%) 29±27 (0–62) 54±18 (18–81)
N (%) or mean±sd (range).
CHD = congenital heart defect; n = number of patients; FP = first procedure; yrs = Years;
asD = atrial septal defect; aVD = aortic valve defect; aVsD = atrioventricular septal defect; ccTGa = con-
genitally corrected transposition of the great arteries; Coa = coarctation of the aorta; CorT = cor triatrium; 
ebs = Ebstein anomaly; Pa+VsD = pulmonary valve atresia with ventricular septal defect; PDa = patent 
ductus arteriosus; Ps = pulmonary valve stenosis; si = situs inversus; TGa = transposition of the great arter-
ies; ToF = tetralogy of Fallot; uVH = univentricular heart; VsD = ventricular septal defect;
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N=8) and/or severe ventricular dysfunction (N=5). In addition, 29 patients (31%) had at 
most a moderate dysfunction of a valve (aortic N=5, pulmonary N=5, mitral N=7, tricus-
pid N=7) and/or ventricle (N=14). Among the patients without an echocardiographic 
report, 14 patients (13%) underwent a surgical procedure in the year of the first AF 
episode up to 3 years later for either an ASD (N=5) and/or valve repair (mitral valve N=1, 
tricuspid N=4, aortic N=8).
Co-existence of atrial tachyarrhythmia
Figure 2 shows examples of ECGs demonstrating a regular AT preceding development of 
AF observed in an ASD patient (upper panel) and a regular AT observed in a PS patient 
who initially presented with AF and was treated with class II AAD (lower panel).
AF co-existed with regular AT in 65 patients (33%) with 11 different types of CHD 
(upper panel Figure 3). As illustrated in the lower panel of Figure 3, regular AT was docu-
mented 3 (0 – 7) years before AF in 42 patients (65%); in the remaining 23 patients (35%) 
regular AT was observed only 4 (1 – 7) years after the initial episode AF. Patients with AF 
after a documented episode of regular AT (N=42; 44±14 years) tended to develop AF at 
a younger age compared to patients with only AF (N=157; 50±17 years, p=0.05), also 
partially due to a relative high number of patients with ‘complex’ CHD (e.g. TGA) and 
UVH with co-existence (p=0.09).
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Figure 1. Age at the time of first presentation with AF per type of CHD, with the mean age denoted by a 
bar.
ASD=atrial septal defect; AVD=aortic valve defect; AVSD=atrioventricular septal defect; ccTGA=congenitally 
corrected transposition of the great arteries; CoA=coarctation of the aorta; CorT=cor triatrium; Ebs=Ebstein 
anomaly; PA+VSD=pulmonary valve atresia with ventricular septal defect; PDA=patent ductus arteriosus; 
PS=pulmonary valve stenosis; SI=situs inversus; TGA=transposition of the great arteries; ToF=tetralogy of 
Fallot; UVH=univentricular heart; VSD=ventricular septal defect;
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Figure 2. Co-existence of regular AT with AF: ECGs obtained from a patient with an atrial septal defect (up-
per panel) and pulmonary stenosis (lower panel).
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Figure 3. Upper panel: Co-existence of AT and AF for every CHD group separately.
Lower panel: Co-existence classification according to either first AT or first AF per type of CHD.
ASD=atrial septal defect; AVD=aortic valve defect; ccTGA=congenitally corrected transposition of the great 
arteries; CorT=cor triatrium; PA+VSD=pulmonary valve atresia with ventricular septal defect; PDA=patent 
ductus arteriosus; PS=pulmonary valve stenosis; TGA=transposition of the great arteries; ToF=tetralogy of 
Fallot; UVH=univentricular heart; VSD=ventricular septal defect;
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initial treatment of atrial fi brillation
Therapy of AF at the moment of the fi rst presentation is summarized in Figure 4 and 5 for 
199 patients with complete repair, complex repair and UVH. At the initial presentation 
with AF, CV was performed in 73 (37%) patients and AAD were started in 79 (40%). Initial 
therapy could not be retrieved in 7 patients. During the follow-up period, ePVI (N=7) 
and surPVI (N=8) was performed in 14 patients, mainly with complete repair. surPVI was 
performed concurrent with other surgical procedures except for 1 patient. All ePVI and 
surPVI (N=14,7%) were successful during procedure although one patient with ePVI un-
derwent an additional surPVI 1 year after the initial procedure. Six patients underwent a 
pacemaker implantation followed by a His bundle ablation due to recurrent drug refrac-
tory AF episodes. Despite ablative therapy, episodes of AF were still found after a period 
of 5 (0 – 13) years in 5 of them (36%) and one patient developed a regular AT after surPVI.
Rhythm was evaluated in 197 patients after a follow-up period of 5 (2 – 11) years; two 
patients were lost to follow-up. At the end of the follow-up period, 21 patients (11%) had 
died at the age of 61±18 years (ASD: N=7, ToF: N=6, AVD: N=3, TGA: N=2, ccTGA: N=1, 
cor triatrium : N=1, UVH: N=1); only 7 (33%) of them were treated with AAD, ePVI and/
or surPVI. Causes of death were heart failure (N=11), (post-operative) infection (N=3), 
ventricular fi brillation (VF, N=2), respiratory insuffi  ciency (N=1), VF after defi brillator 
threshold-testing during ICD implantation (N=1) or unknown (N=3). Twelve patients 
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Figure 4. Flowchart showing the initial AF therapy and long-term outcome in patients with complete 
repair: aortic valve disease, atrial septal defect, cor triatrium, pulmonary stenosis, atrioventricular septal 
defect and ventricular septal defect. See text for detailed explanation.
AAD=anti-arrhythmic drugs; CV=cardioversion; HBA=His bundle ablation; ePVI= endovascular pulmonary 
vein isolation; surPVI=surgical pulmonary vein isolation.
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had AF prior to death. In the remaining 176 patients, the last ECG demonstrated AF in 69 
patients (39%); the other patients had sinus rhythm (N=72, 41%), atrial ectopic rhythm 
(N=11, 6%), AT (N=1, 1%) or paced rhythm (N=24, 14%). AF was most often found in the 
patients with ASD (N=26; 51%), whereas AF was only observed in 1 UVH patient (7%).
Progression of atrial Fibrillation
Progression of AF from paroxysmal to (long-standing) persistent/permanent AF over 
time was studied in a subgroup of 112 patients of whom at least a yearly ECG was 
available. As illustrated in Figure 6, progression was observed in 29 patients (26%). Four 
patients were already known with persistent AF when presenting for the fi rst time. AF 
progressed from paroxysmal to (long-standing) persistent/permanent AF after only 3 
(1 – 7) years in 29 patients, despite therapy aimed at rhythm control after the initial AF 
episode (AAD: N=20,69%, surPVI: N=3, 12%). In the 79 patients without progression to 
(long-standing) persistent/permanent AF, 77 (97%) were treated with AAD. Five patients 
(6%) also underwent an ePVI/surPVI.
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Figure 5. Left panel: fl owchart demonstrating the initial AF therapy and long-term outcome in patients 
with complex repair (coarctation of the aorta, congenitally corrected transposition of the great arteries, 
Ebstein anomaly, pulmonary atresia with ventricular septal defect, situs inversus, tetralogy of Fallot and 
transposition of the great arteries). See text for detailed explanation.
Right panel: fl owchart illustrating AF therapy and long-term outcome in patients with univentricular heart 
defects
AAD=anti-arrhythmic drugs; CV=cardioversion; HBA=His bundle ablation; ePVI= endovascular pulmonary 
vein isolation; surPVI=surgical pulmonary vein isolation.
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Thromboembolic complications of atrial fibrillation
Sixteen patients (8%) experienced a cerebrovascular event 14 (2 – 33) years before the 
initial AF episode (TIA N=5 and stroke N=11). In addition, AF was discovered in 3 patients 
when presenting with a stroke. Two of them were already using anti-coagulant drugs of 
whom one patient had a hemorrhagic stroke.
Furthermore, 9 patients (5%) had a cerebrovascular event 2 (1 – 6) years after the initial 
documented AF episode; including 6 TIA and 3 stroke. Five of them were using anti-
coagulant drugs; data regarding prescribed drugs was missing in 3 patients. Altogether, 
26 patients experienced a cerebrovascular event of whom 2 patients had a TIA as well 
as a stroke.
DisCussion
To our knowledge, this is the first study examining development of AF over time in a 
large cohort of CHD patients. Onset of AF occurred at a relatively young age, particu-
larly in patients with ‘complex’ CHD (TGA and UVH). Co-existence of episodes of AF and 
regular AT occurred in a considerable number of patients (33%). Most of them initially 
presenting with regular AT; this occurred more frequently in patients with complex de-
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Figure 6. Upper panel: Progression of paroxysmal AF to (long-standing) persistent /permanent AF in 29 
patients with a diverse CHD. See text for detailed explanation.
Lower panel: Kaplan-Meyer curve with the cumulative risk for progression from paroxysmal to (longstand-
ing) persistent/permanent AF.
ASD=atrial septal defect; AVD=aortic valve disease; CoA=coarctation of aorta; Ebs=Ebstein anomaly; 
ToF=tetralogy of Fallot; VSD=ventricular septal defect.
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fects such as TGA and UVH. Progression from paroxysmal to (long-standing) persistent 
AF was observed in patients with a variety of CHD, especially ASD, and occurred only 3 
years after the initial documented AF episode.
Development of (post-operative) aF
Areas of intra-atrial conduction delay or dispersion in refractoriness perpetuate AF.(10-
12) (13) Previous electrophysiological studies have demonstrated that multiple zones 
of intra-atrial conduction delay and increased dispersion in refractoriness are indeed 
present in patients with surgically corrected CHD.(14) Multiple or complex surgical pro-
cedures give rise to scarring with interposition of fibrotic tissue hampering intra-atrial 
conduction. Conduction abnormalities may be further aggravated by dilatation of the 
atria due to persisting pressure/volume overload after cardiac surgery, (15) or due to 
(longstanding) residual septal defects, valvular or ventricular dysfunction as observed 
in our study population. Dilatation of the atria also promotes triggered activity, giving 
rise to premature beats.(16, 17) Thus, a high number of premature beats combined with 
large areas of conduction delay and local dispersion in refractoriness increase the likeli-
hood for AF to occur in this patient group.
So far, observations on the mechanism underlying AF in CHD patients are rare. Map-
ping studies in patients without CHD have demonstrated that the mechanism under-
lying AF may be either focal activity giving rise to fibrillatory conduction or multiple, 
narrow, independently propagated fibrillatory waves.(18) Ectopic activity giving rise 
to fibrillatory conduction and hence AF on the surface ECG has been described in a 
patient with Fontan circulation and a TGA patient who had undergone an arterial switch 
procedure.(19) The origin of ectopic activity was found in respectively the right atrial 
septum and right atrial free wall and AF was eliminated by encircling the area of focal 
activity in both patients.(19)
aging and atrial Fibrillation
Patients in our study with ASD, AVD and VSD developed AF between the fifth and sixth 
decade. As demonstrated in the Rotterdam and Framingham Study, the incidence of 
AF in the general population starts to increase in the fifth decade.(20, 21) Thus, CHD 
patients with these defects developed AF in the same decade as subjects in the general 
population. However, patients with other defects, in particular UVH and TGA, frequently 
developed AF already in the third or fourth decade. It is therefore likely that develop-
ment of AF in CHD patients is not only a result of aging.
Co-existence of aT and aF
Co-existence of AF with regular AT was found in 33% of our population. Kirsh et al. 
examined the relation between IART and AF in CHD patients who underwent electrical 
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cardioversion.(6) They found that only 17 out of 149 subjects had both AFL and AF; there 
was no evidence for progression from AFL to AF in these patients or vice versa.(6)
Ghai et al. observed in a cohort of Fontan patients that development of atrial arrhyth-
mias, including AF and regular AT, was related to a higher number of surgical procedures.
(22) Cardiac surgery results in e.g. atrial incisions and insertion of prosthetic materials 
and the post-operative (persisting) pressure/volume overload may further give rise 
to extensive atrial scarring.(23-25) These alterations facilitate development of macro 
reentrant tachycardia as the reentry wavelet can circulate around surgically inserted 
prosthetic materials, suture lines and areas of scar tissue. Focal AT also frequently arise in 
CHD patients as low voltage areas result in diminishing electrical coupling thereby facili-
tating ectopic activity. Regular AT cause electrical remodeling, consisting of shortening 
of atrial refractoriness and inverse rate adaptation, thereby facilitating development of 
AF.(26, 27) This may explain why regular AT preceded development of AF in a large pro-
portion of our population. These findings suggest that catheter ablation of regular AT, 
which is nowadays an accepted treatment modality with a reported successful outcome 
of at least 70% in patients with CHD, could prevent or delay the development of AF in 
some CHD patients.(19, 28, 29)
In some patients episodes of regular AT were documented only after development of 
AF. It could simply be that episodes of AF and AT alternate in CHD patients, due to e.g. 
formation of a functional line of conduction block between the caval veins (30, 31) and 
that the “first AF” or “first regular AT” episode is just a matter of which tachycardia is by 
chance documented.
Recurring episodes of AF may also play an important role in the progression of parox-
ysmal to persisting AF. Twenty-six percent of our population showed deterioration from 
paroxysms of AF to (long-standing) persistent/permanent AF. Progression to persistent 
or permanent AF has been reported up to 18% and 25% in patients without CHD after a 
follow-up period of respectively 4 and 5 years.(32, 33)
In patients without CHD, electrical and structural remodeling both contribute to the 
persistence of AF, (34) which might be aggravated by chronic atrial stretch due to persis-
tent pressure/volume overload.(35) However, at present there are no data available on 
the relation between remodeling and progression from paroxysmal to (long-standing) 
persistent/permanent AF in CHD patients. Older age at the moment of first AF presenta-
tion may influence progression to (long-standing) persistent/permanent AF as patients 
with progression in the European Heart Survey tended to be older than those who did 
not.(36) In our study population, progression of paroxysmal to (long-standing) persis-
tent/permanent AF was relatively often observed in patients with ASD; a group that 
presents with AF at a relative old age compared to the other groups.
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Role of the Pulmonary Vein area
Deal et al. reported on surgical treatment of atrial arrhythmias in patients with a Fontan 
correction.(37) After palliative surgery combined with a Cox-Maze III procedure in 76 pa-
tients with AF, there were no recurrences observed. ePVI has been reported as well.(38) 
Likewise our study, ePVI was especially performed in patients with complete repaired 
defects such as ASD and VSD. After a follow-up period of 4 years, 27% was successfully 
treated which was comparable to patients without CHD (36%; p=0.46). In a study by 
Kirsh et al., patients who underwent palliative surgery or with residual left ventricular 
valvular lesions tended to develop AF more frequently.(6) A substantial part of our study 
population was uncorrected at the time of presentation or needed a reoperation for val-
vular regurgitation/stenosis or residual shunting. These data suggest that the posterior 
left atrial wall also plays a role in the development of AF in CHD patients, possibly due to 
remodeling after long-term volume and pressure overload.
Cerebrovascular complications of atrial Fibrillation
The total incidence of TIA/stroke in our population was 13%. However, a considerable 
number of cerebrovascular events occurred before the initial documented AF episode. 
We cannot exclude that these patients had asymptomatic AF episodes. In patients with 
lone AF without concomitant heart disease, there is a lower incidence of TIA/stroke 
compared to our study population.(39) Six percent had a TIA/stroke during a long-term 
follow-up period of 15 years. Hoffmann et al. also demonstrated a higher risk of cerebro-
vascular accidents in CHD patients. A 10 to 100-fold higher risk to develop CVA was found 
in the relative young CHD population, with and without atrial arrhythmias, compared 
with patients of the same age.(40) A higher CVA rate was associated with absence of sinus 
rhythm and cyanotic heart disease. Therefore, other risk stratifications might be neces-
sary in order to prevent cerebrovascular events in CHD patients with, but also without AF.
Limitations
Due to the retrospective design of this multicenter study, data on exact surgical details 
or prescribed anti-arrhythmic/anticoagulant drugs during the entire follow-up period 
were insufficient for some patients. Onset of AF was defined as the first documenta-
tion of an AF episode using available ECG or 24-hour Holter monitoring. Asymptomatic 
paroxysms of AF could therefore have been missed. In addition, differentiation between 
(long-standing) persistent or permanent AF could not always be made. Furthermore, 
due to the selection of patients with a yearly ECG to assess to progression of parox-
ysmal to longstanding persistent/permanent AF, the relative number of patients with 
progression might have been overestimated compared to patients encountered in daily 
practice. Patients in this study underwent the first surgical procedure at a relatively older 
age compared to newborn CHD patients nowadays.
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ConCLusions
CHD patients develop AF at a young age, particularly in patients with complex defects, 
and progress frequently from paroxysmal AF to (long-standing) persistent/permanent 
AF. Co-existence of episodes of AF and regular AT occurred in a considerable number 
of patients; most of them initially presented with regular AT. The findings of our study 
suggest that aggressive therapy and close follow-up of CHD patients with atrial tachyar-
rhythmia is justified. Early (ablative) therapy for regular AT could theoretically prevent 
development of AF and hence also reduce long-term complications such as stroke.
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absTRaCT
Background: sustained ventricular tachycardia (susVT) and ventricular fibrillation (VF) 
are observed in adult patients with congenital heart disease (CHD). These dysrhythmia 
may be preceded by non-sustained ventricular tachycardia (NSVT). The aims of this 
study are to examine the 1] time course of ventricular tachyarrhythmia (VTA) in a large 
cohort of patients with various CHDs and 2] the development of susVT/VF after NSVT.
Methods: in this retrospective study, patients with VTA on ECG, 24-hour Holter or ICD-
printout or an out-of-hospital-cardiac arrest due to VF were included. In patients with an 
ICD, the number of shocks were studied.
Results: patients (N=145 patients, 59% male) initially presented with NSVT (N=103), 
susVT (N=25) or VF (N=17) at a mean age of 40±14 years. Prior to VTA, 58 patients had 
intraventricular conduction delay, 14 an impaired ventricular dysfunction and 3 had 
coronary artery disease. susVT/VF rarely occurred in patients with NSVT (N=5). Fifty-two 
(36%) patients received an ICD; appropriate and inappropriate shocks, mainly due to 
supraventricular tachycardia (SVT), occurred in respectively 15 (29%) (NSVT: N=1, susVT: 
N=9, VF: N=5) and 12 (23%) (NSVT: N=4, susVT: N=5, VF: N=3) patients.
Conclusion: VTA in patients with CHD appear on average at the age of 40 years. susVT/
VF rarely developed in patients with only NSVT, whereas recurrent episodes of susVT/VF 
frequently developed in patients initially presenting with susVT/VF. Hence, a wait-and-
see treatment strategy in patients with NSVT and aggressive therapy of both episodes 
of VTA and SVT in patients with susVT/VF seems justified.
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inTRoDuCTion
Sustained ventricular tachycardia (susVT) and ventricular fibrillation (VF) are recognized 
as late complications in adult patients with congenital heart defects (CHD).(1) The re-
ported prevalence of these dysrhythmia is up to 30% and increases with an older age.
(2-5) susVT and VF have mainly been reported in patients with tetralogy of Fallot (ToF) 
and transposition of the great arteries (TGA).
Various factors, such as surgical incisions, patches, ventricular volume and/or pressure 
overload contribute to development of susVT/VF.(6) It has been suggested that scarring 
of ventricular tissue after cardiac surgery in ToF patients might give rise to enhanced 
automaticity or reentry with susVT as a consequence.(7-10) These dysrhythmia increase 
both morbidity and mortality in CHD patients and are associated with sudden cardiac 
death (SCD) in ToF and TGA patients.(11-13) It is therefore of utmost importance to 
determine whether the development of these life-threatening dysrhythmia in patients 
with CHD can be predicted.(6, 11) So far, prolongation of the QRS duration complex in 
both ToF (≥180ms) and TGA (≥140ms) patients has been identified as a sensitive predic-
tor for development of ventricular tachycardia.(2, 5, 14) The prognostic value of non-
sustained VT (NSVT) detected during ambulatory monitoring in CHD patients has mainly 
been investigated in ToF patients and remains debatable. NSVT predicted implantable 
cardioverter defibrillator (ICD) shocks in these patient groups, (15, 16) although other 
studies did not find a correlation between NSVT or (asymptomatic) ventricular runs and 
development of susVT or sudden cardiac death.(2, 17)
The purpose of this multicenter study is to examine 1) the time course of ventricular 
tachyarrhythmia (VTA) including NSVT, susVT and VF and 2) the occurrence of susVT or 
VF after earlier NSVT in a large cohort of patients with a variety of CHDs.
MeTHoDs
This retrospective study is part of the “DysrhythmiAs in patients with congeNitAl heaRt 
diseAse” (DANARA) project (MEC-2012-482), which was approved by the local medical 
ethical committee of the Erasmus University Medical Center Rotterdam. According to 
Dutch law, informed consent was not required for this project.
study Population
Patients were included in this study if they presented either at the emergency room or 
at the outpatient clinic with a VTA in the following centers: Erasmus University Medical 
Center, Rotterdam; Amphia Hospital, Breda; Medisch Spectrum Twente, Enschede; VU 
Medical Center, Amsterdam; Haga Hospital, The Hague; Catharina Hospital, Eindhoven; 
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and Cardiology, Inselspital, University of Bern, Switzerland. A documented dysrhythmia 
was identified on a surface electrocardiogram (ECG), 24-hour Holter recording or pace-
maker/implantable cardioverter defibrillator printout. For this study, CHD patients with 
documented VTA episode before January 2014 were included. The follow-up period is 
defined as the time between the initial VTA until the last visit to the outpatient clinic 
in June 2014. Patients who received an ICD as part of secondary prevention after an 
out-of-hospital cardiac arrest were also included.
Clinical Characteristics
After inclusion, subsequent clinical and demographic information prior to VTA was 
retrospectively collected for the purpose of this study. Clinical data consisted of type 
of CHD, number and time-interval of corrective/palliative surgical procedures, ablative 
therapy, indications for an ICD and death.
Patients with aortic valve disease (AVD), atrial septal defect (ASD), atrioventricular sep-
tal defect, coarctation of the aorta, mitral valve insufficiency, patent ductus arteriosus, 
pulmonary stenosis and ventricular septal defect (VSD) were considered as having a 
complete repaired/simple CHD. The rest of the patients were classified as complex CHD. 
In case of an ICD implantation after the VTA, the number of delivered appropriate and 
inappropriate shocks was also documented. Echocardiogram obtained before the first 
VTA were used to determine left and/or right ventricular function and classified accord-
ing to the guidelines.(18) Classification of the ventricular function was based on ejection 
fraction; an ejection fraction ≤35% was considered as impaired.
analysis of rhythm registrations
Surface ECG, 24-hour Holter registrations and ICD printouts were examined in order to 
assess the occurrence of episodes of VTA including NSVT, susVT or VF. Non-sustained 
VT was defined as ≥3 consecutive ventricular beats with a frequency >100 beats per 
minute and a duration ≤30 seconds and not interrupted by anti-tachycardia pacing or 
delivery of an electrical shock. The last available ECG within a year prior to onset of VTA 
was selected to assess mean QRS duration. QRS duration of ≥120ms was considered as 
prolonged; QRS duration was not measured in ventricular paced rhythm.
statistical analysis
Continuous variables were expressed as mean±SD or median (range) depending on the 
distribution. Categorical data were denoted by percentages. Patient groups were com-
pared with conventional group descriptive statistics. The Mann-Whitney U, t-test, X² test 
or Fisher’s exact test was used to evaluate statistical significance of characteristics and 
frequencies where appropriate. Missing data are described in the text and excluded in 
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the calculations. Statistical analysis was performed with SPSS, version 21 (IBM, Armonk, 
New York). A P-value of <0.05 was considered statistically significant.
ResuLTs
study population
The study population consisted of 145 CHD patients with ToF (N=42), TGA (N=19), 
univentricular heart (UVH, N=18), aortic valve disease (N=18), atrial septal defect (ASD, 
N=14), coarctation of the aorta (N=6), congenitally corrected TGA (ccTGA, N=6), pulmo-
nary stenosis (PS, N=6), ventricular septal defect (N=6), truncus arteriosus (N=3), mitral 
Table 1. Characteristics of the study population.
CHD n Males surgery age FP age VTa
all 145 86 (59%) 137 (94%) 12±16 (0-70) yrs 40±14 (15-70) yrs
ASD 14 (10%) 8 (57%) 13 (93%) 30±22 (1-70) yrs 48±14 (21-70) yrs
AVD 18 (12%) 13 (72%) 17 (94%) 27±15 (8-57) yrs 50±12 (29-68) yrs
AVSD 1 (1%) 0 (0%) 1 (100%) 11 yrs 28 yrs
ccTGA 6 (4%) 5 (83%) 4 (67%) 26±14 (15-43) yrs 43±17 (22-64) yrs
CoA 6 (4%) 2 (33%) 6 (100%) 13±12 (1-32) yrs 42±14 (21-57) yrs
Ebs 1 (1%) 0 (0%) 0 (0%) – 48 yrs
LVA 1 (1%) 1 (100%) 1 (100%) 11 yrs 18 yrs
MI 2 (1%) 2 (100%) 1 (50%) 22 yrs 36±26 (17-54) yrs
PDA 2 (1%) 0 (0%) 2 (100%) 18±11 (10-26) yrs 48±13 (38-57) yrs
PS 6 (4%) 5 (83%) 6 (100%) 18±22 (2-58) yrs 53±11 (37-65) yrs
TA 3 (2%) 1 (33%) 3 (100%) 0±0 (0) yrs 26±7 (19-33) yrs
TGA 19 (13%) 15 (79%) 19 (100%) 1±2 (0-10) yrs 32±7 (15-42) yrs
ToF 42 (28%) 25 (60%) 42 (100%) 6±9 (0-55) yrs 40±13 (18-69) yrs
UVH 18 (12%) 7 (39%) 18 (100%) 2±4 (0-16) yrs 28±10 (16-46) yrs
VSD 6 (4%) 4 (67%) 4 (67%) 28±24 (0-49) yrs 43±18 (18-62) yrs
Simple 55 (38%) 34 (62%) 50 (91%) 24±18 (0 – 70) 47±14 (17 – 70)
Complex 72 (50%) 47 (65%) 69 (96%) 6±10 (0 – 55) 37±13 (15 – 68)
UVH 18 (12%) 7 (39%) 18 (100%) 2±4 (0-16) yrs 28±10 (16-46) yrs
N (%) or mean±sd (range)
CHD = congenital heart defect; n = number of patients; FP = first procedure; yrs = Years; asD = atrial septal 
defect; aVD = aortic valve disease; aVsD = atrioventricular septal defect; ccTGa = congenitally corrected 
transposition of the great arteries; Coa = coarctation of the aorta; ebs = Ebstein anomaly; LVa = left ven-
tricular aneurysm; Mi = mitral valve insufficiency; PDa = patent ductus arteriosus; Ps = pulmonary valve 
stenosis; Ta = truncus arteriosus; TGa = transposition of the great arteries; ToF = tetralogy of Fallot; uVH = 
univentricular heart; VsD = ventricular septal defect
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valve disease (N=2), patent ductus arteriosus (N=2), atrioventricular septal defect (N=1), 
left ventricular aneurysm (N=1) and Ebstein anomaly (N=1); characteristics of the vari-
ous CHD groups are summarized in Table 1.
Ninety-two percent of the patients (N=134) underwent corrective/palliative cardiac 
surgery prior to onset of the VTA at a mean age of 12±16 years. Mean age of the first sur-
gical procedure differed among patients with a complex defect (median 2 years; range 0 
– 55) compared to patients with a simple defect (median 21 years; range 0 – 70) (p<0.01).
Only 11 patients (8%) did not have a history of corrective/palliative cardiac surgery 
at the time of the first presentation with a VTA (AVD N=2; ASD N=1; ccTGA N=3; Ebstein 
anomaly N=1, mitral valve disease N=2 and VSD N=2); 3 of them underwent cardiac 
surgery after revelation of the first VTA.
Presentation of ventricular tachyarrhythmia
Patients presented with either NSVT (N=103, 71%), susVT (N=25, 17%) or VF (N=17, 12%); 
Figure 1 illustrates the age at first presentation of the VTA for every CHD separately. The 
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Figure 1. Age at the moment of first presentation with VTA.
Patients were classified according to the type of CHD for NSVT (orange), VT (purple) and VF (red) separately. 
The horizontal bars indicate the average age in years.
ASD = atrial septal defect; AVD = aortic valve disease; AVSD = atrioventricular septal defect; ccTGA = con-
genitally corrected transposition of the great arteries; CHD = congenital heart defect; CoA = coarctation of 
the aorta; Ebs = Ebstein anomaly; LVA = left ventricular aneurysm; MI = mitral valve insufficiency; PDA = 
patent ductus arteriosus; PS = pulmonary valve stenosis; TA = truncus arteriosus; TGA = transposition of the 
great arteries; ToF = tetralogy of Fallot; UVH = univentricular heart; VSD = ventricular septal defect
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first episode of VTA occurred at a mean age of 40±14 years (15–70); age of develop-
ment of NSVT (40±14 years), susVT (36±13 years) and VF (44±16 years) were comparable 
(p>0.05).
Clinical data regarding coronary artery disease was available in 114 patients; only 3 
patients presenting with either NSVT (N=2; ccTGA and CoA) or VF (N=1; ToF) had un-
dergone percutaneous coronary intervention (N=2) or coronary artery bypass surgery 
(N=1) for obstructive coronary artery disease. Information on ventricular function and 
QRS duration is summarized in Table 2.
In patients with UVH (N=11, 30±12 years) and complex CHD (N=48, 38±13 years) 
NSVT developed at a relative young age compared to patients with a simple CHD (N=44, 
45±13 years; p=0.001 and p=0.017).
VTAs (susVT and VF) occurred at a relative young age in patients with UVH (N=7, 
26±8 years) and complex CHD (N=24, 36±11 years), whereas patients with simple CHD 
appeared to be older at the time of presentation with susVT/VF (N=11, 56±13 years; 
p<0.01).
The time window between the first surgical procedure and documentation of VTA 
was similar for either NSVT (28±13 years), susVT (27±12 years, p>0.05) and VF (28±13 
years, p>0.05). Within the pre-operative and uncorrected VTA group (N=11), 7 patients 
developed NSVT (39±18 years), 1 susVT (62 years) and 3 VF (58±10 years).
Table 2. Ventricular function and QRS duration.
all
n=145
nsVT
n=103
susVT
n=25
VF
n=17
echocardiography, n (%) 122 (84) 89 (86) 22 (88) 11 (65)
- impaired ventricular function (%) 14 (11) 8 (9) 2 (9) 4 (36)
QRs, n (%) 97 (67) 80 (78) 12 (28) 5 (29)
QRs duration, mean±sD 134±32 129±29* 157±35* 149±28
- Prolonged, n (%) 58 (60) 43 (54) 10 (83) 4 (80)
- ToF ≥180ms, n (%) 5 (19) 2 (10) 3 (50) 0
- TGa ≥140ms, n (%) 5 (31) 4 (33) 1 (25) 0
The number of patients with echocardiography and an impaired left and/or right ventricular function.
Electrocardiograms with mean QRS duration and the number of patients with prolonged QRS duration 
(≥120ms). Additionally, patients with ToF and QRS duration ≥180ms and patients with TGA and QRS dura-
tion ≥140ms are summarized.
sD = standard deviation; * = statistical significant difference (p < 0.05)
impaired venctricular function = ejection fraction ≤35%
nsVT = non-sustained ventricular tachycardia; VF = ventricular fibrillation; susVT = sustained ventricular 
tachycardia; TGa = transposition of the great arteries; ToF = tetralogy of Fallot
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iCD-implantation and follow-up
Patients were followed for a median period of 5 years (range: 0–27) after their first VTA. 
Figure 2 illustrates the long-term outcome of the 103 patients who presented with NSVT. 
In these patients 15% of the initial ventricular runs were 10 beats or longer; none of these 
patients developed susVT/VF. The other episodes consisted mainly of 3 (47%), 4 (15%) 
or 5 (11%) consecutive beats. Sixteen patients (16%) had an ICD implanted for inducible 
susVT during an electrophysiology study (25%), severe decreased ventricular function 
and NSVT (19%) or symptomatic NSVT (13%). In 7 patients, the exact indication for ICD 
implantation could not be retrieved from the available hospital records. Only one patient 
(6%) who received an ICD for an unknown cause received appropriate shocks (susVT: 
N=1) and three patients (19%) received inappropriate shocks as a result of supraventricu-
lar tachycardia (SVT) during a median follow-up period of 4 years (range: 0–15). Of the 
remaining 87 patients without ICD (84%), 3 patients (3%) were resuscitated as a result 
of susVT/VF and another patient with ToF developed a hemodynamic stable susVT. One 
patient died and the other three received an ICD; inappropriate shocks occurred in one. 
Altogether, 5 patients (5%) who initially presented with NSVT developed susVT/VF over 
time. Among these 5 patients, there were 3 CHD patients (7%) with a complete repaired/
simple defect who were followed for a median period of 5 years (range 0 – 15). The TGA 
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Figure 2. Time course of NSVT.
Flowchart demonstrating the time course of VTA in patients initially presenting with NSVT.
ASD = atrial septal defect; AVD = aortic valve disease; AVSD = atrioventricular septal defect; ccTGA = con-
genitally corrected transposition of the great arteries; CoA = Coarctation aorta; MI = mitral valve insufficien-
cy; PDA = patent ductus arteriosus; PS = pulmonary stenosis; TA = truncus arteriosus; TGA = transposition 
of the great arteries; ToF = tetralogy of Fallot; UVH = univentricular heart; VSD = ventricular septal defect
SH A = appropriate shocks; SH I = inappropriate shocks; SH A+I=appropriate and inappropriate shocks; VF 
= ventricular fibrillation
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and ToF patient who developed susVT/VF had a QRS of respectively <140ms and <180ms 
during the initial NSVT and none of the 5 patients had coronary artery disease. Seven 
patients (7%) died of heart failure (N=3), perioperative death after re-operation (N=1), 
VF (N=1), asystole after defibrillator threshold test during ICD implantation (N=1) and 
of unknown cause (N=1). Only one of the patients, who died of heart failure, had an ICD.
As demonstrated in the flowchart in Figure 3, the majority of the patients presenting 
with susVT (N=17, 68%) had an ICD implanted. Ablative therapy of susVT was performed 
in only 5 patients; (ToF: N=3, UVH: N=2). Ablative therapy resulted in non-inducibility of 
susVT in two of them (ToF: N=1; UVH: N=1). Appropriate shock therapy was delivered 
to 9 patients (53%, VF in 1 patient) after 5 years (0–13). Five patients (29%) received 
inappropriate shocks due to SVT of whom 4 also had appropriate shocks. One of these 
patients died as a result of ongoing VF despite multiple ICD shocks and 3 patients due 
to heart failure. Another patient with initial susVT did not receive an ICD and died within 
the same year as the susVT emerged; circumstances of death were unknown.
An ICD was implanted in all patients (N=17) presenting with VF (Figure 4), except for 1 
ToF patient (59 years) with coronary artery disease who refused an ICD. During a follow-
up of 4 years (0–9), shock therapy was delivered in 7 patients (appropriate: N=4, 25%, 
inappropriate N=2, 13% or a combination N=1, 6%). Of the patients with VF, four (25%) 
died after 3 years (1–6) due to heart failure (N=1), urosepsis (N=1), pneumonia (N=1) and 
bronchial carcinoma (N=1).
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Figure 3. Time course of susVT.
Flowchart illustrating the time course of VTA in patients initially presenting with susVT.
ASD = strial septal defect; LVA = left ventricular aneurysm; TA = truncus arteriosus; TGA = transposition of 
the great arteries; ToF = tetralogy of Fallot; UVH = univentricular heart; VSD = ventricular septal defect, SH 
A = appropriate shocks; SH I = inappropriate shocks; SH A+I=appropriate and inappropriate shocks; VF = 
ventricular fibrillation
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In the entire study population 16 patients (11%) with either NSVT, susVT or VF died. 
ICD’s were implanted in 52 patients (36%) of whom 15 (29%) received appropriate 
shocks, in particular in patients with susVT and VF. Inappropriate shocks occurred in 12 
(23%) patients, especially in patients with VT.
DisCussion
Patients with CHD, in particular adults, are at risk for sudden cardiac death caused by 
VTA. This study described development of VTA over time in patients with a variety of 
CHD presenting with either NSVT, susVT or VF. Most patients had a history of cardiac 
surgery and presented first with NSVT; susVT or VF occurred less frequently. Interest-
ingly, patients with documented NSVT, normal to moderate prolonged QRS duration 
and at least a moderate cardiac function rarely developed susVT or VF during a follow-
up period of 5 years. In patients with susVT and VF, recurrent episodes of VTA occurred 
in a considerable number of patients. In addition, the incidence of SVT was also high.
Prognostic value of non-sustained Ventricular Tachyarrhythmia
Patients with CHD are at risk for developing VTA. VTA in this population results most 
often due to macro-reentry, but might also be the result of either stretch-induced auto-
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Figure 4. Time course of VF.
Flowchart demonstrating the time course of VTA in patients initially presenting with VF.
ASD = strial septal defect; AVD = aortic valve disease; ccTGA = congenitally corrected transposition of the 
great arteries; CoA = Coartation aorta; Ebs = Ebstein anomaly; TGA = transposition of the great arteries; ToF 
= tetralogy of Fallot; UVH = univentricular heart
SH A = appropriate shocks; SH I = inappropriate shocks; SH A+I=appropriate and inappropriate shocks
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maticity or triggered activity comparable with patients with cardiomyopathy.(7, 19, 20) 
Areas of scar tissue or suture lines caused by surgical procedures often serve as borders 
of reentry circuits.(20, 21) In addition, the on-going post-operative ventricular overload 
causes ventricular remodeling giving rise to abnormalities in conduction which further 
increase the likelihood for developing VTA. Sudden cardiac death has mainly been ob-
served in patients with ToF, TGA, UVH, CoA and AVD.(5, 11, 22-24) In line with this finding, 
the underlying CHD presented with VTA in our study population was also mainly ToF 
(28%), (cc)TGA (17%), UVH (13%) and AVD (12%). However, there was also a considerable 
number of ASD patients (10%).
susVT/VF developed in only five patients with documented NSVT. Previous studies in 
ToF patients did not find a relation between asymptomatic NSVT during 24-hour Holter 
recordings and development of VT (2, 17) whereas more recent studies demonstrated 
that (symptomatic) NSVT in CHD patients is a predictor for appropriate shocks in pa-
tients with an ICD for primary prevention.(15, 16) Based on these findings, the guidelines 
suggest that ICD therapy is reasonable in ToF patients with multiple risk factors such as 
NSVT.(18) Data from our study suggest that in CHD patients with a moderate to good 
ventricular function, normal or limited conduction delay and NSVT, a wait-and-see treat-
ment strategy seems justified. This strategy seems not only applicable for ToF patients, 
but seems also applicable for CHD patients with a complete repaired/simple defect and 
other complex defects (e.g. TGA, CoA and UVH). However, most patients had NSVT with 
a short duration and only 15% had NSVT lasting 10 beats or longer. In addition, we only 
had a limited number of 24-hours recordings available and longer, asymptomatic NSVT 
could therefore have been missed. The burden of NSVT over time could be a more ac-
curate predictor of susVT/VF. Future prospective studies evaluating the burden of susVT/
VF using new recording devices (e.g. implantable loop recorders) could therefore be 
useful to further elucidate the importance of NSVT. In addition, further research focusing 
on the role of NSVT in different types of CHD separately might give more insight in the 
predictive value of NSVT for development of susVT/VF. Nevertheless, we think that our 
current observation – the presence of NSVT without the occurrence of susVT/VF in the 
majority of patients during a 5-years follow up period – does not support a predictive 
value of NSVT as a single risk factor for development of susVT/VF.
In contrast, a relative high incidence of appropriate shocks occurred in patients who 
received an ICD for susVT (53%) and VF (31%) during 5-years follow-up. This observation 
is in line with other studies showing that during a follow-up period of 4 years, appropri-
ate shocks occurred in 30% of CHD patients who received an ICD for secondary preven-
tion.(4, 15)
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supraventricular tachycardia
Unfortunately, there was a high incidence of inappropriate shocks (22%) caused by 
SVT, especially in patients with susVT (29%), suggesting a more advanced stage of the 
cardiomyopathy. Other studies reported comparable or even higher incidences of inap-
propriate shock, ranging from 25 to 41%.(15, 25) Hence, these findings emphasize that 
(ablative) therapy aimed at eliminating SVT is mandatory in this patient group.(26-28)
Limitations
Due to the retrospective design of the study, we may have underestimated the occur-
rence of VTA, in particular NSVT, as a result of asymptomatic VTA episodes. In addition, as 
a result of the observational study design and the inclusion of all patients with a VTA, it 
was impossible to retrospectively add a control group without a high chance of selection 
bias. The relative risk is therefore missing in the study as well. Data of intraventricular 
conduction delay and depressed cardiac function was not available in all patients.
ConCLusion
VTA in patients with CHD appear on average at the age of 40 years, which is about thirty 
years after the first surgical procedure. susVT or VF rarely develops in patients with NSVT 
and a moderate ventricular function whereas recurrent episodes of both VT or SVT fre-
quently develop in patients with susVT or VF. Hence, a wait-and-see treatment strategy 
in patients with solely NSVT and aggressive therapy of both episodes of susVT and SVT 
in patients with susVT/VF seems justified.
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absTRaCT
Aims: fragmented QRS complexes (fQRS) on 12-lead ECG are known predictors of ven-
tricular tachyarrhythmia (VTA) in patients with coronary artery disease. There is limited 
knowledge of the clinical implications of fQRS in patients with congenital heart defects 
(CHD). Aims of this study were to examine 1) the occurrence of fQRS in patients with 
various types of CHD and 2) whether fQRS is associated with development of VTA.
Methods: this study was designed as retrospective case-control study. CHD patients 
with VTA were included and matched with control patients of the same age, gender and 
CHD type Clinical data and fQRS were analysed and compared.
Results: the initial VTA episode developed in 139 CHD patients at a mean age of 
39±14years. Compared to controls (N=219, age 38±13 years), QRS-duration was longer 
in VTA patients (110ms vs 100; p<0.01). Furthermore, fQRS was more frequently ob-
served in VTA patients in the last ECG prior to VTA (N=73 (53%) vs N=67 (31%); p<0.001); 
especially in patients with sustained VTA (64%). Multiple conditional logistic regression 
demonstrated more fQRS (OR 2.9, 95% CI 1.5–5.8; p=0.002), non-systemic ventricular 
dysfunction (OR 5.1, 95% CI 2.1–12.4; p<0.001) and more prolonged QRS complexes (OR 
2.8, 95% CI 1.3–6.2; p=0.011) in VTA patients.
Conclusion: the presence of fQRS on ECG may be a useful tool in daily clinical practice 
to identify patients at risk for developing VTA in patients with CHD, in addition to known 
predictors of VTA.
Keywords:
Electrocardiography, Congenital Heart Disease, Ventricular Tachyarrhythmia, QRS frag-
mentation, Risk Stratification
Condensed abstract
This study examined the occurrence of fragmented QRS complexes (fQRS) and associa-
tion with development of VTA in patients with congenital heart defects (CHD). Results 
suggest fQRS is common in patients with CHD and is associated with development of 
VTA. Therefore, fQRS may be useful to predict VTA in CHD patients.
what’s new?
– Our data show fragmented QRS complexes are not uncommon in patients with dif-
ferent types of congenital heart disease.
– Fragmented QRS complexes are increasingly observed before a ventricular tachyar-
rhythmia.
– Fragmented QRS complexes may therefore be used in daily clinical practice for the 
risk stratification of cardiac death in adult patients with congenital heart disease.
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inTRoDuCTion
The survival rate of patients with congenital heart defects (CHD) into their adulthood has 
increased significantly during the past decades.(1) Ventricular tachyarrhythmia (VTA) is 
one of the leading causes of (sudden) death in these adult CHD patients.(2) However, 
predictors to assess the risk of sudden death caused by ventricular arrhythmias in CHD 
patients are limited.(3)
Fragmentation of QRS complexes (fQRS) on surface electrocardiograms (ECG), defined 
as additional R waves (R’) or S waves (S’) in the QRS complex, has been observed in 
patients with coronary artery disease.(4) In these patients, fQRS is associated with devel-
opment of cardiac events such as myocardial infarction or (sudden) cardiac death and a 
higher rate of all-cause mortality.(5, 6) Besides that, fQRS were more sensitive to detect 
prior myocardial infarction compared to the frequently used pathological Q-waves in 
electrocardiograms.(4)
fQRS in CHD patients have been described in patients with tetralogy of Fallot (ToF) and 
is associated with extensive right ventricular scarring.(7) Furthermore, in patients with 
Ebstein’s anomaly fQRS is associated with a larger atrialized ventricular volume and the 
occurrence of an arrhythmic event.(8) However, fQRS and the relation with ventricular 
arrhythmic events have not yet been studied in various other CHD types.
The purpose of this retrospective case-control study is 1) to examine the occurrence of 
fQRS in patients with various types of CHD and 2) to evaluate whether fQRS is associated 
with development of VTA.
MeTHoDs
This retrospective case-control study was conducted as part of the “DysrhythmiAs in pa-
tients with congeNitAl heaRt diseAse” (DANARA) project (MEC-2012-482) at the Erasmus 
Medical Center in Rotterdam, The Netherlands. The study protocol was approved by the 
local ethics committee (MEC-2012-482); informed consent was waived.
Patient selection
CHD patients with documented VTA episode on a surface ECG or 24-hour Holter reg-
istration before March 2016 in one of the tertiary medical centers were included. VTA 
episodes consisted of non-sustained VT (≥3 consecutive ventricular beats with a rate 
>100/min with a duration <30 seconds), sustained VT and VF. Patients with ventricular 
pacing or missing of an electrocardiogram (ECG) were excluded.
All patients with a VTA were matched with control patients without VTA by type of 
underlying CHD, age (at the moment of the initial VTA episode) and gender. Every VTA 
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patient was matched with 2 controls if possible, otherwise solely 1 control was matched. 
Patients were excluded when no suitable control match was found. Selection of control 
patients by the investigators was done without information of the ECGs.
eCG selection
For VTA patients the last recorded ECG prior to VTA was retrieved. For control patients, an 
ECG matching the date of the VTA ECG as closely as possible was selected.
eCG analysis
We determined fQRS and QRS duration by using a standard 12-lead ECG (fi lter range 
0.05–150 Hz; AC fi lter 50 Hz, 25 mm/s, 10 mm/mV); the defi nition of a fQRS was mainly 
based on criteria used in previous studies.(6) Figure 1 demonstrates the criteria applied: 
1) a clear distinct additional defl ection is visible in the R or S wave, 2) one R’ or S’ is 
present in narrow QRS complexes (<120ms), two or more R’ or S’ in wide QRS complexes 
(≥120ms), 3) the proportion of R-R’ or S-S’ is 1:6 or less, 4) more than half of the QRS 
complexes within one lead have fQRS, 5) a minimum of two leads corresponding to a 
particular heart area contain fQRS. Three diff erent areas of the heart were distinguished: 
inferior (II, III, aVF), anterior (V1, V2, V3, V4) and lateral (I, aVL, V5, V6).
All ECG’s were independently evaluated by 2 investigators; there was 99% concor-
dance for the presence of fQRS. The remaining 1% was classifi ed after consultation and 
mutual agreement.
1. Additional 
deflection 
R 
R’ R’’ R’ 
2. Wide QRS 
≥2 R’ or S’  
1:9 9:2 
3. Minimum  
Ratio 6:1 
4. >50%QRS complex with fQRS 5. ≥2 leads of 1 heart area 
aVF V2 III aVF 
R  
’ ’’ R’ 
Figure 1. fQRS criteria.
The fi ve criteria used for assessment of fQRS.
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Patient characteristics and selection VTa predictors
Electronic patient files were used to extract clinical data including age, gender and ECG 
characteristics. Known predictors of VTA such as a history of atrial tachyarrhythmia (AT), 
ventricular dysfunction and valve stenosis- or regurgitation were examined.(3, 9) Ven-
tricular dysfunction of both the right/non-systemic and left/systemic ventricle and valve 
stenosis- or regurgitation were classified as normal-mild-moderate-severe according to 
European guidelines.(10, 11)
statistical analysis
Statistical analysis was performed using SPSS software, version 21.0 (IBM Corp, Armonk, 
NY, USA). Dichotomous variables were presented as a number and percentage, and 
compared using the χ² test. Normally distributed continuous variables were expressed 
as mean±standard deviation and compared using a paired t-test. Skewed data were 
described with median (interquartile range) and compared with non-parametric tests 
including Mann-Whitney U tests. Conditional logistic regression models were used for 
univariate analyses to compare patient characteristics between the VTA group and con-
trol group. Patient characteristics of interest after univariate analyses were selected for 
a multiple regression model. In patients with a univentricular heart, systemic and non-
systemic ventricular function were defined as the same. A p -value <0.05 was considered 
to be statistically significant.
ResuLTs
Patient population
The study group consisted of 139 (54% male) VTA patients with 219 matched controls 
(median age difference 1 year, range 0 – 5); 80 VTA patients had 2 controls and 59 solely 
1 control. The last ECG recorded prior to VTA (median 0 years, range 0 – 2) was compared 
with the control ECG for all matches. Sixty-six VTA patients were excluded due to no 
suitable match (N=27), ventricular paced rhythm (N=20) or a missing ECG (N=19).
Patient characteristics
Patient characteristics are summarized in Table 1. Mean age was 39±14 (range 14 – 73) 
years in VTA group and 38±13 (range 17 – 72) years control group. The majority of patients 
had ToF (N=97), aortic valve disease (N=52) transposition of the great arteries (N=52) or 
univentricular heart (N=45). The remaining group consisted of patients with pulmonary 
stenosis (N=27), atrial septal defect (N=32), coarctation of the aorta (N=19), ventricular 
septal defect (N=16), pulmonary atresia (n=7), Ebstein anomaly (N=5), congenitally cor-
rected transposition of the great arteries (N=4) and patent ductus arteriosus (N=2).
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Control patients underwent more frequently only one surgical procedure (N=108; 49% 
vs. N=36; 26%, p=<0.001), while ≥3 surgical procedures were more often performed in 
VTA patients (N=48; 35% vs. N=33; 15%, p<0.001).
Hundred-six VTA patients presented with non-sustained VT and 33 had sustained VT/
VF. More Holter registrations were available in VTA patients than in controls, respectively 
1 (range 0 – 6) and 0 (range 0 – 7) (p<0.001). Most Holter registrations were performed 
for palpitations, syncope or nonspecific symptoms (dyspnoe, chestpain, dizziness).
Table 1. Baseline characteristics.
VTa Control P value
number of patients 139 219
age, years; (mean ± sD) 39 ± 14 38 ± 14
Male (%) 75 (54) 116 (53)
CHD, n (%)
AVD 19 (13.7) 33 (15.1)
ASD 13 (9.3) 19 (8.7)
ccTGA 2 (1.4) 2 (0.9)
CoA 7 (5.0) 12 (5.5)
Ebstein 2 (1.4) 3 (1.4)
PA 3 (2.2) 4 (1.8)
PDA 1 (0.7) 1 (0.5)
PS 10 (7.2) 17 (7.8)
TGA 20 (14.4) 32 (14.6)
ToF 38 (27.3) 59 (26.5)
UVH 18 (12.9) 27 (12.3)
VSD 6 (4.3) 10 (4.6)
number of surgical procedures, n (%)
0 12 (8.6) 26 (11.9) 0.33
1 36 (25.9) 108 (49.3) <0.001
2 43 (30.9) 52 (23.7) 0.13
3+ 48 (34.5) 33 (15.1) <0.001
number of Holter registrations; median (range) 1 (range 0-6) 0 (range 0-7) <0.001
Type of VTa
non-sustained VT 106
sustained VT / VF 33
n=number of patients; sD=standard deviation;
asD=atrial septal defect; aVD= aortic valve disease; ccTGa = congenitally corrected transposi-
tion of the great arteries; Coa=coarction of the aorta; Pa=pulmonary atresia PDa=patent ductus ar-
teriosus; Ps=pulmonary stenosis; TGa=transposition of the great arteries; ToF=tetralogy of Fallot; 
uVH=univentricular heart; VsD=ventricular septal defect
VF=ventricular fibrillation; VT=ventricular tachycardia; VTa=ventricular tachyarrhythmia
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QRs complex
As demonstrated in the upper panel of Figure 2, median QRS duration was higher in 
VTA patients compared to the control group prior to VTA (110ms (IQR 100 – 150) vs 
100ms (IQR 90 – 120)). Bundle branch blocks were seen more frequently in VTA patients 
than controls, respectively 64 (46%) vs 70 (32%); p=0.010). In VTA patients, different 
bundle branch blocks were observed including right (N=46; 33%), left (N=4; 3%) and 
nonspecific (N=14; 10%) interventricular conduction delay. Controls with interventricu-
lar conduction delay had either a right (N=52; 24%), left (N=7 (3%) or nonspecific (N=11; 
5%) bundle branch block. The lower panels in Figure 2 shows that the presence of fQRS 
was not related to the presence of conduction abnormalities in both VTA patients (lower 
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Figure 2. QRS-duration and fQRS incidence in VTA patients and controls.
Upper panel: a box-to-box plot illustrating QRS-duration in patients with VTA (red) and controls (green).
Lower left panel: incidence of fQRS in VTA patients. The left bar shows the incidence in patients with a small 
QRS-complex (<120ms), the right bar in patients with a wide QRS complex (≥120ms).
Lower right panel: incidence of fQRS in controls. The left bar shows the incidence in patients with a small 
QRS-complex (<120ms), the right bar in patients with a wide QRS complex (≥120ms).
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left panel, 53% vs 52%) or controls (lower right panel, 31% vs 30%). Furthermore, there 
was no difference in the presence of fQRS between patients with atrial and ventricular 
CHD, respectively 39% vs 39% (p=0.93).
Figure 3 illustrates the difference observed in the presence of fQRS between controls, 
patients with non-sustained VT and sustained VT/VF, respectively 67 (31%), 52 (49%) and 
21 (64%) patients. The prevalence of fQRS was significant lower in controls (p=0.001 and 
p<0.001), but did not differ between patients with non-sustained VT and sustained VT/
VF (p=0.143).
Prediction of Ventricular Tachyarrhythmia
fQRS and known predictors of VTA are summarized for both groups in Table 2. Univariate 
analysis showed that a total of 94 patients developed an atrial tachyarrhythmia (either 
regular atrial tachycardia or atrial fibrillation) including 51 (37%) VTA patients and 43 
(20%) controls (p=0.002). Systemic ventricular dysfunction was observed in 24 (18%) 
VTA patients vs 34 (15%) controls (p=0.814) and non-systemic ventricular dysfunction in 
34 (33%) vs 14 (9%) (p<0.001). Furthermore, moderate/severe valvular stenosis or insuf-
ficiency was measured in 58 (46%) VTA patients and 93 (46%) controls (p=0.58).
Multiple regression analysis demonstrated that the number of patients with non-
systemic ventricular dysfunction was significantly higher in the VTA group (OR 5.1, 95% 
CI 2.1 – 12.4; p<0.001). In addition, patients with fQRS had a 2.9 times higher risk of 
31% 
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Figure 3. fQRS in VTA group versus control group.
The number of patients with fQRS in controls compared with patients with non-sustained ventricular tachy-
cardia (orange) and sustained ventricular tachycardia/fibrillation (red).
NSVT = non-sustained ventricular tachycardia; VT / VF = sustained ventricular tachycardia/fibrillation.
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developing VTA (OR 2.9, 95% CI 1.5 – 5.8; p=0.002), patients with ≥3 surgical procedures 
a 2.5 times higher risk (OR 2.5, 95% CI 1.1 – 5.5; p=0.027) and patients with QRS ≥120ms 
had a 2.8 times higher risk to develop VTA (OR 2.8, 95% CI 1.3 – 6.2; p=0.011).
Localization of fQRs
Figure 4 illustrates examples of fQRS in inferior leads (Patient 1), anterior leads (Patient 
2) or both (Patient 3). fQRS were observed in a variety of ECG leads. Prior to VTA, the 
majority of the patients with VTA showed fQRS in leads corresponding to 1 area (N=53; 
72.7%), including the anterior (N=18; 24.7%), inferior (N=31; 42.5%) or lateral (N=4; 5.5%) 
area. Two- or three areas with fQRS were also relatively frequent present (N=20; 27.3%). 
In patients with fQRS present in leads corresponding to multiple areas, most patients 
(N=18; 90%) showed involvement of the lateral areas.
In control patients, fQRS in 1 lead (N=54; 80.7%) was most common in the inferior area 
(N=33; 49.3%) and less observed in anterior (N=15; 22.4%) or lateral areas (N=6; 9.0%). 
Solely 13 patients (18.3%) in the control group presented with fQRS in two areas.
fQRs and surgical procedures
In patients who underwent 0, 1, 2 or 3 or more surgical procedures, fQRS was observed 
in respectively 34% (n=13), 34% (n=49), 38% (n=36) and 52% (n=42) (p=0.229). How-
ever, there was a significant higher prevalence of fQRS in patients who underwent 3 or 
more surgical procedures compared to patients with ≤2 surgical procedures (p=0.008). 
Furthermore, there was a trend towards a younger age of initial surgical procedure in 
patients with fQRS (2 years, IQR 1 – 9) compared to patients without fQRS (5 years, IQR 
1 – 16) (p=0.089).
Table 2. Association of clinical variables and VTA.
Clinical Variables Control
n=219
VTa
n=139
oR
95% Ci
P
univariate
oR
95% Ci
P
Multivariate
aT, n 43 (20%) 51 (37%) 2.3 (1.4 – 3.9) 0.002 2.1 (0.96 – 4.6) 0.062
QRs ≥120ms 70 (32%) 64 (46%) 2.0 (1.2 – 3.4) 0.008 2.8 (1.3 – 6.2) 0.011
Moderate/severe systemic 
ventricular dysfunction, n
34 (15%) 24 (18%) 0.92 (0.46 – 1.8) 0.814
Moderate/severe non-
systemic ventricular 
dysfunction, n
14 (9%) 34 (33%) 5.3 (2.4 – 11.6) <0.001 5.1 (2.1 – 12.4) <0.001
Moderate/severe valvular 
disease, n
93 (46%) 58 (46%) 0.88 (0.53– 1.4) 0.58
≥3 surgery, n 33 (15%) 48 (35%) 3.0 (1.7 – 5.4) <0.001 2.5 (1.1 – 5.5) 0.027
fQRs 67 (31%) 73 (53%) 2.5 (1.6 – 4.0) <0.001 2.9 (1.5 – 5.8) 0.002
n = number; iQR = interquartile range; aT = atrial tachyarrhythmia
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DisCussion
The main new finding of this study is that the presence of fQRS is higher in CHD patients 
who develop VTA compared to matched control CHD patients without VTA. Develop-
ment of VTA in patients with various CHD was also associated with known (surrogate) 
predictors of sustained VT in ToF patients including an increased QRS-duration, a history 
of atrial tachyarrhythmia and ventricular dysfunction. After correction for each param-
eter, fQRS, QRS prolongation, more surgical procedures and non-systemic ventricular 
dysfunction increased the risk for VTA development. Therefore, fQRS might be used 
as a surrogate marker in addition to the aforementioned clinical variables to predict 
development of VTA in CHD patients more accurately.
assessment of fragmented QRs
As previously described by Das et al., (4) most studies defined fQRS as complexes with 
additional R or S waves, in 2 contiguous leads corresponding to a major coronary artery 
area. In our study, these criteria for the assessment of fQRS were extended in order to 
Anterior + Inferior 
Leads 
V1 
✚ 
V2 
aVF 
Anterior Leads 
V1 
aVF 
Inferior Leads 
III 
III 
✚ 
V2 
Figure 4. Examples of fQRS in 3 patients.
Patient 1: narrow complex QRS with fragmented complexes in the inferior leads (III and aVF).
Patient 2: wide complex QRS with fragmented complexes only in the anteroseptal leads (V1 and V2).
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decrease the risk of overestimating the amount of fQRS as a result of noise. For ECG’s 
included in this study, a relatively high frequency low-pass filter of 150 Hz was used. 
This frequency allows enhanced sensitivity to identify fQRS.(12) However, a higher 
low-pass filter frequency gives less reduction of electrical noises; hence noise levels in 
some ECG’s were relatively high. We therefore introduced a new criterion to distinguish 
more precisely between noise and the presence of fQRS: the proportion of R’ or S’ to the 
normal R and S waves had to be higher than 1:6. At present, computerized techniques 
allowing assessment of fQRS are being developed.(13) It is likely that the use of these 
computerized measurements of fQRS can aid in detecting and quantifying fQRS in daily 
clinical practice.
Similar to previous studies, fQRS in QRS complexes ≥120ms were defined as three or 
more, instead of two or more, notches in the R or S wave. This prevents falsely marking of 
typical RSR’ patterns in patients with intraventricular conduction delays. The absence of 
an association between fQRS and QRS-duration confirms that it is not likely that typical 
RSR’ patterns are marked as fQRS.
Mechanism of fragmented QRs and development of VTa
The exact mechanism of the relation between fQRS and VTA is not entirely clear. With 
the use of single-photon emission computed tomography in patients with CAD, Das et 
al. associated fQRS with the presence of ventricular scar due to myocardial infarction.(4) 
fQRS are the result of non-uniform anisotropic conduction caused by myocardial scar-
ring, facilitating development of reentrant arrhythmias.(6, 12, 14, 15) Therefore, fQRS 
might be an early manifestation of fibrotic tissue due to hemodynamic deterioration 
preceding possible development of VTA, as observed in this study.
It is well known that cardiac surgery also results in ventricular suture lines or scar 
tissue.(16, 17) Most of the CHD patients are operated at a young age.(18) The majority 
of the patients in our study also underwent one or more corrective or palliative opera-
tions, either during childhood and/or at adult age. VTA patients in our study showed 
more fQRS in anterior and lateral areas of the heart compared to controls, correspond-
ing to anatomical sites that are surgically corrected in CHD patients such as the right 
ventricular outflow tract (RVOT) and the septum in ToF patients. Studies in patients with 
ToF have shown that VTA mostly originates from the interventricular septum and RVOT, 
(19) suggesting fQRS might show a substrate for VTA.
Predicting VTa in CHD patients: perspectives for clinical practice
So far, several risk factors for the development for VTA in patients with CHD have been 
identified. Most studies report on patients with ToF due to the relative high incidence of 
VTA in this specific patient population. Known predictors of VTA in adults with repaired 
ToF include ventricular dysfunction and prolonged QRS-duration.(9) In this study, we 
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confirm these associations and also identified fQRS as a possible new surrogate marker 
for development of VTA. Our findings on fQRS correspond to previous studies, where 
fQRS was correlated with the location of VTA in patients with various diseases other than 
CHD. Morita et al. concluded that fQRS in patients with Brugada syndrome is a predictor 
for VF.(12) Sha et al. found that fQRS has a high predictive value for VTA and all-cause 
mortality in patients with dilated cardiomyopathy.(20) Other studies showed that fQRS 
is an independent marker for VTA and (cardiac) death in patients with coronary artery 
disease (CAD).(5, 6)
Assessment on the presence of fQRS in patients with CHD might improve risk stratifi-
cation for development of VTA and consequently assist in clinical decision making and 
might consequently reduce mortality. The prediction of VTA and decision for implanta-
tion of an ICD has been challenging in this patient group. Although these relative young 
patients are at risk to develop VTA, a conservative therapy strategy is often chosen. The 
quality of life in patients with CHD and an ICD is often negatively influenced and inap-
propriate shocks occur not seldomly. Research in a larger CHD patient population is re-
quired in order to further assess the role and potential benefits of fQRS in CHD patients.
Limitations
Our study has several limitations. First, the majority of VTA patients in our study pre-
sented with non-sustained VT and although it might be a marker for deterioration, the 
relation with adverse long-term outcomes remains uncertain. Yet, we observed an even 
higher incidence of fQRS in patients with life-threatening sustained VTA. Second, this 
study is also limited as a result of excluded ventricular paced patients, which increases 
the risk of selection bias due to exclusion of possible sicker patients. Another limita-
tion is that analyses were performed for CHD in general instead of per type of CHD. 
The limited number of patients in each group, the role of fQRS and risk of VTA per type 
of CHD was not assessed. In line with that, the higher frequency of fQRS in patients 
with more surgical procedures and at a younger age should be carefully interpreted as 
this may be the result of more ‘complex’ CHD or different types of surgical correction 
(e.g. extracardia). Furthermore, the need to extend commonly used criteria for fQRS 
to reduce false-positive markings of fQRS due to noise, possibly underestimated the 
amount of fQRS in our study. However, we decided underestimation was preferred over 
overestimation of fQRS. In addition, the criteria were applied in for both the VTA- and 
control group. Finally, due to the retrospective design, cardiac imaging was not available 
to identify a substrate responsible for the fQRS as demonstrated before in patients with 
coronary heart disease.
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ConCLusion
In summary, the presence of fQRS on the ECG is associated with development of VTA 
in CHD patients and might be a valuable tool in daily clinical practice to predict the 
occurrence of VTA. Early recognition of patients at risk for VTA might reduce the risk of 
sudden cardiac death. fQRS can therefore be of additional value combined with other 
factors such as prolonged QRS-duration, ventricular dysfunction and a history of atrial 
tachyarrhythmia to predict development of VTA.
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Endovascular Catheter Ablation of Ventricular 
Tachycardia in a Patient with a Surgically Repaired 
Congenital Left Ventricular Aneurysm
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A 19-year-old male with a surgically corrected congenital left ventricular aneurysm 
(LVA) in the basal posterior wall visited our outpatient clinic for a routine check-up. LVA 
recurrence was discovered only one year after surgery. The left ventricle (LV) was dilated 
(end-diastolic diameter 70 mm) and its ejection fraction was depressed (36%). During 
this visit, the patient lost consciousness due to sustained ventricular tachycardia (VT) 
(left upper part of Figure 1). The ICD, which was earlier implanted for non-sustained 
VT, did not deliver therapy as the cycle length (CL) of the VT was longer than the 
programmed detection interval. During external cardioversion, the VT degenerated in 
ventricular fibrillation. Sinus rhythm (SR) was finally achieved after external defibrillation 
combined with amiodarone infusion. A CT scan, made prior to the ablation procedure, 
clearly showed an aneurysm in the basal posterior wall part of the LV (central part of 
Figure 1). The patient was scheduled for ablative therapy of the VT. First, an anatomical 
reconstruction was created during SR in order to localize the LVA; electrograms with an 
abnormal morphology (low voltage, double and fractionated potentials) were recorded 
from this area. After accurate delineation of the LVA (white circle in Figure 1), a VT, which 
LVRV
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Figure 1. Surface ECG demonstrating a monomorphic VT of 218 beats per minute. The CT scan showed an 
aneurysm in the basal posterior wall part of the left ventricle (white circle). During the mapping procedure, 
an anatomical reconstruction (AR) was created during sinus rhythm in order to accurately delineate the LVA. 
Fractionated electrograms (F) were observed during sinus rhythm within the LVA, indicating local dissocia-
tion in conduction. During VT, pacing within the LVA area resulted in entrainment with concealed fusion 
(left lower panel). RF ablation at this site terminated the VT.
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was identical to the clinical VT, was induced by fixed rate pacing (CL 270 ms) and could 
repeatedly be terminated by overdrive pacing (CL 210 ms). The earliest activation rela-
tive to the QRS complex during VT was found within the aneurysm. Pacing at this site 
resulted in entrainment with concealed fusion and a post-pacing interval of 10 ms (left 
lower part of Figure 1). The VT terminated during the first radiofrequency application. 
The clinical VT was non-inducible after encircling the site of earliest activation.
DisCussion
In this case report we presented a patient with recurrence of a surgically repaired con-
genital LVA, who underwent endovascular ablative therapy of post-operative VT.
Reports on VT associated with congenital LVA are limited to several cases.(1) In 
a group of 108 patients with either LV aneurysm or diverticulum who were followed 
during a median period of 50 months, VTs occurred only in ten patients.(2) Ablation 
procedures of VT in LVA patients have been described in only a few subjects.(3) Only 
Ouyang et al. reported on cardiac mapping prior to ablation in four LVA patients with 
recurrent exercise-induced syncope attributable to sustained fast monomorphic VT. The 
aneurysm was located in the inferolateral part of the LV in all patients. Endocardial map-
ping during SR revealed no abnormalities (fractionated and late potentials), but those 
were found on the epicardial site. In one patient with a stable VT, epicardial mapping 
showed a macro-reentrant VT with a focal pattern of activation on the endocardial site. 
Epicardial ablation was successfully performed in three patients.(4) Hence, our case is 
this first LVA patient in whom 1) endocardial mapping revealed extensive conduction 
abnormalities (low voltage, double and fractionated potentials), 2) successful ablation 
was accomplished on the endocardial site. Our patient had a dilated LV and depressed 
ejection fraction which indicates a more advanced stage of LVA compared to the pa-
tients in the study of Ouyang.(4) The underlying mechanism of the VT is most likely a 
microreentry circuit on the endocardial site. However, endocardial breakthrough of an 
epicardial wavefront cannot be excluded.
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Survival of patients with congenital heart disease (CHD) has improved significantly in 
the past decades due to improved clinical care.(1, 2) However, the incidence of cardiac 
dysrhythmias in patients with CHD after palliative or corrective cardiac surgery remains 
higher compared to subjects with normal atrial anatomy. This is not only related to prior 
surgical procedures but also to e.g. an ongoing hemodynamic overload.(3) As discussed 
in chapter 2, management of post-operative cardiac dysrhythmia is challenging and 
failure rates of the different treatment modalities are high. Improvement of therapy can 
only be achieved if the mechanism underlying initiation and perpetuation of cardiac 
dysrhythmia in CHD patients is better understood.
eaRLy PosT-oPeRaTiVe aTRiaL TaCHyaRRHyTHMia
Data on early, post-operative cardiac arrhythmias in patients with CHD are rare. Despite 
the presence of CHD and complexity of the surgical procedures, the incidence of early, 
post-operative atrial tachycardia (AT) in adult (chapter 3) and pediatric CHD patients 
(chapter 4) was low. The incidence of atrial ectopy was, however, high but did not trig-
ger sustained tachyarrhythmia. In our studies, we used continuous rhythm recordings 
to detect cardiac dysrhythmia and it is therefore unlikely that we would have missed 
any episodes. Previous studies in patients without CHD observed that frequently oc-
curring supraventricular premature beats (SVPB) were associated with development of 
atrial fibrillation (AF).(4, 5) In addition, Conen et al. examined factors associated with 
the occurrence of SVPB in the general population aged ≥50 years.(6) One of the strong 
independent determinants associated with SVPB was a higher age. In our, relatively 
young study population, patients who developed regular AT and AF had more SVPB 
compared to patients without SVT, which suggests that frequent SVPB can predict early 
post-operative regular AT and AF on the short-term. In addition, we observed that CHD 
patients with early post-operative regular AT and AF had a higher incidence of SVPB, but 
these patients were also older. As SVPB and early post-operative AF are both associated 
with a higher age in adults without CHD (6, 7), development of early, post-operative AF 
in our study population might be associated with either a higher age, increased SVPB or 
both. The prevalence of sustained tachyarrhythmia was surprisingly low (6%) compared 
to patients who had undergone cardiac surgery for acquired heart disease (8, 9), but also 
compared to another study that included adult CHD patients.(10) The relative young 
age of our study population might explain the lower incidence of regular AT and AF, 
as an older age is also associated with early post-operative AF. Patients operated at an 
older age are longer exposed to volume and/or pressure overload leading to stretch and 
hence conduction disorders. Correction of CHD at a younger age may prevent further 
structural damage, thereby decreasing the risk of SVPB and development of AF.
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Data on the prevalence of intraoperative arrhythmias in children who underwent 
corrective or palliative surgery for a CHD is scarce. Patients in our study population had 
atrioventricular conduction block (AVCB), junctional and ectopic atrial rhythm during 
cardiac surgery. Children who were operated with the use of both aortic cross clamp 
(ACC) and cardiopulmonary bypass (CPB) or CPB alone tended to develop intraoperative 
arrhythmias more frequently. However, after closure of the sternum most arrhythmias 
were resolved. Aslam et al. described that hypothermia during CPB can result in slowing 
of the impulse conduction resulting in AVCB.(11) Patients in our study population also 
frequently had junctional or ectopic atrial rhythm. This could be explained by the fact 
that hypothermia reduces automaticity of cardiac cells, which might facilitate onset 
of ectopic rhythms.(12) The transient nature of AVCB in our study population, makes 
it more plausible that this is caused by hypothermia and not by damage to the con-
duction system. Prior studies demonstrated that development of early post-operative 
arrhythmias was (partly) caused by hypoxia and ischemia during CPB and repurfusion 
after cessation of CPB.(13-16) In addition, longer duration of CPB was identified as an 
independent risk factor for post-operative arrhythmias.(13, 15, 17, 18) The relation 
between early- and late postoperative tachyarrhythmia was studied in patients with 
various CHD, which resulted in the identification of early post-operative tacharrhythmia 
as a predictor for late postoperative tachyarrhythmia.(19, 20) This observation implied 
an association between early and late postoperative tachyarrhythmia which might also 
apply to intraoperative arrhythmias. In our study population, however, most patients 
with intraoperative arrhythmias did not have any arrhythmias in the early- or late post-
operative period. Instead, intraoperative arrhythmias in our study population were 
transient in nature and late post-operative arrhythmias were not related to the presence 
of intraoperative arrhythmias.
eaRLy PosT-oPeRaTiVe VenTRiCuLaR TaCHyaRRHyTHMia
Ventricular tachyarrhythmia (VTA) in the early post-operative period were rare in our 
study population (chapter 3) though the incidence of ventricular ectopy was high. The 
low prevalence of life threatening VTA during the early post-operative period found in 
our studies is comparable to other studies with adult CHD patients or those who had 
undergone cardiac surgery for acquired heart disease.(10, 21) Fifty percent of our adult 
study population showed non-sustained ventricular tachycardia (NVST) in the early 
post-operative period. The role of early, post-operative non-sustained ventricular tachy-
cardia (NSVT) in the prediction of long-term VTA has been a matter of debate and seems 
variable between different types of CHD.
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LaTe PosT-oPeRaTiVe aTRiaL TaCHyaRRHyTHMia
In this thesis, we demonstrated that particularly in patients with complex CHD, AF devel-
oped at a relatively young age compared to patients without CHD (chapter 5).
Co-existence of AF with regular AT was found in one-third of the study population. In 
addition, we demonstrated that progression from paroxysmal to (longstanding) persis-
tent or permanent AF occurs in a short time period of only 3 years. Hence, treatment of 
late, post-operative AF will be the next challenge in management of patients with CHD.
Areas of intra-atrial conduction delay or dispersion in refractoriness perpetuate 
AF.(22-25) Previous electrophysiological studies have demonstrated that multiple zones 
of intra-atrial conduction delay and increased dispersion in refractoriness are indeed 
present in patients with surgically corrected CHD.(26) Dilatation of the atria promotes 
triggered activity, giving rise to premature beats.(27, 28) Thus, a high number of pre-
mature beats combined with large areas of conduction delay and local dispersion in 
refractoriness increase the likelihood for AF to occur in this patient group. It is generally 
assumed that AF alters from a trigger-driven to a substrate mediated arrhythmia over 
time.(29) In a recent study, the importance of atrial extrasystoles in the pathophysiology 
of AF in CHD patients was demonstrated. In a large cohort of patients with CHD, a high 
frequency of atrial extrasystolic beats was associated with a higher risk of development 
of AF; a total number of ≥441 AES per day showed a high specificity for prediction of 
AF.(30) Progression from trigger-driven to substrate mediated AF is caused by structural 
damage of cardiomyocytes which in turn causes abnormalities in electrical conduction, 
defined as electropathology. In patients with CHD, extensive structural damage of the 
atria is caused by an ongoing pressure-volume overload which makes the atria more 
prone to persistence of AF.(27, 28) As demonstrated in the Rotterdam and Framingham 
Study, the incidence of AF in the general population starts to increase in the fifth decade.
(31, 32) However, patients with more complex CHDs, such as UVH and TGA frequently 
developed AF already in the third of fourth decade, which indicates that development 
of AF in CHD patients is not only the result of aging.
Co-existence of AF with regular AT was frequently observed in our study populations. 
Kirsh et al. examined the relation between intra-atrial reentry tachycardia and AF in 
patients with CHD who underwent cardioversion, and found that in only a minority of 
the patients regular AT co-existed with AF. In these patients, there was no evidence of 
progression from regular AT to AF.(33) Development of AT in a cohort of Fontan patients 
was related to a high number of surgical procedures.(34) Cardiac surgery resulted in 
atrial incisions, inserted prosthetic materials and the post-operative pressure/volume 
overload may give further rise to extensive scarring.(35-37) These alterations facilitate 
development of macro reentrant tachycardia which may progress to AF over time. Focal 
AT also frequently arise in patients with CHD as low voltage areas result in diminishment 
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of electric coupling, thereby facilitating arisal of ectopic activity. Both macro-reentrant 
and focal AT cause electrical remodeling, consisting of shortening of atrial refractoriness 
and inverse rate adaptation, thereby facilitating development of AF.(38, 39) This may 
explain why regular AT preceded AF in a large proportion of our population. Our obser-
vations suggest that catheter ablation of AT, which is nowadays an accepted treatment 
modality with reported successful outcome of at least 70% in patients with CHD, could 
prevent or delay development of AF in some patients.(40-42)
A quarter of the study population showed progression from paroxysmal AF to (long-
standing) persistent/permanent AF. Progression to persistent or permanent AF has been 
reported up to 25% in patients without CHD.(43, 44) In patients without CHD, electrical 
and structural remodeling both contribute to persistence of AF (45), which might be 
aggravated in CHD patients by chronic atrial stretch because of persistent pressure/
volume overload.(46) However, at present, there is no data available on the relation 
between remodeling and progression from paroxysmal to (long-standing) persistent/
permanent AF in CHD patients. Older age at the moment of AF onset may influence 
progression to (long-standing) persistent/permanent AF as patients with progression in 
the European Heart Survey tended to be older; an age of >75 years was identified as an 
independent risk factor for progression of AF.(47) In our study population, progression 
to (long-standing) persistent/permanent AF was frequently observed in ASD patients, 
who tended to be older at the moment of AF onset.
The incidence of TIA/stroke in our study population was slightly more than ten percent, 
which was about twice as much compared to the general population after a follow-up 
period of 15 years.(48) Hofmann et al. also demonstrated a higher risk to develop cere-
brovascular accidents in CHD patients. A 10- to 100-fold higher risk to develop cerebro-
vascular accidents was found in the relatively young CHD population, with and without 
atrial arrhythmias, compared with patients with the same age.(49) Other risk stratifica-
tions instruments might be necessary to prevent cerebrovascular events not only in CHD 
patients with AF but also in CHD patients without AF. We therefore recommend close 
follow-up in CHD patients and aggressive therapy in case of onset of regular AT or AF.
We demonstrated in chapter 6 that ToF patients in our study population developed AF 
in the 4th and 5th decade of life, which did not differ between patients who underwent 
either initially a shunt creation or ToF correction. Khairy et al. demonstrated that the 
prevalence of AF started to rise from the age of 45 years in ToF patients (50), which is 
comparable with the mean age of AF onset in our study population. In a review by Apitz 
et al., it was suggested that the optimal age for ToF correction is between the three and 
six months old.(51) Our patient group was a subset of patients that were operated in 
the early days of cardiac surgery and is actually presenting the long-term present–day 
complications of corrective surgery for ToF some decades ago. In our group, ToF correc-
tion was done on average 40 years ago.
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Both AF and VTA occurred in a considerable number of patients in our study popu-
lation. Denes et al. demonstrated that AF might facilitate the onset of VTA. When AF 
activates the ventricles at a high rate, ventricular refractoriness is shortened which in 
turn promotes onset of VTA.(52) In another study it was proposed that short-long-short 
sequences caused by AF are proarrhythmic and facilitate VTA onset.(53) Somberg et al. 
showed that induction of VTA by programmed electrical stimulation in canine ventricles 
only induced VTA (96%) during AF and not during sinus rhythm (SR). This finding also 
supports the concept that the presence of AF episodes facilitates development of VTA.
(54)
Progression of AF from either paroxysmal to persistent/permanent AF or persistent to 
permanent AF was observed in a large number of ToF patients. Usage of either class II 
or class III AAD did not prevent progression of AF. AF induced remodeling is more likely 
to occur in patients with only rate control therapy as development of AF episodes is not 
prevented. In patients without CHD, it has been demonstrated that AF episodes induce 
shortening of the atrial refractory period (ARP) and inversed rate adaptation thereby 
facilitating perpetuation of AF.(55, 56) In addition, it has been shown that effectiveness 
of AAD and CV for paroxysmal AF decreases over time, also indicating that AF episodes 
promote development of longer-lasting AF episodes and hence progressiveness of 
AF.(57, 58) Atrial extra systoles due to e.g. chronic sinus bradycardia in the presence of 
a shorter ARP makes the CHD patient more vulnerable to induction of AF episodes and 
hence AF progression.
In chapter 7 we described that AF recurred in the majority of the study population 
relatively short after arrhythmia surgery. The high percentage of AF recurrences in this 
study was not in accordance with previous reports on concomitant arrhythmia surgery 
in patients with CHD.(59-61) BiA surgery was less effective in preventing AF recurrences 
compared to LA surgery. In patients without CHD with drug-refractory AF or intolerance 
for AAD, who underwent cardiac surgery combined with either a Cox-Maze III procedure 
or concomitant arrhythmia surgery using either radiofrequent (RF) or cryothermal en-
ergy, it was shown that BiA and LA surgery were equally effective in restoring SR (83,2% 
versus 77,5%).(62) However, both BiA (28%) and LA surgery (41%) were far less effective 
in preventing AF recurrences in our study population which could be explained by the 
fact that our study population contained more much patients with (long-standing) 
persistent AF.
Important to note is, that in our study, patients who underwent cryothermal ablation 
had an AF recurrence rate up to 90 percent compared to slightly less than sixty percent 
in the RF ablation group. Experience with either RF current or cryothermal ablation for 
concomitant arrhythmia surgery in CHD patients is scarce and limited to case series.
(63-65) Agnoletti et al. performed Fontan conversions accompanied by concomitant 
arrhythmia surgery in 2 patients who had pre-operative AF; RF ablation was performed 
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in one patient and cryothermal ablation in the other patient. After a follow-up period 
of 16.8 months, none of the patients had AF recurrences.(65) The fact that cryothermal 
ablation resulted in more AF recurrences in our study population, could be explained 
by the disparity between the size of the acute lesion and the less voluminous size of 
the definitive lesion.(66) Cryothermal ablation resulted in more homogenous lesions 
with both less damage to the endothelium and less necrosis without excessive fluid 
discharge.(67) Deisenhofer et al. proposed that tissue is more preserved in patients who 
underwent cryothermal ablation compared to those who underwent RF ablation.(66) 
Therefore, it is important to investigate the effectiveness of cryothermal ablation in a 
larger cohort of CHD patients.
AF recurrence was in a considerable group of patients with persistent AF accompanied 
by progression to permanent AF within a relative short period. This is in concordance 
with observations in an earlier study with CHD patients who had AF but did not undergo 
any concomitant arrhythmia surgery.(68) However, none of the patients in the current 
study with paroxysmal AF showed progression of AF.
LaTe PosT-oPeRaTiVe VenTRiCuLaR TaCHyaRRHyTHMia
Late post-operative susVT/VF are rare but devastating complications after surgery for 
CHD and develop in the 4th or 5th decade of life.(69-71) VTA in this population are most 
often the result of macro-reentry, but they might also be the result of either stretch-
induced automaticity or triggered activity.(72-74) Areas of scar tissue or suture lines 
caused by surgical procedures often serve as borders of reentry circuits.(74, 75) In addi-
tion, the on-going post-operative ventricular overload causes remodeling giving rise to 
abnormalities in conduction which further increase the likelihood of developing VTA.
At present, there are no sensitive predictors for development of susVT/VF in patients 
with CHD. Prolonged QRS duration has been suggested to be a predictor for susVT/VF, 
but the reproducibility of these findings are debatable.(76-78) Previous studies in ToF 
patients did not find a relation between asymptomatic NSVT during 24-hour Holter 
recordings and development of sustained VT.(76, 79) In this thesis, we demonstrated 
that NSVT are no predictors of susVT/VF in patients with various CHDs.
However, (symptomatic) NSVT in CHD patients was identified as a predictor for ap-
propriate shocks in patients who have an ICD for primary intervention.(80, 81) Based 
on these findings, the guideline suggests that ICD therapy is reasonable in ToF patients 
with multiple risk factors such as NSVT.(82) Data from our study suggest that in CHD 
patients with a good to moderate ventricular function, normal or limited conduction 
delay and NSVT, a wait-and-see treatment strategy seems justified. This strategy seems 
not only applicable for ToF patients, but seems also applicable for other CHD patients. A 
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relative high incidence of appropriate shocks occurred in patients who received an ICD 
for susVT (53%) and VF (31%) during the 5-year follow-up period. This observation is in 
line with other studies showing that during a follow-up period of 4 years, appropriate 
shocks occurred in 30% of CHD patients, who received an ICD for secondary prevention.
(80, 83) Unfortunately, there was a high incidence of inappropriate shocks (22%) caused 
by SVT, especially in patients with susVT (29%). Other studies reported comparable or 
even higher incidences of inappropriate shocks, ranging from 25% to 41%.(80, 84) These 
findings emphasize the importance of (ablative) therapy aimed at eliminating SVT in this 
patient group to prevent inappropriate shocks.(41, 85, 86)
PReDiCTiVe VaLue oF FRaGMenT QRs CoMPLexes
We introduced fragmented QRS complexes (fQRS) on the surface electrocardiogram 
as a novel electrophysiological marker to identify patients at risk for developing life-
threatening VTA. The exact mechanism of the relation between fQRS and VTA is not 
clear. With the use of single-photon emission computed tomography in patients with 
coronary artery disease (CAD), Das et al. associated fQRS with the presence of ventricular 
scar due to myocardial infarction.(87) fQRS are the result of non-uniform anisotropic 
conduction caused by myocardial scarring, facilitating development of reentrant ar-
rhythmias.(88-92) Therefore, fQRS might be an early manifestation of fibrotic tissue due 
to hemodynamic deterioration preceding possible development of VTA, as observed in 
this study. Our findings correlate with earlier studies in patients without CHD. Morita 
et al. concluded that fQRS in patients with Brugada syndrome are predictors of VF.(89) 
Sha et al. found that fQRS have a high predictive value for VTA and all-cause mortality 
in patients with dilated cardiomyopathy.(93) Other studies showed that fQRS is an in-
dependent marker for VTA and (cardiac) death in patients with CAD.(88, 94) Prospective 
studies in larger study populations will have to further establish the value of this novel 
predictor of late, post-operative ventricular tachyarrhythmia in patients with CHD.
HiGH ResoLuTion, inTRa-oPeRaTiVe ePiCaRDiaL MaPPinG
In order to gain insight into the degree of electropathology in patients with CHD, we 
performed intra-operative, high resolution mapping of the entire epicardial surface 
of the atria in patients with right atrial overload. Mapping was performed at the right 
atrium (RA) Bachmann’s bundle (BB), pulmonary vein area (PVA) and left atrial ventricular 
groove (LVAG).
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In contrast to most clinical mapping studies which used bipolar voltage mapping to 
guide ablative therapy of post-operative atrial tachyarrhythmia in CHD patients (95, 
96), we performed unipolar voltage mapping. As bipolar voltage mapping is addition-
ally influenced by inter-electrode distances, angles between activation wavefront and 
recording electrodes, bipolar voltages provide less accurate information on the arrhyth-
mogenicity of the underlying myocardial tissue.(97, 98)
Voltage mapping in our study was performed during sinus rhythm (SR), which might 
be preferable in when atrial tachyarrhythmia cannot be induced or when multiple differ-
ent tachycardias are induced during ablative therapy. We did not find any predilection 
sites for low voltages, which could be explained by variability in the atrial architecture. 
In a previous study with 97 human necropsy hearts, large inter-individual variations 
in the arrangement and thickness of atrial muscle fibers in the pectinate muscles was 
described.(99) Similar observations were also reported in the PVA and BB region.(100-
103) These findings may explain why there were no preferential sites identified for low 
voltages.
In a subsequent study, we quantified conduction disorders at the entire atrial epicar-
dial surface during SR at a high-resolution scale in CHD patients with RA stretch.
In previous studies, dispersion of atrial refractoriness as a result of increased atrial 
stretch was described.(104, 105) Whether atrial stretch leads to an increase or decrease 
in effective refractory period is not well known (106-108) and remains a matter of 
debate. In our study population, heterogeneity in conduction was most pronounced 
at both the RA and BB. Interestingly, long lines of conduction block (≥16mm) at these 
sites were mainly observed in patients with AF. The predictive value of these long lines 
of conduction block will have to be evaluated in further studies. Comparable to low 
voltages, there were also considerable inter-individual and regional differences in the 
degree and extensiveness in conduction delay and conduction block. Our observations 
emphasizes the necessity of an individualized, patient-tailored diagnosis and therapy of 
electropathology underlying post-operative atrial tachyarrhythmia.
ConCLusions:
– Atrial ectopy is commonly observed during the early post-operative period in adult 
CHD patients who had undergone cardiac surgery.
– Although ventricular ectopy and ventricular runs were frequently observed during 
the early post-operative period, they are no predictors of sustained life-threatening 
VTA.
– Intraoperative arrhythmias were frequently observed in children undergoing surgery 
for CHD; most of them were transient and clinically insignificant.
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– Development of late, postoperative arrhythmias are not related to arrhythmias in the 
intraoperative and early post-operative period.
– Age of development of AF in patients with CHD, is relatively young compared with 
patients without CHD.
– Coexistence of episodes of AF and regular AT occurred in considerable number of 
patients; most of them initially presented with regular AT.
– Catheter ablation of regular AT could delay or prevent development of AF.
– The fast and frequent progression from paroxysmal to (long-standing) persistent 
or permanent AF episodes justifies close follow-up and early, aggressive therapy of 
both AT and AF.
– ToF patients developed AF in the 4th and 5th decade of life, which did not differ 
between patients who underwent either initially a shunt creation or ToF correction.
– AF frequently recurred in CHD patients who underwent concomitant arrhythmia 
surgery relatively short after the procedure.
– AF recurrence was similar among those who underwent arrhythmia surgery during 
the first surgical procedure and those who had undergone surgical procedures prior 
to arrhythmia surgery.
– VTA in patients CHD appear at a mean age of 40 years.
– susVT/VF rarely developed in patients with only NSVT, whereas recurrent episodes of 
susVT/VF occurred frequently in patients initially presenting with susVT.
– A wait-and-see treatment strategy in patients with NSVT and aggressive therapy of 
both episodes of VTA and SVT in patients with susVT/VF seems justified.
– Ablative therapy of SVT in CHD patients with susVT/VF who received an ICD seems 
mandatory.
– Presence of fQRS on the ECG is associated with development of VTA in CHD patients.
– Early recognition of patients at risk for VTA might reduce the risk of sudden cardiac 
death.
– fQRS can be of additional value combined with other factors such as prolonged QRS 
duration, ventricular dysfunction and a history of atrial tachyarrhythmia to predict 
development of VTA.
– In CHD patients with RA stretch, unipolar voltage mapping demonstrated consider-
able dissimilarities in voltages at various atrial sites.
– No predilection sites for occurrence of low voltages could be identified in CHD pa-
tients with RA stretch.
– Conduction disorders quantified at a high-resolution scale in adult CHD patients 
with RA volume overload demonstrated that lines of conduction delay and conduc-
tion block are predominantly located at BB and the RA.
– The length of lines of conduction block, rather than just the presence of conduction 
block, may play an important role in the development of AF.
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FuTuRe sTuDies
Due to improvements in surgical techniques and clinical care, the CHD population 
presenting with tachyarrhythmia will also change over time. For example, patients with 
transposition of the great arteries corrected by a Mustard procedure having atrial reen-
trant tachycardia will disappear and replaced by patients corrected by an arterial switch 
procedure presenting with AF.(109) Despite the fact that the incidence of early, post-
operative tachyarrhythmia is low, the incidence of late, post-operative tachyarrhythmia 
will remain high. Scarring of the atria due to surgical incisions, insertion of prosthetic 
materials and pressure and/or volume overload all contribute to ongoing structural 
damage of the atrial tissue (35-37), thereby promoting development of atrial reentrant 
tachyarrhythmia, focal tachycardia or substrate-mediated AF. In addition to this, ageing 
of the CHD population will cause a rise in the number of CHD patients presenting with 
AF and treatment of AF will therefore become the next challenge in this patient group. 
Thus, continuing research into the mechanism of tachyarrhythmia in patients with 
congenital heart disease remain of utmost important as ……
congenital heart disease and tachyarrhythmia remain a predestined match ……
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The goal of this thesis was to examine the pathophysiology of both early and late post-
operative dysrhythmias in patients with congenital heart disease (CHD). The outline of 
the thesis is described in chapter 1. In chapter 2 we gave an overview of the epidemi-
ology, pathophysiology and outcome of different therapies of atrial fibrillation (AF) in 
patients with CHD. CHD accounts for almost 30% of all major congenital defects. Due 
to improved care and surgical treatment, more than 90% of the children born with CHD 
survive into adulthood. As a consequence of this ageing population, new complications 
such as cardiac dysrhythmia develop over time. AF is identified as one of the most 
commonly observed dysrhythmia in patients with CHD. Besides the type of CHD, age 
seems to play an important role in the occurrence of AF. It has been suggested that 
long-standing regular atrial tachycardia (AT) might induce atrial remodeling which in 
turn would facilitate development of AF. Early and effective therapy of regular AT might 
therefore prevent development of AF.
Development of intraoperative and early post-operative tachyarrhythmia in CHD 
patients were discussed in chapter 3 and 4. The occurrence of both supraventricular 
premature beats (SVPB) and ventricular premature beats (VPB) is associated with the de-
velopment of tachyarrhythmia in patients without CHD. Therefore, the aims of the study 
in chapter 3 were to examine the incidence of early, post-operative (S)VPB in adult CHD 
patients and to correlate the occurrence of (S)PVB with development of tachyarrhyth-
mia. Five days of continuous rhythm registrations were obtained from adult patients 
who had various types of CHD. Slightly more than 50% of the patients underwent their 
initial surgical procedure. SVPB occurred in all patients and approximately 26% had at 
least one hour with ≥30 SVPB during the entire recording. AF and regular AT episodes 
were observed in 6% of the patients who also had more atrial ectopy. VPB also occurred 
in all patients; an incidence of ≥30 VPB during at least 1 hour was documented in 28%. 
However, none of the patients developed ventricular tachyarrhythmia (VTA) including 
sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). There was a positive 
correlation between the incidence of SPVB and an age of ≥40 years. None of the clinical 
determinants were associated with frequent VPB, including aging. Only 2% of the study 
population developed regular AT or AF during the 12-month follow-up period. None 
of the patients who have had AF episodes during the continuous rhythm registrations, 
showed recurrences of AF. Both atrial and ventricular ectopy occurred relatively frequent 
during the early post-operative period of five days. Atrial ectopy was more frequently 
observed in those who developed regular AT or AF, but ventricular ectopy was not a pre-
dictor of sustained life-threatening VTA in adult CHD patients early after cardiac surgery.
In chapter 4, we determined the incidence of intraoperative arrhythmias in children 
during surgery for CHD; identified clinical features which might be related to the onset 
of intraoperative arrhythmias; and examined whether intraoperative arrhythmias are 
associated with development of persistent arrhythmias during long-term follow-up. On 
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the electrocardiograms (ECG) prior to cardiac surgery, sinus rhythm (SR) was present 
in 98% of the patients. Eighty-five percent of the study population had one or more 
intraoperative arrhythmias; episodes of arrhythmias were identified as 2nd degree 
atrioventricular block (AVB), 3rd AVB, ectopic atrial rhythm (EAR) and junctional rhythm 
(JR). All patients who underwent surgery with the use of aortic cross-clamp (ACC) and 
cardiopulmonary bypass (CPB) or CPB only developed arrhythmias compared to 9% of 
the patients who were operated without the use of CPB (p<0.01). In a subanalysis with 
the patients who were operated with the use of ACC and CPB, most arrhythmias were 
observed during CPB (30-60%), but this significantly decreased after CPB (0-18%, p<0.01) 
and after sternum closure (0-5%, p<0.01). The number of SVPB and supraventricular cou-
plets was higher between the end of CPB and sternum closure compared to during CPB 
(respectively p<0.01 and p=0.03). A relatively large number of patients developed VPB, 
ventricular couplets and ventricular runs in the intraoperative period before sternum 
closure (41–84%). However, this number decreased significantly after closure of the 
sternum (0–6%), p<0.01). All episodes of non-sustained VT and VF occurred during CPB.
Of the patients with an intraoperative arrhythmia, 69% still had an arrhythmia in 
the intensive care unit (ICU), whereas of the patients without intraoperative arrhyth-
mias (15%) only 20% developed an arrhythmia in the ICU (p<0.01). During a median 
follow-up of 37 months, SR was present in 87% of the patients, which was significantly 
lower (p<0.01) compared to the percentage of the study population with SR prior to 
cardiac surgery. New onset, late post-operative arrhythmias arose in 17 patients (13%), 
including ectopic atrial rhythm (N=7), junctional rhythm (N=2), sinus bradycardia (N=2), 
paroxysmal AT (N=2), SR with SVPB bigeminy (N=2) or VPB bigeminy (N-1) and sick sinus 
syndrome (N=1). Seven patients died during follow-up. The most common cause of 
death was circulatory failure (86%). In conclusion, intraoperative arrhythmias, mainly 
2nd degree AVB, SVPBs and VPBs, were frequently observed in children with CHD under-
going cardiac surgery with the usage of CPB. Most arrhythmias were short-lasting and 
transient, which was not related to the incidence of postoperative arrhythmias during 
follow-up.
Development of late, post-operative tachyarrhythmia was discussed in chapters 5, 6, 
7, 8 and 9. The aims of the multicenter study in chapter 5 were to examine factors as-
sociated with AF, outcomes of AF therapy, coexistence of various regular AT and AF, and 
progression of paroxysmal to (long-standing) persistent/permanent AF during long-
term follow-up in a large cohort of patients with a variety of CHD. Only patients with 
documented AF episodes were included in this study. Corrective or palliative surgery 
was performed in 75% of the study population at a median age of 12 (3-37) years. AF 
developed at a mean age of 49±17 years. However, patients with more complex CHD 
developed AF mainly before the age of 40 years. Regular AT coexisting with AF occurred 
in 33% of the study population; 65% initially presented with regular AT approximately 3 
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(0-7) years before AF onset. Furthermore, patients with AF after a documented episode 
of regular AT tended to develop AF at a younger age compared to patients with only AF. 
At the initial presentation with AF, cardioversion (CV) was performed in 37% and anti-
arrhythmic drugs (AAD) were started in 40% of the patients. Pulmonary vein isolation 
(PVI) was performed in 7% of the study population and was 100% successful during 
procedure, although one patient required an additional PVI after the initial procedure. 
At the end of a follow-up period of 5 (0-24) years, 11% of the patients had died at a mean 
age 61±18 years. The ECG showed AF in 41% of the patients. In a sub-analysis, deteriora-
tion from paroxysms of AF to (long-standing) persistent/permanent AF was observed in 
26% after only 3 (0-18) years. Cerebrovascular accidents/transient ischemic attacks oc-
curred in 13%, although a substantial number occurred before the first documented AF 
episode. Age at development of AF in patients with CHD is relatively young compared 
with patients without CHD. Co-existence of episodes of AF and regular AT occurred in a 
considerable number of patients; most of them initially presented with regular AT. The 
fast and frequent progression from paroxysmal to (long-standing) persistent or perma-
nent AF episodes justifies close follow-up and early, aggressive therapy of both AT and 
AF. Early (ablative) therapy for regular AT could theoretically prevent development of AF 
and hence also reduce long-term complications, such as stroke.
Late post-operative AF onset after correction and progression of AF in ToF patients 
during long-term follow-up was studied in chapter 6. Shunts prior to ToF correction 
were created in 50% of the study population at a mean age of 8±6 years. ToF correction 
was performed at a mean age of 21±14 years. Prior to AF onset, 58% of the patients had 
right atrial (RA) dilatation and a mildly (33%), moderately (25%) or severely impaired 
(25%) right ventricular ejection fraction (RVEF). AF onset occurred at a mean age of 
45±13 years and 26±13 years after ToF correction. The first AF episode was classified as 
paroxysmal (34%), persistent (58%) and permanent (8%). Patients who underwent initial 
shunt creation developed AF at the same age as patients who underwent initial ToF cor-
rection at respectively 44±14 years and 45±14 years (p=0.83). The mean period between 
ToF correction and onset of AF showed a trend towards a longer interval after initial 
ToF correction (30±10 years versus 21±15 years, p=0.09). ToF correction was performed 
on average 42±9 years ago and was comparable for both groups (40±10 years versus 
44±8 years, p=0.32). Mean age of the first AF episode after ToF correction did not differ 
significantly between the various decades (1950s: 72 years, 1960s: 48±14 years, 1970s: 
40±10 years, 1980s: 43±12 years, 1990s: 39±13 years, p=0.19). Co-existence of regular AT 
and VTA occurred in respectively 54% and 42% of the study population. The majority of 
patients with paroxysmal AF was treated with AAD after onset of AF. At the end of the 
follow-up period of 11±10 years, 38% of the study population had died at a mean age 
of 56±12 years which was 8±8 years after the first AF onset. The majority of the patients 
died due to heart failure. Death occurred in 21% of patients with prior shunts compared 
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to 17% of the patients who were initially treated with ToF correction (p=1.00). On the 
last available ECG, 40% of the surviving study population had AF. Progression of AF was 
observed in 42% of the patients after 5±5 years. There was no difference in AAD usage 
between patients who showed progression of AF and those who did not.
In chapter 7 we investigated the immediate and long-term outcome of arrhythmia 
surgery in CHD patients and the progression of recurrent AF after arrhythmia surgery.
The study population consisted of patients with a variety of CHD. Approximately one-
third underwent corrective or palliative surgery prior to arrhythmia surgery. AF onset 
occurred at a mean age of 48±14 years and was paroxysmal (24%), persistent (62%) or 
long-standing persistent (14%). Progression from paroxysmal AF to persistent AF was 
observed in 43% of the patients after 4±2 years. Concomitant arrhythmia surgery was 
performed 4±6 years after the initial AF onset. Most patients underwent left atrial (LA) 
arrhythmia surgery; bi-atrial (BiA) surgery was performed in 38% of the study popula-
tion. Early post-operative AF (initial 30 days after arrhythmia surgery) was observed 
in 48% of the patients 6±9 days after surgery; 24% of the patients had also late post-
operative starting 152±140 days after arrhythmia surgery. Solely late post-operative AF 
occurred in 18% of the study population after 172±131 days. Noteworthy is that 86% of 
the patients with both early and late post-operative AF developed early post-operative 
AF within one day. AF recurrences were observed in 72% of the patients who underwent 
BiA arrhythmia surgery, compared to 59% in those who underwent only LA arrhythmia 
surgery. The incidence of AF recurrence was similar among those who underwent ar-
rhythmia surgery during first corrective or palliative surgery (63%) and patients who 
had undergone surgical procedures before the procedure with concomitant arrhythmia 
surgery (70%). A total of 66% of the study population showed recurrences of AF 3±4 
years after arrhythmia surgery; patients presented with paroxysmal AF (32%), persistent 
AF (63%) and permanent AF (5%). Two patients died during the follow-up period; cause 
of death was either a malignancy or unknown. Recurrences of AF occurred in respec-
tively 43%, 59% and 100% of the patients who presented with respectively paroxysmal, 
persistent and long-standing persistent AF prior to arrhythmia surgery. Progression to 
permanent AF occurred in 25% of the patients who had persistent AF after 3±2 years. 
In conclusion, AF frequently recurred in CHD patients who underwent concomitant 
arrhythmia surgery after a relatively short period. Progression from persistent tot per-
manent AF occurred in a considerable number of patients at a relatively young age.
The clinical value of NSVT in patients with CHD was discussed in chapter 8. We exam-
ined 1) the time course of VTA including non-sustained VT (NSVT), sustained VT (susVT) 
and VF and 2) the occurrence of susVT or VF after earlier NSVT in a large cohort of patients 
with a variety of CHD. CHD patients with VTA on ECG, 24-hour Holter or ICD-printout or 
out-of-hospital-cardiac arrest due to VF were included in this study. Corrective or pal-
liative surgery prior to onset of VTA was performed in 92% of the study population at a 
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mean age of 12±16 years. Most patients initially presented with NSVT (71%), compared 
to 17% and 11% with resp. susVT or VF at a mean age of 40±14 years; age of development 
of NSVT, susVT or VF were comparable. In addition, the time window of approximately 
30 years between corrective or palliative surgery and development of VTA was similar 
among patients with initial presentation of NVST, susVT or VF. Prior to VTA, 40% present-
ed with intraventricular conduction delay, 10% with impaired ventricular function and 
2% with coronary artery disease. susVT/VF rarely occurred in patients with NSVT (3%). 
An ICD was implanted in 36% of the included patients; appropriate and inappropriate 
shocks, mainly due to supraventricular tachycardia (SVT), occurred in respectively 29% 
and 23% of the study population. In contrast to susVT/VF, which rarely developed during 
the 5-year follow-up period in patients with only NVST, recurrent episodes of susVT/VF 
frequently developed in patients initially presenting with susVT/VF. Death occurred in 
11% of the study population after 5 years of follow-up; 69% was not arrhythmia related. 
Hence, a wait-and-see treatment strategy in patients with NSVT and aggressive therapy 
of both episodes of VTA and SVT in patients with susVT/VF seems justified.
Fragmented QRS complexes (fQRS) on 12-lead ECG are known predictors of VTA in 
patients with coronary artery disease. There is limited knowledge of the clinical implica-
tions of fQRS in patients with CHD. Therefore, in chapter 9, we examined the occurrence 
of fragmented QRS complexes (fQRS) in patients with various types of CHD and whether 
fQRS is associated with development of VTA. CHD patients with documented VTA on 
a surface ECG or 24-hour Holter registration were included in this study. All included 
patients were matched with control patients of the same age, gender and CHD type. Pa-
tients developed VTA at a mean age of 39±14 years. QRS duration was longer in patients 
with VTA compared to the control patients (110 ms vs. 100 ms; p<0.01). Bundle branch 
blocks were seen more frequently in VTA patients versus controls (resp. 46% and 32%; 
p=0.010). Furthermore, fQRS was more frequently observed in VTA patients in the last 
ECG prior to VTA (53% vs. 31%; p<0.001); this was more common in patients with susVT 
(64%). However, presence of fQRS was not related to the presence of conduction abnor-
malities in both VTA patients or controls. In addition, there was no difference in pres-
ence of fQRS between patients with atrial and ventricular CHD (resp. 39% versus 39%; 
p=0.93). Multiple conditional logistic regression demonstrated more fQRS, non-systemic 
ventricular dysfunction and prolonged QRS complexes in VTA patients. Therefore, the 
presence of fQRS on ECG may be a useful tool in daily clinical practice to identify patients 
at risk of developing VTA in patients with CHD, in addition to the known predictors of 
VTA such as prolonged QRS duration, ventricular dysfunction and a history of AT.
In chapter 10, we examined the unipolar voltage distribution of the entire epicardial 
surface of the RA, Bachmann’s Bundle (BB) and LA during SR at a high-resolution scale 
in twelve patients with CHD and RA overload prior to corrective surgery. Paroxysmal AF 
prior to surgery was documented in 25% of the study population. Electrograms were 
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recorded from 417 quadrants containing 22,965 atrial recording sites (1,914±329 sites/
patient). From each recording site, 6.8±0.8 beats with a cycle length of 770±121 ms 
were analysed with a total duration of five seconds. Low voltage areas were not only 
observed in the RA region, but also along the BB, pulmonary vein area (PVA) and left 
atrioventricular groove (LVAG). Both inter-individual variations in the median atrial volt-
ages ranging from 1.4 to 3.5 (median: 2.5 mV) and intra-individual variations ranging 
from 3.1 to 9.5 (median 5.8 mV) were measured. Voltages were quantified by 1  cm² 
to study regional differences; voltages in the study population ranged from 0.3 to 9.8 
mV/cm² (median 2.6 mV). No significant differences at a regional level were identified 
between the RA, BB, LVAG and PVA. Voltages ≤0.5 mV/cm² (11%) were identified at the 
superior RA (2%) and BB (6,3%), but also at the LVAG (3,4%) and PVA (1,2%). In conclu-
sion, unipolar voltage mapping at a high-resolution scale in patients with CHD and RA 
overload, demonstrated dissimilarities in voltages between both the various atrial sites 
and the individual patients. No predeliction sites for occurrence of low voltages were 
identified. Both considerable intra- and inter-individual variation in voltages were found 
in our study population, which emphasizes the necessity of an individualized, patient 
tailored diagnosis and therapy of atrial tachyarrhythmia.
We subsequently conducted a study, as described in chapter 11, in which the hypoth-
esis was tested that heterogeneity in conduction in CHD patients with RA overload is 
mainly RA-related and that long lines of conduction block are associated with AF. High-
resolution epicardial mapping of the RA, BB, LVAG and PVA during SR was performed in 
thirteen CHD patients with RA overload. Either pre- or post-operative AF was observed 
in five patients. We recorded unipolar signals from 25,197 sites (1,9138±327/patient). 
At each recording site 7.3±0.9 beats with a cycle length of 766±116 ms were analysed. 
Both conduction delay (CD) and block (CB) were quantified per 1 cm² quadrants, which 
resulted in median values of respectively 1,6;1,3 (0.9-2.9)% and 1,5;1.3 (0.3-3.5%). Quad-
rants at the BB and RA had most frequently CD (38% versus 50%) and CB (38% versus 
25%). In addition, CB lines were longest (≥16 mm) in the five patients with AF (p=0.036) 
and were mainly identified in the BB and RA region. In conclusion, mapping at a high-
resolution scale in CHD patients with RA overload demonstrated that CB and CD lines 
were predominantly identified in the BB and RA and that long lines of CB were mainly 
observed in patients with AF. We therefore propose that the length of CB, more than the 
presence of CB, might play a key role in the development of AF.
In chapter 12, we presented a patient with a surgically corrected congenital left 
ventricular aneurysm (LVA) in the basal posterior wall referred for ablative therapy of 
susVT. Surgical resection was performed ten years ago, but LVA recurrence occurred only 
one year after the surgical procedure. During a visit at our outpatient clinic for a routine 
check-up, the patient lost consciousness due to susVT. Endocardial mapping during 
a subsequent electrophysiology study revealed extensive conduction abnormalities 
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within the endocardial surface of the aneurysm. The susVT terminated during creation 
of the first ablation lesion and was non-inducible after encircling the site of the susVT 
origin. During one year follow-up after the ablation procedure, there were no recur-
rences of the susVT.
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Het doel van dit proefschrift was om meer inzicht te krijgen in de pathofysiologie van 
zowel vroege- als laat postoperatieve aritmieën in patiënten met een congenitaal hart-
defect (CHD). De opzet van dit proefschrift is beschreven in hoofdstuk 1. In hoofdstuk 2 
geven wij een overzicht van de epidemiologie, pathofysiologie en uitkomst van verschil-
lende therapeutische modaliteiten voor atriumfibrilleren (AF) in patiënten met een CHD. 
CHD’s zijn verantwoordelijk voor bijna 30% van alle belangrijke aangeboren afwijkingen. 
Dankzij verbeterde zorg en chirurgische technieken overleeft heden ten dage meer dan 
90% van de kinderen met een CHD tot ver in de volwassenheid. Wat echter samengaat 
met het steeds ouder worden van deze populatie, is dat er nieuwe complicaties zoals 
aritmieën meer naar de voorgrond treden. AF wordt beschouwd als een van de meest 
voorkomende aritmieën bij patiënten met een CHD. Behalve het type van het CHD lijkt 
ook de leeftijd een belangrijke rol te spelen in de ontwikkeling van AF. Het is voorgesteld 
dat het langdurig bestaan van een atriale reentry tachycardie (ART) het mogelijk remo-
delleren van het atrium zou bewerkstelligen, hetgeen als consequentie zou hebben dat 
daardoor de ontwikkeling van AF wordt gefaciliteerd. Tijdige behandeling van de ART 
zou daarom mogelijk de ontwikkeling van AF kunnen voorkomen.
Het ontstaan van intra-operatieve en vroeg postoperatieve tachycardieën in CHD 
patiënten werd besproken in de hoofdstukken 3 en 4. Het voorkomen van zowel su-
praventriculaire extra systolen (SVES) als ventriculaire extrasystolen (VES) wordt geas-
socieerd met het ontstaan van tachycardieën in patiënten zonder CHD. Het doel van 
de studie in hoofdstuk 3 was om de incidentie van (S)VES in volwassen CHD-patiënten 
te onderzoeken en mogelijk het voorkomen van (S)VES te correleren aan het ontstaan 
van tachycardieën. Gedurende vijf dagen werd continue ritmebewaking toegepast bij 
volwassen patiënten met verschillende CHD. Iets meer dan 50% van de geïncludeerde 
patiënten onderging een eerste chirurgische procedure. SVES werden gedurende de 
ritmebewaking bij alle patiënten gedocumenteerd en ongeveer 26% had tenminste 1 
uur waarin ≥30 SVES voorkwamen. AF en regulaire atriale tachycardieën (AT) werden 
bij ongeveer 6% van de patiënten gedocumenteerd; bij deze patiënten werd ook meer 
atriale ectopie vastgelegd. VES kwamen bij alle patiënten voor; een incidentie van ≥30 
VES gedurende tenminste 1 uur werd bij 28% van de patiënten geobserveerd. Geen 
enkele patiënt ontwikkelde echter ventriculaire tachyaritmieën (VTA), zoals een ven-
triculaire tachycardie (VT) of ventrikelfibrilleren (VF). Er werd een positieve correlatie 
gezien tussen de incidentie van SVES en een leeftijd van ≥40 jaar. Daarnaast werd er ook 
geen verschil geobserveerd tussen rechtszijdige afwijkingen, linkszijdige afwijkingen of 
afwijkingen beiderzijds. Geen van de klinische determinanten, inclusief leeftijd, was ge-
associeerd met frequente VES. Slechts 2% van de studiepopulatie ontwikkelde regulaire 
AT of AF gedurende de follow-up van 12 maanden. Bij geen van de patiënten, bij wie ge-
durende de vijf dagen durende ritmebewaking AF werd gedocumenteerd zien, werden 
recidieven zien. Zowel atriale als ventriculaire ectopie werd relatief frequent gedurende 
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de vroeg postoperatieve periode van vijf dagen gezien. Atriale ectopie werd frequenter 
gedocumenteerd in patiënten die regulaire AT of AF ontwikkelden, maar ventriculaire 
ectopie was geen voorspeller voor levensbedreigende VTA in volwassen CHD patiënten 
gedurende de vroeg postoperatieve periode.
In hoofdstuk 4 werd de incidentie van intra-operatieve aritmieën in kinderen gedu-
rende chirurgie voor een CHD onderzocht. Er werden klinische variabelen die mogelijk 
gerelateerd zijn aan het ontstaan van intra-operatieve aritmieën geïdentificeerd. 
Tenslotte werd onderzocht of er sprake is van een verband tussen intra-operatieve 
aritmieën en het ontstaan van persisterende aritmieën gedurende langdurige follow-
up. Op het elektrocardiogram (ECG) voorafgaand aan correctieve of palliatieve chirurgie 
werd bij 98% van de patiënten sinusritme (SR) gedocumenteerd. Vijfentachtig procent 
van de studiepopulatie had een of meerdere aritmieën; episodes van aritmieën werden 
geïdentificeerd als een tweedegraads atrioventriculair (AV) blok, derdegraads AV-blok, 
ectopisch atriaal ritme (EAR) en junctioneel ritme (JR). Alle patiënten die chirurgie 
ondergingen met behulp van een “aortic cross clamp” (ACC) en een cardiopulmonale 
bypass (CBG) of alleen CBG ontwikkelden aritmieën vergeleken met 9% van degenen 
die zonder het gebruik van CBG werden geopereerd (p<0.01). In een subanalyse bij 
patiënten die geopereerd werden met behulp van ACC en CBG, werden de meeste 
aritmieën geobserveerd gedurende CBG (30-60%), maar een significante daling werd 
gezien na CBG (0-18%, p<0.01) en na het sluiten van het sternum (0-5%, p<0.01). Het 
aantal geregistreerde SVPB en supraventriculaire coupletten was significant groter tus-
sen het eind van de CBG en sluiten van het sternum vergeleken met gedurende CBG 
(respectievelijk p<0.01 en p=0.03). Een relatief groot aantal van de patiënten ontwik-
kelde VPB, ventriculaire coupletten en ventriculaire runs in de intraoperatieve periode 
voor sluiting van het sternum (0-6%, p<0.01). Alle episoden van non-sustained VT of VF 
vonden plaats gedurende CPB. Van de patiënten met een intraoperatieve aritmie had 
69% op de intensive care nog steeds een aritmie vergeleken met 15% van de patiënten 
zonder intraoperatieve aritmieën bij wie 20% een aritmie ontwikkelde op de intensive 
care (p<0.01). Gedurende een mediane follow-up duur van 37 maanden was er sprake 
van SR in 87% van de patiënten. Dit was significant lager (p<0.01) vergeleken met het 
percentage van de studiepopulatie met SR voorafgaand aan chirurgie. Nieuw ontstane, 
laat postoperatieve aritmieën ontwikkelden zich in 17 patiënten (13%), wat bestond 
uit ectopische atriale ritmes (N=7), junctionele ritmes (N=2), sinus bradycardie (N=2), 
paroxysmale AT (N=2), SR met een SVPB bigeminie (N=2) of VPB bigeminie (N=1) en 
sick sinus syndroom (N=1). Zeven patiënten kwamen gedurende de follow-upperiode 
te overlijden met circulatoir falen (86%) als meest voorkomende doodsoorzaak. Con-
cluderend werden intra-operatieve aritmieën, voornamelijk bestaand uit tweedegraads 
AVB, SVES en VES, frequent geobserveerd in kinderen met een CHD, die chirurgie on-
dergingen met behulp van CPB. De meeste aritmieën waren voorbijgaand van aard en 
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niet gerelateerd aan het ontstaan van postoperatieve aritmieën gedurende de follow-
upperiode.
De ontwikkeling van laat postoperatieve tachyaritmieën werd besproken in hoofd-
stukken 5, 6, 7, 8 en 9. Het doel van de multicenterstudie in hoofdstuk 5 was om de 
leeftijd van het ontstaan van AF, de initiële therapie van AF, co-existentie van een re-
gulaire AT en de progressie van paroxysmaal naar persistent/permanent AF gedurende 
een langdurige follow-up in een groot cohort met patiënten met verscheidene CHD te 
bestuderen. Alleen patiënten met een gedocumenteerde AF episode werden geïnclu-
deerd in de studie. Correctieve of palliatieve chirurgie werd uitgevoerd bij ongeveer 
75% van de studiepopulatie op een gemiddelde leeftijd van 12 (3-37) jaar. AF ontstond 
op een gemiddelde leeftijd van 49±17 jaar. Echter, patiënten met een complex CHD 
ontwikkelden AF vooral voor het veertigste levensjaar. Co-existentie van een regulaire 
AT en AF werd bij 33% van de studiepopulatie gedocumenteerd; 65% presenteerde zich 
eerst ongeveer 3 (0-7) jaar eerder met een regulaire AT en daarna met AF. Bovendien 
leken patiënten die AF ontwikkelden na een episode van een regulaire AT, het AF op een 
jongere leeftijd te ontwikkelen, vergeleken met patiënten bij wie alleen AF werd gedocu-
menteerd. Bij de eerste presentatie van het AF werd bij 37% een cardioversie uitgevoerd 
en startte 40% met anti-aritmica. Ablatie van de pulmonaal venen werd bij 7% van de 
patiënten uitgevoerd met een initieel succespercentage van 100%; bij één patiënt werd 
een additionele ablatie van de pulmonaal venen uitgevoerd. Na een follow-upperiode 
van 5 (0-24) jaar, werd op het ECG bij 41% van de patiënten AF gedocumenteerd. In een 
subanalyse werd bij 26% na slechts 3 (0-18) jaar een progressie van paroxysmaal AF naar 
persistent/permanent AF geobserveerd. Cerebrovasculaire accidenten vonden plaats bij 
13% van de studiepopulatie, hoewel een substantieel deel dit doormaakte voorafgaande 
aan de eerst gedocumenteerde AF-episode. Aan het eind van de follow-upperiode was 
11% van de patiënten overleden op een gemiddelde leeftijd van 61±18 jaar. De leef-
tijd waarop CHD-patiënten AF ontwikkelden is relatief laag vergeleken met patiënten 
zonder CHD. Co-existentie van zowel episodes van AF als regulaire AT kwam voor bij 
een substantieel deel van de studiepopulatie; de meeste patiënten presenteerden zich 
eerst met een regulaire AT. De snelle en frequente progressie van paroxysmaal AF naar 
persistent/permanent AF staat een stringente follow-up en agressieve therapeutische 
aanpak toe van zowel regulaire AT als AF. Vroege ablatie van een regulaire AT zou in 
theorie het ontstaan van AF kunnen voorkomen en daaropvolgend het risico verlagen 
van complicaties, zoals een CVA.
De ontwikkeling van laat postoperatief AF na correctie en de progressie van AF in 
patiënten met een tetralogie van Fallot (ToF) gedurende langetermijnfollow-up werd 
onderzocht in hoofdstuk 6. Shunts voorafgaand aan de totale correctie werden gecre-
eerd in 50% van de geïncludeerde patiënten op een gemiddelde van leeftijd van 8±6 
jaar. Totale ToF correctie werd op een gemiddelde leeftijd van 21±14 jaar uitgevoerd. 
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Voorafgaand aan de ontwikkeling van AF had 58% van de studiepopulatie dilatatie van 
het rechter atrium (RA) en was de ejectie fractie van het rechter ventrikel mild (33%), 
matig (25%) of ernstig (25%) aangedaan. AF werd voor het eerst gedocumenteerd op 
de leeftijd van 45±13 jaar en 26±13 na totale ToF correctie. Het nieuw ontstane AF werd 
geclassificeerd als paroxysmaal (34%), persistent (58%) of permanent (8%). Patiënten 
bij wie eerst een shunt werd gecreëerd voorafgaand aan de totale ToF correctie ontwik-
kelden AF op dezelfde leeftijd als bij wie initieel een totale ToF correctie werd uitgevoerd 
op respectievelijk een gemiddelde leeftijd van 44±14 en 45±14 jaar (p=0.83). De periode 
tussen de totale ToF correctie en het nieuw ontstane AF leek een trend te laten zien 
richting langer durend na een initiële totale ToF correctie (30±10 jaar versus 21±15 jaar, 
p=0.09). Totale ToF correctie werd gemiddeld 42±9 jaar geleden uitgevoerd en was 
vergelijkbaar voor beide groepen (40±10 jaar versus 44±8 jaar, p=0.32). De gemiddelde 
leeftijd waarop het AF ontstond na totale ToF correctie verschilde niet significant tussen 
de verschillende decennia waarin dit werd uitgevoerd (jaren ‘50: 72 jaar, jaren ‘60: 48±14 
jaar, jaren ‘70: 40±10 jaar, jaren ‘80: 43±12 jaar, jaren ‘90: 39±13 jaar, p=0.19).
Co-existentie van regulaire AT en VTA kwam voor in respectievelijk 54% en 42% van de 
studiepopulatie. Het grootste deel van de patiënten met paroxysmaal AF werd behan-
deld met anti-aritmica na het ontstaan van het AF. Aan het eind van de follow-upperiode 
van 11±10 jaar was 38% van de studiepopulatie overleden op een gemiddelde leeftijd 
van 56±12 jaar wat 8±8 jaar na het ontstaan van het AF was. Het grootste deel van de 
patiënten kwam te overlijden ten gevolge van hartfalen. Overlijden werd gedocumen-
teerd bij 21% van de patiënten bij wie eerst een shunt was gecreëerd voorafgaand aan 
totale ToF correctie vergeleken met 17% van de patiënten die initieel een totale ToF cor-
rectie ondergingen (p=1.00) Op het laatst beschikbare ECG had 40% van de patiënten 
AF. Progressie van AF werd in 42% van de patiënten gezien na 5±5 jaar. Er was geen 
verschil in gebruik van anti-aritmica tussen patiënten die progressie van AF lieten zien 
en patiënten die dat niet hadden.
In hoofdstuk 7 werden de korte- en lange termijn uitkomsten van ritmechirurgie on-
derzocht in CHD patiënten en de progressie van opnieuw ontstaan AF na ritmechirurgie. 
De studiepopulatie bestond uit patiënten met verscheidene CHD en ongeveer een derde 
had correctieve of palliatieve chirurgie ondergaan voorafgaand aan de ritmechirurgie. 
AF ontstond op een gemiddelde leeftijd van 48±14 jaar en was paroxysmaal (24%), 
persistent (62%) of long-standing persistent (14%). Progressie van paroxysmaal AF naar 
persistent AF werd geobserveerd in 43% van de patiënten na 4±3 jaar. Gelijktijdige 
ritmechirurgie werd 4±6 jaar na het ontstaan van AF uitgevoerd. De meeste patiënten 
ondergingen ritmechirurgie in het linker atrium (LA); bi-atriale (BiA) ritmechirurgie werd 
uitgevoerd in 38% van de studiepopulatie. Vroeg postoperatief AF (binnen 30 dagen 
na ritmechirurgie) werd na 6±9 dagen gezien in 48% van de patiënten; 24% van deze 
patiënten had ook laat postoperatief AF, wat 152±140 dagen na ritmechirurgie optrad. 
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Alleen laat postoperatief AF kwam voor in 18% van de studiepopulatie na 172±131 
dagen. Belangrijk om te vermelden is dat 86% van de patiënten die zowel vroeg- als laat 
postoperatief AF lieten zien, het vroeg postoperatief AF binnen een dag na ritmechi-
rurgie ontwikkelden. Recidief AF werd in 72% van de patiënten met BiA ritmechirurgie 
gezien vergeleken met 59% in patiënten die alleen in het LA werden behandeld. De 
incidentie van AF recidieven was vergelijkbaar tussen patiënten die ritmechirurgie on-
dergingen ten tijde van de eerste correctieve of palliatieve chirurgie (63%) en anderen 
die eerder waren geopereerd voor de procedure met daarbij ritmechirurgie. In totaal 
liet 66% van de studiepopulatie recidief AF zien 3±4 jaar na ritmechirurgie; patiënten 
presenteerden zich met paroxysmaal AF (32%), persistent AF (63%) en permanent AF 
(5%). Twee patiënten kwamen gedurende de follow-upperiode te overlijden; de reden 
van overlijden was bij één patiënt een maligniteit en bij de andere een onbekende 
oorzaak. Recidief AF kwam voor in respectievelijk 43%, 59% en 100% van de patiënten 
die zich presenteerden met paroxysmaal, persistent en long-standing persistent AF 
voorafgaand aan ritmechirurgie. Progressie naar permanent AF kwam voor in 25% van 
de patiënten met persistent AF en na 3±2 jaar. Concluderend is er frequent en na een 
relatief korte periode sprake van recidief AF in CHD-patiënten die gelijktijdige ritme-
chirurgie ondergingen. Progressie van persistent naar permanent AF kwam voor in een 
behoorlijk aantal patiënten en op een relatief jonge leeftijd.
De klinische waarde van NSVT in CHD-patiënten werd besproken in hoofdstuk 8. 
In deze studie was het doel om de ontwikkeling van VTA te bestuderen met daarin 
NSVT, sustained VT (susVT) en VF en werd daarnaast onderzocht of susVT of VF (veel) 
voorkwamen na een eerdere NSVT in een groot cohort met patiënten met verschil-
lende CHD. CHD-patiënten met een gedocumenteerde VTA episode op een ECG, 24-uur 
Holter opnam en een ICD verslag of een out-of-hospital-cardiac arrest op basis van VF 
werden geïncludeerd in deze studie. Correctie of palliatieve chirurgie voorafgaand aan 
een VTA-episode werd uitgevoerd bij 92% van de studiepopulatie op een gemiddelde 
leeftijd van 12±16 jaar. De meeste patiënten presenteerden zich initieel met NSVT (71%) 
vergeleken met susVT (17%) en VF (11%) op een gemiddelde leeftijd van 40±14 jaar; de 
leeftijd van eerste presentatie was vergelijkbaar tussen NSVT, susVT en VF. Bovendien 
was het tijdsinterval van ongeveer 30 jaar tussen correctieve of palliatieve chirurgie en 
de eerst gedocumenteerde VTA-episode vergelijkbaar tussen patiënten die zich met 
NSVT, susVT or VF presenteerden. Voor de eerste documentatie van VTA, liet 40% van 
de patiënten intra-ventriculaire geleidingsstoornissen op het ECG zien, had 10% een 
verminderde ventriculaire functie en was bij 2% coronaire hartziekte gediagnosticeerd. 
susVT of VF ontstonden zelden (3%) bij patiënten met NSVT. Een ICD werd bij 36% van 
de geïncludeerde patiënten geïmplanteerd; terechte en onterechte shocktherapie, 
voornamelijk door supraventriculaire tachycardieën (SVT), vond plaats bij respectievelijk 
29% en 23% van de studiepopulatie. In tegenstelling tot susVT of VF welke zelden voor-
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kwamen gedurende de follow-upperiode van vijf jaar bij patiënten met NSVT, vonden er 
herhaalde episodes van susVT of VF plaats bij patiënten die zich initieel presenteerden 
met susVT of VT. Na ongeveer vijf jaar follow-up was 11% van de studiepopulatie overle-
den; in 69% van de gevallen was het niet gerelateerd aan een aritmie. Daarom lijkt een 
afwachtende houding betreffende patiënten met NSVT en juist agressieve therapie van 
zowel VTA als SVT bij patiënten met susVT of VT gerechtvaardigd.
Gefragmenteerde QRS-complexen op een standaard ECG zijn bekende voorspellers 
van VTA in patiënten met coronaire hartziekten. Er is echter beperkte kennis betreffende 
de klinische consequenties van gefragmenteerde QRS-complexen in CHD-patiënten. In 
hoofdstuk 9 werd daarom het voorkomen van gefragmenteerde QRS-complexen bij 
patiënten met verscheidene CHD onderzocht en bestudeerd of er mogelijk een associ-
atie is tussen het voorkomen van gefragmenteerde QRS-complexen en het ontwikkelen 
van VTA in CHD-patiënten. Patiënten met gedocumenteerde VTA op een ECG of op een 
24-uur Holter opname werden geïncludeerd in de studie. Alle geïncludeerde patiënten 
werden gematched met controlepatiënten van dezelfde leeftijd, hetzelfde geslacht en 
type CHD. Patiënten ontwikkelden VTA op een gemiddelde leeftijd van 39±14 jaar. De 
QRS duur was langer bij patiënten met VTA vergeleken met de controlegroep (110 ms 
versus 100 ms; p<0.01). Bundeltakblokken werden bij patiënten met VTA frequenter 
gedocumenteerd ten opzichte van de controlepatiënten (46% versus 32%; p=0.010). 
Bovendien werden gefragmenteerde QRS-complexen frequenter vastgelegd op het 
laatste ECG voor het ontstaan van VTA bij deze patiënten (53% versus 31%; p<0.001); dit 
kwam veel voor bij patiënten met susVT (64%). Voorkomen van gefragmenteerde QRS-
complexen was echter niet gerelateerd aan geleidingsstoornissen in zowel de patiënten 
met VTA als de patiënten in de controlegroep. Bovendien was er geen verschil in het 
voorkomen van gefragmenteerde QRS-complexen bij patiënten met ofwel een atriaal 
CHD dan wel een ventriculair CHD (39% versus 39%; p=0.93). Multipele conditionele 
logistische regressie liet zien dat gefragmenteerde QRS complexen, niet-systemische 
ventriculaire dysfunctie en verlengde QRS duur, meer voorkwamen bij VTA patiënten. 
Daarom lijkt de aanwezigheid van gefragmenteerde QRS-complexen op het ECG 
mogelijk een indicator om CHD patiënten met een risico op het ontwikkelen VTA te 
identificeren in combinatie met een verlengde QRS duur, ventriculaire dysfunctie en AT 
in de voorgeschiedenis.
In hoofdstuk 10 werd de unipolaire voltage distributie van het gehele epicardiale 
oppervlak van het RA, Bachmann’s bundel (BB) en het LA gedurende SR op een hoge 
resolutie vastgelegd in twaalf CHD-patiënten met RA-overbelasting voorafgaand aan 
correctieve chirurgie. Paroxysmaal AF voorafgaand aan de correctieve chirurgie werd 
gedocumenteerd in 25% van de studiepopulatie. Elektrogrammen werden opgenomen 
in 417 kwadranten, die 22,965 atriale opname punten bevatten (1,914±329 punten/
patiënt). Vanaf elke plek van opname, werden 6.8±0.8 slagen met een cycluslengte van 
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770±121 ms geanalyseerd met een totale duur van 5 seconden. Gebieden met lage 
voltages werden niet alleen gezien in het RA-gebied, maar ook bij de BB, het gebied 
rondom de pulmonaal venen en bij de linker atrioventriculaire groeve. Zowel interin-
dividuele variaties in de mediane atriale voltages van 1.4 tot 3.5 (mediaan 2.5 mV) en 
de intra-individuele variaties in het mediane atriale voltage van 3.1 tot 9.5 (mediaan 5.8 
mV) werden gemeten. Voltages werden gekwantificeerd per 1 cm² om verschillen per 
atriale gebieden te bestuderen; voltages in de studiepopulatie varieerden tussen 0.3 
en 9.8 mV/cm² (mediaan 2.6 mV). Er waren geen significante verschillen tussen het RA, 
BB, het gebied rondom de pulmonaal venen en bij de linker atrioventriculaire groeve. 
Voltages ≤0.5 mV/cm² (11%) werden geïdentificeerd in het superieure deel van het RA 
(2%) en BB (6,3%), maar ook in de linker atrioventriculaire groeve (3,4%) en het gebied 
rondom de pulmonaal venen (1,2%). Unipolaire voltage mapping op een hoge resolutie 
in patiënten met CHD en RA-overbelasting liet verschillen zien in voltages tussen de 
verschillende atriale gebieden, maar ook tussen de individuele patiënten. Er werd geen 
voorkeurslocatie voor het ontstaan van lage voltages geïdentificeerd. In de studiepopu-
latie werden zowel aanzienlijke intra- als interindividuele variaties in voltages gezien, 
wat de noodzakelijkheid aanstipt van een op het individu toegespitste diagnose en 
therapie van atriale tachycardieën.
In een vervolgstudie, beschreven in hoofdstuk 11, toetsten wij de hypothese dat de 
heterogeniteit in de geleiding in CHD-patiënten met RA-overbelasting voornamelijk ge-
relateerd is aan het RA en dat lange lijnen van geleidingsblok geassocieerd zijn met AF. 
Hoge-resolutie epicardiale mapping werd uitgevoerd in het RA, de BB, linker atrioventri-
culaire groef en het gebied rondom de pulmonaal venen gedurende SR in dertien CHD-
patiënten met RA-overbelasting. Pre- of postoperatief AF was gedocumenteerd in vijf 
patiënten. Er werden unipolaire signalen opgenomen op 25,197 plekken (1,9138±327/ 
patiënt). Op elke plek van opname werden 7.3±0.9 slagen met een cycluslengte van 
766±116 ms geanalyseerd. Zowel de geleidingsvertraging als het geleidingsblok wer-
den gekwantificeerd in kwadranten van 1 cm², wat resulteerde in mediane waarden van 
respectievelijk 1,6;1,3 (0.9-2.9)% en 1,5;1.3 (0.3-3.5%). Kwadranten bij de BB en het RA 
hadden het meest frequent geleidingsblok (38% versus 50% en geleidingsvertraging 
(38% versus 25%). Bovendien waren de lijnen van geleidingsblok (≥16 mm) het langst 
in de vijf patiënten met AF (p=0.036) en werden deze voornamelijk geïdentificeerd in 
het BB en RA-gebied. Mapping op een hoge resolutie in CHD patiënten met RA over-
belasting liet zien dat lijnen van geleidingsblok en geleidingsvertraging voornamelijk 
werden geobserveerd in het BB en RA-gebied en dat lange lijnen van geleidingsblok 
voornamelijk werden geobserveerd in patiënten met AF. Op basis van deze gegevens, 
lijkt de lengte van geleidingsblok in plaats van überhaupt de aanwezigheid van gelei-
dingsblok een belangrijke rol te spelen in de ontwikkeling van AF.
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In hoofdstuk 12 presenteerden wij een patiënt met een chirurgisch gecorrigeerd con-
genitaal linker ventrikel aneurysma (LVA) in de basaal-posterieure wand, die nu verwezen 
was voor ablatie van een VT. Chirurgische resectie vond ongeveer tien jaar eerder plaats, 
maar na een jaar was er sprake van een recidief van het LVA. Gedurende een bezoek aan 
de polikliniek voor een reguliere controle, verloor de patiënt het bewustzijn ten gevolge 
van een susVT. Endocardiale mapping volgend op een elektrofysiologisch onderzoek 
bracht naar voren dat er uitgebreide geleidingsstoornissen waren aan de endocardiale 
zijde van het aneurysma. De VT werd getermineerd na een enkele ablatieve applicatie. 
De klinische VT was niet meer te induceren na het aanbrengen van applicaties rondom 
de oorsprong van de VT. Na ongeveer één jaar follow-up was er geen sprake geweest 
van een recidief van de VT.
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Congenital heart disease (CHD) is defi ned as a developmental malformation 
of the heart chambers, valves or great vessels. The incidence of newborns 
with CHD has increased signifi cantly over the past century, thereby making 
CHD a major public health issue. The number of adult CHD patients has also 
increased in the past decades, as nowadays over 90% of pediatric patients 
survive into adulthood due to improved clinical care and surgical techniques. 
Although survival of CHD patients has been signifi cantly prolonged, many of 
them frequently experience complications such as rhythm disorders by the 
time they reach adulthood. These postoperative dysrhythmia may cause a 
wide range of symptoms, ranging from palpitations to even sudden cardiac 
death. Many of these late postoperative tachyarrhythmia are, however, 
insuffi  ciently controlled by antiarrhythmic drugs. Atrial pacing in order 
to prevent tachyarrhythmia is o en not eff ective. However, endovascular 
catheter ablation has arisen since the 1990s and both short- and long-term 
outcomes are promising. The high incidence of tachyarrhythmia in ageing 
patients with CHD and the improved mapping techniques over the years 
went together with increased knowledge of the underlying mechanism and 
improved outcome of ablative therapy. Another challenge is to elucidate 
the mechanism of atrial fi brillation (AF) in this study population, as the 
incidence of AF continues to rise in this ageing population. The aim of this 
thesis is to gain further insight into the pathophysiology of post-operative 
dysrhythmia in patients with CHD.
